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ABSTRACT 
 
 Red meat is a factor risk for colorectal cancer, considered as probably carcinogenic to 
humans. Red meat is associated to colorectal cancer through the oxidative properties of heme 
iron released in the colon. This latter is a potent catalyst for lipid peroxidation, resulting in the 
neoformation of deleterious aldehydes present in the fecal water of heme-fed rats, including 
4-hydroxynonenal (HNE). Fecal water of heme-fed rats preferentially induced mortality in 
mouse normal colon epithelial cells than in those harboring mutation on APC (adenomatous 
polyposis coli) gene, considered as preneoplastic. This relative resistance of preneoplastic 
cells to fecal water of heme-fed rats was associated with their higher activity of Nrf2 (Nuclear 
factor (erythroid-derived 2)-like 2) compared to normal cells, as evidenced by Nrf2 
invalidation. To investigate the importance of secondary aldehydes derived from lipid 
peroxidation, depletion of carbonyl compounds in the fecal water was optimized and this 
turned out to abolish the difference of mortality between normal and preneoplastic cells. By 
using human colon epithelial cell (HCEC) lines to approach human physiology, we confirmed 
that HNE and fecal water of heme-fed rats also induced higher mortality in normal HCECs 
compared to APC-invalidated HCECs, and that higher Nrf2 activity in APC-invalidated 
HCECs was also associated with such a difference. Furthermore, autophagy, found to be up-
regulated in APC-invalidated HCECs, was suggested to exert protective effects against HNE 
and fecal water toxicity by activating Nrf2. Taken together, these findings suggest that Nrf2 
and autophagy were potentially involved in the resistance of preneoplastic cells upon 
exposure to HNE or fecal water of heme-fed rats. This different resistance could explain the 
promoting effect of red meat and heme-enriched diet on colorectal cancer, by initiating 
positive selection of preneoplastic cells over normal cells. 
 
Keywords: 
colorectal cancer, heme iron, lipid peroxidation, 4-hydroxynonenal, Nrf2, autophagy 
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RESUME 
 
 La viande rouge est un facteur de risque du cancer colorectal, considérée comme 
probablement cancérigène chez l’Homme. Le lien entre la viande rouge et le cancer colorectal 
impliquerait la lipoperoxydation induite par le fer héminique, aboutissant à la formation 
d’aldéhydes cytotoxiques présents dans les eaux fécales des rats ayant consommé de l’hème, 
dont le 4-hydroxynonénal (HNE). Ces eaux fécales ont préférentiellement induit la mort 
cellulaire dans des cellules coliques murines normales plutôt que dans des cellules coliques 
murines mutées pour le gène APC (adenomatous polyposis coli), considérées comme 
prénéoplasiques. Cette résistance des cellules prénéoplasiques est associée à une activité plus 
élevée du Nrf2 (Nuclear factor (erythroid-derived)-like 2) par rapport aux cellules normales, 
mise en evidence par l’invalidation du Nrf2. Afin de valider l’importance des aldéhydes 
néoformés derives de la lipoperoxydation, nous avons optimisé la depletion des composes 
carbonyls dans les eaux fécales qui a aboli le différentiel de mortalité entre les cellules 
normales et prénéoplasiques. En utilisant des cellules épithéliales coliques humaines (CECH) 
afin de se rapprocher de la physiologie humaine, nous avons confirmé que le HNE et les eaux 
fécales des rats ayant consommé de l’hème ont aussi induit une mortalité plus élevée dans les 
CECHs normales que dans celles invalidées pour APC ; et qu’une activité de Nrf2 plus élevée 
est aussi observée dans ces dernières. L’autophagie, dont le niveau est plus élevé dans les 
CECHs invalidées pour APC, exercerait des effets protecteurs contre la toxicité du HNE et 
des eaux fécales en activant Nrf2. Globalement, nos résultats suggèrent que le Nrf2 et 
l’autophagie seraient impliqués dans la résistance des cellules prénéoplasiques suite à une 
exposition aux eaux fécales des rats ayant consommé de l’hème. Ce différentiel de résistance 
pourrait expliquer l’effet promoteur de la viande rouge sur la cancérogenèse colorectale, en 
établissant une sélection positive des cellules prénéoplasiques au détriment des cellules 
normales.  
 
Mots-clés: 
Cancer colorectal, fer héminique, lipoperoxydation, 4-hydroxynonénal, Nrf2, autophagie 
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Chapter I 
INTRODUCTION 
 
1.1. Introduction to colorectal cancer  
1.1.1. Characteristics of colorectal cancer 
Colorectal cancer (CRC) is the third most frequently diagnosed cancer worldwide, 
which makes up about 10% of all cancer cases. It is ranked second in women after breast 
cancer while in men it is ranked third after lung and prostate cancer. In terms of global 
mortality by cancer, CRC is ranked fourth behind breast cancer, prostate cancer and lung 
cancer. In 2012, 1.4 million new global cases of CRC have been identified with 694,000 
reported deaths from the disease. The incidence of CRC is more common in affluent 
countries, where 65% of cases were found. It also tends to commonly develop in men than in 
women [1-3]. In France, 42,152 new CRCs and 17,722 deaths caused by CRC were reported 
in 2012. The survival rate of CRC patients is 79% (in 1 year), 56% (in 5 years) and 50% (in 
10 years) following first diagnostics [4]. The survival rate, however, depends on how 
advanced the cancer is, the possibility of cancer removal through surgery, and the person’s 
general health condition [5]. 
 The signs and symptoms of CRC depend on the location of the tumor in the bowel and 
whether the cancer itself has spread elsewhere in the body (metastasis). The classic warning 
signs include the presence of blood in the stool, worsening constipation, decrease in stool 
caliber, loss of appetite, loss of weight, and sometimes, vomiting. While rectal bleeding or 
anemia are high-risk features in those over the age of 50, other commonly-described 
symptoms including weight loss and changes in bowel habit are typically only concerning if 
associated with bleeding [6,7].   
 The common diagnosis of CRC consists in obtaining a sample of the colon during a 
sigmoidoscopy or colonoscopy. While sigmoidoscopy only allows the observation of anus, 
rectum, and lower part of colon, colonoscopy enables the observation of entire colon in 
addition to rectum and anus. This observation is usually accompanied by removal or isolation 
of colon tissues which are suspicious for possible tumor development, such as polyps for 
further analyses [5,8]. 
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 The treatments for CRC can be aimed at cure or palliation, depending on the person’s 
health and preferences, as well as the stage of the tumor [9]. The cancer detected at early stage 
can be removed during a colonoscopy [5]. For people with localized cancer, complete surgical 
removal attempting at achieving a cure is the most common. In case of metastasis, some parts 
of the organs in which the cancer has spread can also be removed if possible (in most cases, 
lungs and liver) [8]. Chemotherapy medications are preferred for late-stage colorectal cancer 
(stage III or IV). Chemotherapy drugs for this condition may include capecitabine, 
fluorouracil, irinotecan and oxaliplatin [10]. Palliative care may implicate non-curative 
surgical removal of some cancer tissues, bypassing part of the intestines, or stent placement. 
These procedures can be considered to improve symptoms and reduce complications such as 
bleeding from the tumor, abdominal pain, or intestinal obstruction [11]. Non-operative 
methods of palliative treatments include radiation therapy to reduce tumor size and 
medications to relieve pain [12]. 
 Several risk factors regarding CRC have been identified and established. Among the 
known risk factors, physical activity and dietary fiber appear to be convincing factors that 
decrease the colorectal cancer risk whereas red meat, processed meat, alcoholic drinks (in 
men, considered as probable increasing risk in women) and body fatness are considered as 
convincing factors that increase the colorectal cancer risk. Garlic, milk and calcium are 
categorized as factors that probably decrease the risk of colorectal cancer [1]. Some studies 
revealed that people suffering from inflammatory bowel disease (Crohn’s disease and 
ulcerative colitis) are at increased risk of CRC. The reported risks in meta-analysis studies  
were 2.5 (95% CI 1.3-4.7) and 2.4 (95% CI 2.1-2.7) for Crohn’s disease and ulcerative colitis 
respectively [13,14]. However, people with inflammatory bowel disease account for less than 
2% of annual CRCs [15]. 
1.1.2. Presentation of colon-rectum anatomy 
Colon and rectum are the last part of human digestive system connecting small intestine 
and anus in which fecal matters are formed. With the cecum, they construct the large 
intestine. Unlike the small intestine, the colon does not play a major role in absorption of 
nutrients. Its main role is extracting water and salt from solid wastes before they are excreted 
from the body. It is also the site in which flora-aided fermentation of unabsorbed material 
ensues [16]. The average length of human colon is 155 cm (range of 80-214 cm) for women 
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and 166 cm (range of 80-313 cm) for men, making up about 20% of the whole length of 
gastrointestinal tract [17]. 
Human colon consists of four sections (Figure 1): 1) ascending colon (also called 
proximal colon) on the right side of the abdomen which is connected to the small intestine by 
a section of bowel called the cecum, 2) transverse colon located in the upper part of the 
abdomen which links ascending and descending colon, 3) descending colon (also called distal 
colon) on the left side of the body, and 4) sigmoid colon (called so for its S-like shape) which 
is linked with rectum. Rectum is about 12 cm in long and acts as temporary storage site for 
feces before defecation [18]. 
 
 
 
 
 
 
 
 
 
Figure 1. Anatomy of human colon and rectum [19]. 
 
 The wall of colon and rectum is composed of four layers (Figure 2A): 1) mucosa, the 
inner layer consisting of simple columnar epithelium with invaginations called colonic crypts 
(crypts of Lieberkühn), 2) submucosa, a fibrous connective tissue layer containing fibroblasts, 
mast cells, and blood and lymphatic vessels, 3) muscularis (muscularis propria), two layers of 
smooth muscle mainly responsible for contractility, and 4) serosa (adventitia), the outermost 
layer of connective tissues [20]. 
 
19 
 
A .                 B.  
 
 
 
 
 
 
 
 
Figure 2. Structure of A) colon wall [21] and B) colon epithelium with its crypts [22]. 
 
 As mentioned above, the epithelial inner surface of the colon mucosa is punctuated by 
invaginations, the colonic crypts. These latter are shaped like microscopic thick walled test 
tubes with a central hole down the length of the tube (the crypt lumen). Several types of 
epithelial cells construct the colonic crypts and epithelial surface: 1) colonocytes (absorptive 
cells) which absorb water and electrolytes, 2) mucus-secreting goblet cells, 3) hormone-
secreting enteroendocrine cells, and 4) stem cells at the bottom of the crypts [23]. The average 
circumference of a crypt is 23 cells [24] with 1,500-4,900 cells constructing a crypt [25]. 
Stem cells produce proliferative progenitors (also known as transit amplifying cells or TA 
cells) which migrate upward along the crypt axis and differentiate into epithelial cells with 
specific functions before being shed into the colonic lumen (Figure 2B). The complete 
turnover of this process is every 4-5 days. There are 5-6 stem cells at the base of the crypts 
[24].  
The homeostasis of colonic epithelium depends on a dynamic equilibrium between 
rapid stem cells proliferation and cellular differentiation. Any disruption of this equilibrium, 
such as uncontrolled cellular growth or proliferation might lead to cancer.  
1.1.3. Types of colorectal cancer 
Two major types of CRC are discussed in this chapter: 1) hereditary forms of CRC 
and 2) sporadic CRC. 
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1.1.3.1. Hereditary forms of colorectal cancer 
While the majority cases of CRC are sporadic, a significant minority occur as a result 
of inherited genetic mutation. Two major forms of hereditary CRC are: 1) familial 
adenomatous polyposis (FAP) and 2) hereditary non-polyposis colorectal cancer (HNPCC). 
These latter account for about 5% of all CRCs [26]. 
1.1.3.1.1. Familial adenomatous polyposis  
Familial adenomatous polyposis (FAP) represents 0.5%-1.0% of all CRCs [27]. The 
clinical features of FAP include hundreds to thousands of adenomatous polyps in the colon 
and rectum that usually appear during adolescence or the third decade of life [26]. CRC is the 
inevitable consequence of FAP if the condition is left untreated. The only treatment of FAP 
consists of surgical resection of colon or rectum by colectomy. This act aims at eliminating 
the risk of subsequent CRC development in the area proven to develop FAP [28]. Attenuated 
FAP is a phenotypic variant of FAP characterized by the presence of less than 100 
adenomatous polyps [29]. 
The origin of FAP is a mutation on a tumor suppressor gene adenomatous polyposis 
coli (APC) located on the chromosome 5q. This mutation contributes to a loss of cellular 
growth control [30]. APC mutation, which occurred in 100% of FAP cases and nearly 70-80% 
of all colorectal tumors, is believed to be an early event in the colorectal tumorigenesis 
process [27,31,32]. 
1.1.3.1.2. Hereditary non-polyposis colorectal cancer 
Hereditary non-polyposis colorectal cancer (HNPCC), also known as Lynch 
syndrome, is the most common form of hereditary colorectal cancer which accounts for 2%-
4% of all CRCs [33]. It is characterized by the tendency of tumors to be present in the 
proximal colon and also in other organs (small intestine, ovary, stomach, endometrium, 
urinary tract, hepatobiliary tract). This syndrome is divided into Lynch syndrome I (familial 
colon cancer) and Lynch syndrome II (HNPCC associated with other cancers of the 
gastrointestinal or reproductive system). The increased cancer risk is due to inherited 
mutations that degrade the self-repair capability of DNA [34]. 
The identification of HNPCC kindreds has been facilitated by the Amsterdam criteria 
defined by the International Collaborative Group on HNPCC. These criteria state that: 1) 
CRC should be present in at least three relatives where one is a first-degree relative of others, 
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2) CRC should occur in at least two generations of a family, and 3) at least one CRC should 
be diagnosed before the age of 50 years [26,35].  
HNPCC is caused by mutations in one of the mismatch repair (MMR) genes, most 
commonly MLH1 (MutL homolog 1), MSH2 (MutS homolog 2), MSH6 (MutS homolog 6) 
and PMS2 (Post-meiotic segregation increase 2). The condition is inherited as an autosomal 
dominant with an 80% life-time risk of colorectal cancer [36]. The MMR system is necessary 
for maintaining genomic stability by correcting single-base mismatches and insertion-deletion 
loops that form during DNA replication. Dysfunctional MMR may lead to microsatellite 
instability (MSI), which is observed in more than 90% of colorectal tumors from HNPCC 
patients [37]. Microsatellites are repeated sequences of DNA made of repeating units of one 
to six base pairs in length, generally in non-coding regions of genome. MSI affects the 
genome only in rare case where the microsatellites are located in the coding regions of DNA, 
such as in the case of gene TGFβ (transforming growth factor beta) involved in cellular 
proliferation or BAX (BCL-2-associated X protein) involved in apoptosis machinery [38]. 
1.1.3.1.3. Other forms of hereditary polyposis syndrome 
There are other, very rare forms of inherited polyposis syndrome that are associated 
with an increased risk of CRC. These include: 1) juvenile polyposis characterized by polyps 
formation in colon and rectum which usually begins before the age of 10 years. Mutations on 
gene SMAD4 (Mothers against decapentaplegic homolog 4), PTEN (Phosphatase and tensin 
homolog) and BMPR1A (Bone morphogenetic protein receptor type IA) are responsible for 
this syndrome, 2) Peutz-Jegher’s syndrome characterized by polyps formation primarily in 
stomach and small intestine. This syndrome is related to mutations on gene STK11 
(Serine/threonine kinase 11) [26].  
1.1.3.2. Sporadic colorectal cancer 
The sporadic form represents about 90% of total CRCs, 15% and 70%-80% of which 
carry a mutation on MMR and APC gene respectively [39,40]. The development of CRC 
consists of the transition from normal colorectal epithelium to adenoma (benign tumor) to 
carcinoma (malignant tumor) which is associated with acquired sequential molecular events, 
mostly mutations [41-43]. A recent statistical study using mathematical models to compare 
the mutation rates and the rates of human CRC development revealed that only three driver 
gene mutations were required for CRC development [44]. There are two major pathways by 
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which alterations of molecular events can lead to colorectal cancer: chromosomal instability 
(CIN) and microsatellite instability (MSI) (Figure 3). These tumor progression models were 
deduced from comparison of genetic alterations observed in normal colon epithelium, 
adenomas of progressively larger size, and malignancies [45]. While the majority of CRCs are 
due to events resulting in CIN, 20%-30% of them display characteristic patterns of gene 
hypermethylation, termed CpG island methylator phenotype (CIMP), of which a portion 
display MSI (15%) [46-48].  
 
 
 
 
 
 
 
Figure 3. Adenoma-carcinoma sequence model for                                                      
chromosomal and microsatellite instability in colorectal tumorigenesis [49]. 
 
Key changes in CIN cancers include widespread alterations in chromosome number 
(aneuploidy) and frequent detectable losses at the molecular level of portions of chromosome 
5q, 18q and 17p; and mutation of the K-RAS (Kirsten rat sarcoma viral oncogene homolog) 
(Figure 3, upper panel). Among the earliest events in the colorectal tumorigenesis is the loss 
of APC gene (5q). Larger adenomas and early carcinomas acquire mutations in the small 
GTPase K-RAS, followed by loss of chromosome 18q with SMAD4 and CDC4 (cell division 
control protein 4) implicated in signal transduction and DNA replication respectively, and 
mutations in p53 (17p) in frank carcinoma [49]. 
MSI-related CRC (Figure 3, lower panel), characterized by a deficiency of the 
mismatch repair system that leads to slippage in microsatellites, only carry the molecular 
events observed in CIN-related CRC infrequently. Therefore, the development of CRC 
through MSI must involve different but analogous genetic changes to those decribed in CIN-
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related CRC. The initial of MSI-related colorectal tumorigenesis is thought to involve 
alterations in Wnt (Wingless/Integrated) signaling (discussed later, in 1.1.5.2.1), possibly 
involving axin. Mutations in B-RAF (v-Raf murine sarcoma viral oncogene homolog B), 
commonly observed in MSI-related CRC, are likely to occur in the place of K-RAS mutations 
although the latter do occur in a minority of cases. Mismatch repair (MMR) deficiency in 
sporadic CRC occurs predominantly by downregulation of MLH1 by promoter methylation. 
Mutations of MSH3 and MSH6 which lead to their inactivation are also observed. Inactivation 
of MMR genes affect mutations of genes carrying microstallites in their coding region 
through which the tumorigenesis gets advanced. Among these genes are TGFβ receptor 2 
(TGFBR2), insulin-like growth factor 2 receptor (IGF2R) and BAX [49].  
1.1.4. Heterogeneity of colorectal cancer 
In general, tumor heterogeneity describes that different tumor cells can show distinct 
phenotype profiles, including cellular morphology, gene expression, metabolism, motility, 
proliferation and metastatic potential. This phenomenon may occur both among tumor 
subtypes (inter-tumor heterogeneity) and among cells constituting a tumor (intra-tumor 
heterogeneity) [50-52]. Indeed, tumor heterogeneity has been observed in numerous cancers 
including colorectal cancer [53-55]. There are two existing models that are generally used to 
explain tumor heterogeneity: (1) cancer stem cells model and (2) clonal evolutional model. 
Both models are not mutually exclusive and it is believed that they both contribute to 
heterogeneity in varying amounts across different tumor types [52]. 
The cancer stem cell model posits that there is only a small portion of cells within a 
population of tumor cells that are tumorigenic (able to form tumors). These cells are termed 
cancer stem cells (CSCs) and are marked by their ability to self-renew, drive tumor growth 
and generate tumor cell progeny forming the tumor bulk. This model points out that the 
heterogeneity observed between tumor cells results from the variability of the stem cells from 
which they were originated. Stem cell variability is often caused by epigenetic changes or 
accumulation of mutations through carcinogenesis [51,52].  
The clonal evolution model emphasizes that tumors arise from a single mutated cell that 
accumulates additional mutations as it progresses (Figure 3) [51,56]. These mutations give 
rise to additional subpopulations and each of these subpopulations possesses the ability to 
divide and undergo further mutations. This heterogeneity later gives rise to subclones that 
possess evolutionary advantages over the others within the tumor environment and these 
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subclones may become dominant in the tumor over time [57,58]. The long-term accumulation 
of mutations may provide selective advantages to certain pressures (such as unfavored tumor 
microenvironment or exposure to drugs) during tumor progression [59]. 
 
 
 
 
 
 
 
 
 
 
Figure 4. Clonal evolution of a cancer [51].                                                                                       
N: normal cells; A and B: intracellular and intercellular/microenvironmental constraints; C: 
decimation by drugs; t: time. Different colored cells: distinctive mutant genotypes. 
 
A well-known implication of tumor heterogeneity is the treatment resistance following 
chemotherapy. Heterogenous tumors exhibit different phenotypes, including different 
sensitivity towards tumor microenvironment or cytotoxic drugs among different clonal 
populations. Tumor microenvironment is capable of altering selective pressures to which 
tumor cells are exposed. Drug administration in heterogenous tumors seldom kills all tumor 
cells. The initial heterogenous population may bottleneck in a manner that such few cells that 
are resistant to tumor microenvironment and cytotoxic drugs will survive (Figure 4). This 
mechanism, which resembles Darwin’s theory of natural selection, would allow resistant 
tumor populations to replicate and grow new tumors that would be resistant to the initial drug 
therapy used. The repopulated tumors may appear to be more aggressive and this is attributed 
to the drug-resistant selective advantages of the tumor cells [50-52,60]. The mutation-driven 
resistance of cancer cells towards tumor microenvironment and drugs may also explain the 
tumorigenesis of CRC. Interestingly, this different resistance is also observed during the early 
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stages of colorectal carcinogenesis, therefore highlighting the importance of this mechanism 
in CRC promotion. Different resistance between normal and preneoplastic colon cells towards 
lipid peroxidation-derived products has been suggested to explain the mechanisms by which 
red meat consumption may promote CRC (discussed later in Chapter 1.3.3) [61-63].  
1.1.5. Roles of adenomatous polyposis coli (APC) in colorectal cancer 
As previously mentioned, mutations in the APC gene are considered as one of the 
earliest events in the initiation and progression of CRC. This highlights the important roles of 
APC in CRC development. While APC mutation directs tumor progression, APC restoration 
has been shown to regress tumor by reestablishing crypt homeostasis in CRC [64]. Here, the 
structure and functions of APC in several cellular functions including those that are directly 
implicated in CRC development will be discussed [65]. 
1.1.5.1. Structure of APC protein 
 APC gene in human is located in the long (q) arm of chromosome between positions 21 
and 22. More precisely, the APC gene is located from base pair 112,707,505 to base pair 
112,846,239 on chromosome 5. The APC gene product is a 310 kDa protein consisting of 
2,843 amino acids (aa) localized in both the cytoplasm and the nucleus (Figure 5). It is 
expressed constitutively within normal colonic epithelium [66].  
 
 
 
 
 
 
 
Figure 5. Structural features of APC protein [66]. 
 
The structure of APC protein with different protein interaction domains is given in 
Figure 5. At the N-terminal site, the APC protein contains oligomerization and armadillo 
repeat binding domain. Armadillo repeat binding domain allows interaction between APC and 
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ASEF (APC-stimulated guanine nucleotide exchange factor) which is involved in linkage 
with cytoskeleton. At the C-terminal site, there are EB1 (end binding 1) and tumor suppressor 
protein DLG binding domains, along with a microtubule binding site. APC protein also 
contains three 15-aa and seven 20-aa repeat regions which are involved in the binding and  
regulation of β-catenin in cells. Three axin-binding sites and five nuclear export signals 
(NESs) allowing nucleus-cytoplasm shuttle have also been identified. Mutator cluster region 
(MCR) is a domain where most APC mutation occurs and creates truncated APC proteins. For 
example, 30% of FAP cases carry APC mutations causing 1061-aa and 1309-aa truncated 
APC proteins [67,68] (note that the truncation of the latter takes place in MCR). In both cases, 
the truncated  proteins contain β-catenin binding sites in the armadillo repeat binding domain 
but lose the β-catenin regulatory activity which is located in the 20-aa repeat domain. It is 
noteworthy that APC mutation is observed in 70-80% of sporadic CRCs and 100% of FAP 
[39,66]. 
1.1.5.2. Functions of APC protein 
APC protein has been shown to be involved in several molecular pathways that 
regulate the sustainability of colon epithelium. Its principal role is in the regulation of β-
catenin via Wnt signaling pathway. Apart from this role, APC is also involved in actin 
cytoskeletal integrity, cell-cell adhesion, cell migration and chromosomal stability [66]. 
1.1.5.2.1. APC regulates β-catenin levels through Wnt signaling pathway 
APC acts indispensably as a negative regulator of β-catenin via Wnt signaling pathway 
in the transformation of colonic epithelial cells and in melanoma progression [69]. Wnt genes 
encode a large family of secreted molecules that have important roles in controlling the fate 
and proliferation of epithelial cells. In humans, there are at least 19 members of Wnt family 
and 10 members of its receptor family, Frizzled [22]. The Wnt receptor complex is made up 
of Frizzled and LRP5/6 (low-density lipoprotein receptor-related protein 5/6) [70]. β-catenin 
is a transcriptional coactivator of transcription factors belonging to the TCF/LEF family (T-
cell factor/lymphoid enhancer factor) [66]. The role of Wnt signaling pathway has been 
described in Drosophila, Xenopus and in vertebrates; and has been shown to exert important 
involvement in organ development, morphology, motility, cellular proliferation and the fate of 
embryonic cells [66,71,72]. 
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Figure 6. Model for Wnt signaling pathway A) in the absence of Wnt ligand                     
and B) in the presence of Wnt ligand [73]. 
 
 
The level of β-catenin is maintained at a low level through degradation by proteasome. 
In the absence of Wnt ligand, cytosolic β-catenin, which is normally bound to membranous E-
cadherin, interacts with “destruction complex” composed of axin, APC, β-catenin, glycogen 
synthase-3β kinase (GSK3β) and casein kinase 1 or 2 (CK1 or 2) (Figure 6A). GSK3β and 
CKA1 or 2 phosphorylate β-catenin at serine and threonine residues in the N-terminal 
domain. The phosphorylated β-catenin then binds to F-box protein β-TrCP (beta transducin 
repeat containing protein) of Skp I-Cullin-F-box (SCF) complex of ubiquitin ligases, is 
ubiquitinated, and undergoes proteasomal degradation. The activity of TCF/LEF transcription 
factor in the nucleus is inhibited by its repressors and corepressors such as carboxy-terminal 
binding protein (CtBP), CREB-binding protein (CBP) and Groucho (Gro) [66]. The Wnt 
target genes are not transcribed. This whole mechanism is important in controlling cell 
growth. 
Wnt signaling pathway is basically a normal mechanism by which cells in the colon 
crypts are regulated. Stem cells in the bottom of colon crypts are very proliferative and 
produce proliferative progenitors (transit amplifying cells or TA cells) that will differentiate 
into epithelial cells such as colonocytes, enteroendocrine cells and goblet cells. In the 
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presence of Wnt ligand, Wnt signaling pathway is activated (Figure 6B). Axin is recruited to 
the Frizzled and another protein called disheveled (Dsh) is activated and uncouples β-catenin 
from the destruction complex. Consequently, the β-catenin is not degraded and activates 
TCF/LEF transcription factor to transcribe Wnt target genes that promote cellular 
proliferation. Indeed, Wnt signaling pathway is active in stem cells and TA cells to promote 
cellular proliferation. However, this pathway is gradually switched off as the cells 
differentiate and migrate to the top of the crypt (Figure 7). Hyperactivity of Wnt signaling 
pathway on the top of colonic crypt may cause uncontrolled cell growth and the formation of 
cellular masses on colon epithelium that are potential to develop cancerousness. 
 
 
 
 
 
 
 
 
 
 
Figure 7. Wnt-signaling along the colon crypt [74]. 
 
In the case of APC mutation, when APC mutation results in the expression of 
truncated APC protein that does not contain β-catenin binding site (Figure 5), the β-catenin 
destruction complex is not formed. Therefore, β-catenin escapes its degradation and 
heterodimerizes with TCF/LEF transcription factor in the nucleus, where it actively 
transcribes cell cycle-related genes promoting cellular proliferation (c-myc, cyclin D1). The 
binding of β-catenin with TCF/LEF inhibits the binding of CtBP, CBP or Gro and therefore 
potentiates its transcriptional activity [66]. Some other genes which are known to be regulated 
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by β-catenin/TCF/LEF pathway are CDH1 (cadherin 1), TCF-1 (T-cell factor 1), c-jun, FRA-1 
(Fos-related antigene 1), PPAR (peroxisome proliferatore-activated receptor delta), Gastrin, 
uPAR (urokinase plasminogen activator surface receptor), MMP7 (matrix metallopeptidase 7), 
Conductin, CD44, Id2 (inhibitor of DNA binding 2), Siamois, Xbra, Twin and Ubx 
(ultrabithorax) [75]. APC mutation, which leads to the expression of genes promoting cellular 
proliferation, may result in uncontrolled cell growth and furthermore, tumor development. 
Here, APC mutation results in a constitutive active Wnt signaling pathway, marked by 
constitutively active β-catenin activity due to the absence of the β-catenin degradation 
complex. 
1.1.5.2.2. APC is involved in actin cytoskeletal integrity, cell-cell adhesion and cell 
migration 
Actin cytoskeletal integrity is necessary to maintain the shape and adherence of 
junctions of cells. The imbalance in actin cytoskeletal integrity can cause disturbance in cell-
cell adhesion and cell migration. In colon epithelium, α-catenin, through direct binding with 
actin, maintains intracellular actin cytoskeletal network [66,76]. β-catenin establishes a link 
between APC and actin by providing a bridge to α-catenin. Along with γ-catenin that is linked 
to α-catenin, β-catenin also maintains the integrity of E-cadherin, Ca2+-dependent 
transmembrane protein forming adherent junctions to binds cells within tissues together 
(Figure 8A). Since APC is one of the building blocks of cytoskeletal integrity, its mutation is 
likely to disrupt the cytoskeletal network. Truncated APC is not able to bind β-catenin. 
Therefore, the actin and E-cadherin networks are disrupted, leading to distorted cytoskeletal 
network, loss of polarity and decreased cell-cell adhesion (Figure 8B). 
Via its armadillo-repeated domain, APC can recruit and activate ASEF and IQGAP1 
(IQ motif-containing GTPase activating protein 1) [66]. Activated ASEF leads to cascade 
activation of CDC42 (cell division cycle 42) and RAC1 (Ras-related C3 botulinum toxin 
substrate 1) which regulate actin polymerization and cell adhesion. APC-mutated cells with 
truncated APC protein have been shown to exhibit ASEF hyperactivity (which is not observed 
in normal cells with full-length APC protein) and active ASEF is linked to a decrease in E-
cadherin-mediated cell-cell adhesion [77,78]. APC and IQGAP1 form a complex with CLIP-
170 (cytoplasmic linker protein 170) that links the actin cytoskeleton and microtubule 
dynamics during cell polarization and directional migration [79]. In addition to these 
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pathways, N-terminal domain of APC contains an EB1 binding site that is also involved in 
APC-microtubules linkage [80].  
 
 
 
 
 
 
 
 
 
 
Figure 8. Model for cytoskeletal network in A) normal colonic epithelium and                     
B) APC-mutated colonic epithelium ([66] with modifications). 
 
Another important role of APC is assigned in cell migration. Colonic epithelial cells, 
derived from stem cells, divide in the lower two-third of the crypts and migrate rapidly to the 
surface to form a single-layer epithelium. APC mutation has been shown to affect cell 
migration. These cells, instead of migrating upwards towards the gut lumen, migrate 
aberrantly or less efficiently towards the crypt base where they accumulate and form polyps 
[81]. In due time, the cells acquire β-catenin stabilization and activation of genes for cell 
proliferation as well as becoming aneuploid due to defects in chromosome segregation (this 
lastly-mentioned role of APC in chromosome segregation is discussed in part 1.1.5.2.3). 
1.1.5.2.3. APC is involved in normal chromosome segregation 
Aneuploidy, the abnormal number of chromosomes both quantitatively and 
qualitatively, is proposed to be a common characteristic of CRC. It is believed that the 
aneuploidy in CRC arises during mitosis through a defective cell division [66]. Microtubules 
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possess a substantial role in mitosis by forming mitotic spindle that associates chromosomes. 
APC, which is able to bind to microtubules, may be involved in maintaining the proper 
connection of microtubules and chromosomes during cell division. 
APC performs a bridging function between microtubules and chromosomes. APC 
binds to microtubules through EB1, stretches it to the chromosomes, and inserts them to 
kinetochores after binding with BUB1 (budding uninhibited by benzimidazole homolog 1) 
[82-84]. The successful complex formation may allow proper growth of spindle formation and 
helps maintain euploidy (Figure 9A). Truncated APC protein, due to APC mutation, may lose 
its ability to bind with BUB1, and it may become unable to properly maintain the attachment 
of microtubules at kinetochores, resulting in defective chromosome segregation (Figure 9B). 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Model for A) normal chromosome segregation in normal cells with wild-type APC 
and B) disrupted chromosome segregation in cells with mutated APC [66]. 
 
1.1.6. In vivo and in vitro models for APC mutation 
Several in vivo and in vitro models for APC mutation have been established and are 
widely used in CRC-related studies. These models, expressing truncated APC protein as a 
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result of APC mutation on specific codons, represent preneoplastic phenotype of colon 
epithelium since APC mutation is considered as one of the earliest events in colorectal 
carcinogenesis. The use of models for APC mutation is interesting since it allows the studies 
on the initial phenomena during colorectal carcinogenesis that would favor tumor promotion. 
Figure 10 displays the truncation position of APC protein in available APC-mutated mice for 
in vivo studies [85].  
 
 
 
 
 
 
Figure 10. Schema of APC protein and the truncation positions of available                              
APC-mutated mice for in vivo studies [85]. 
 
The most well-known and widely used in vivo model of APC mutation is Min 
(multiple intestinal neoplasia) mouse. Min mouse is a genetic in vivo model for FAP 
colorectal carcinogenesis developed from a colony of randomly mutagenized C57BL6/J mice 
with ethylnitrosourea [86]. These mice, discovered in 1990, carry constitutive APC mutation 
resulting in 850-aa truncated APC protein [87] and heterozygous APC mutation (APCMin/+) 
since the mice carrying homozygous mutation are not viable. Min mice develop 
approximately 30 polyps in the small intestine but very rarely reach metastasis [85,88].  
Later, several knock-out mutants of APC gene were engineered, mostly directed to 
produce truncating mutations that disrupt Armadillo repeat domain of APC protein. Armadillo 
repeat binding domain has been shown to suppress intestinal tumorigenesis in mice and the 
deletion of this domain in APC protein increased polyp formation in APC-mutated mice [89]. 
Min mice, that express 850-aa truncated APC protein, possess an intact armadillo repeat 
binding domain. Indeed, APCΔ716/+ mice expressing truncated APC at codon 716 in armadillo 
repeat binding domain developed more than 300 polyps in small intestine [90], compared to 
approximately 30 polyps in Min mice with intact armadillo repeat binding domain. An 
additional mutation of CDX2 (caudal type homeobox 2) in APCΔ716/+ mice resulted in polyp 
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development in the distal colon, making it resemble human FAP and sporadic CRCs [91]. 
Other mice with a frameshift mutation at codon 580 (APCΔ14) and an additional truncation at 
codon 605 (APCΔ580) developed approximately 65 and 120 intestinal polys respectively 
[92,93]. APCΔ474/+ mice harboring a frameshift mutation at codon 474 even developed 
intestinal tumor [94]. Finally, APCneoR and APCneoF mice with neomycin inserted into intron 
13 expressed 80% and 90% less APC protein compared to normal C57Bl/6 rats [95].  
Other mice models carry APC mutations that produce longer APC protein compared to 
Min mice and therefore possess intact armadillo repeat domains. They are APC1638N/+ 
APC1638T/+ mice with truncated APC protein at codon 1638 and APC1309/+ mice with a 
frameshift mutation at codon 1309. These mice develop similar or lower polyp burden 
compared to Min mice (<10 polyps per mice for APC1638N/+ APC1638T/+ mice; and 
approximately 35 polyps per mice for APC1309/+ mice) [96,97]. This highlights the importance 
of armadillo repeat binding domain in suppressing intestinal tumorigenesis in APC-mutated 
mice. Lastly, another mouse model named APC+/Δe1-15, derived by deleting all 15 exons 
composing APC gene, exhibits a complete loss of APC protein and results in more rapid 
tumor development than other models with APC truncation [98]. These mice have reduced 
survival ability compared to Min mice and undergo severe polyposis. 
Interestingly, a mouse model of CRC whereby APC can be conditionally suppressed 
using a doxycycline-regulated shRNA (short hairpin RNA) has been developed to study the 
role of APC disruption in tumor maintenance [64]. APC suppression was shown to produce 
adenomas in the small intestine and the colon that could progress to invasive carcinoma in the 
presence of K-RAS and p53 mutation. In established tumors, APC restoration resulted in 
tumor regression which was accompanied by the re-establishment of crypt-villus homeostasis, 
such that once aberrantly proliferating cells reacquired self-renewal and differentiation ability. 
Finally, it is noteworthy that: 1) Min mice with APC mutation at codon 850 tend to 
develop polyps in the small intestine, not in the colon-rectum as observed in human FAP and 
sporadic CRCs, and 2) APC mutation in Min mice at codon 850 results in shorter truncated 
APC protein than what is observed in human FAP (codon 1061 and 1309). Nevertheless, 
among all murine models, Min mice are still the best characterized model for human FAP and 
sporadic CRCs and, despite their limitations, provide the best tools for evaluation of 
biological consequences of APC mutation. Another promising in vivo model, ApcPirc rat was 
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established in 2007. ApcPirc rats carry APC mutation at codon 1137 and develop adenomas in 
the small intestine and the colon [99]. 
Apart from in vivo model for APC mutation, in vitro models are also available to study 
the early stages of colorectal carcinogenesis. They are: 1) mouse-origin APC +/+ and APC 
Min/+ cells that were established within our team (E9 Prevention and Promotion of 
Carcinogenesis by Food, INRA ToxAlim, Toulouse, France) [100] and 2) human-origin CT 
and CTA cells with shRNA-mediated invalidation of APC [101,102]. These models are 
discussed in a more detailed way in Chapter III: Experimental Models. 
1.2. Colorectal cancer and red meat intake 
In general, most cancer is considered as a disease that is particularly influenced by 
environmental (extrinsic) factors rather than genetic (intrinsic) factors [103,104]. Here, the 
word “environmental” defined broadly to include a wide range of often ill-defined cultural, 
social, and lifestyle factors. These lifestyle factors include cigarette smoking, diet (fried 
foods, red meat), alcohol, sun exposure, environmental pollutants, infections, stress, obesity 
and physical inactivity [104]. As such, cancer is believed to be preventable, especially by 
adopting healthy lifestyle. A recent study has reported that environmental factors contributed 
to 70-90% of lifetime risk to cancer development while genetic factors only contributed to 10-
30% of lifetime risk to cancer development [105]. In 2015, a statistical study harvested 
controversy by stating that only 1/3 of most cancer cases are due to genetic and environmental 
factors, 2/3 of them are due to “bad luck”, that is, random mutations arising during DNA 
replication in normal, noncancerous stem cells [106]. Interestingly, in this study, human CRC 
in general is categorized as cancer that is more likely to be dependent on genetic and 
environmental factors rather than on “bad luck”. 
CRC is widely considered to be an environmental disease and therefore, is preventable 
[107,108]. Some of the evidence of environmental risk came from studies of migrants and 
their offsprings. Among migrants from low-risk to high-risk countries, incidence rates of CRC 
tended to increase toward those typical of the population of the host country [109,110]. For 
example, among offsprings of southern European migrants to Australia and Japanese migrants 
to Hawaii, the CRC risk increased in comparison with that of populations of the country of 
origin. These studies showed that the incidence of CRC is greatly dependent on 
environmental factors, not merely on genetic factors. Several environmental factors have been 
identified as CRC risk factors: nutritional practices, physical activity and obesity, cigarette 
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smoking and alcohol consumption [1,107]. To clarify the role of environmental factors, in 
particular nutritional practices, World Cancer Research Fund (WCRF) and American Institute 
for Cancer Research (AICR) published systematic literature reviews called Expert Report in 
1997 and 2007. Since 2008, the Continuous Update Project (CUP) developed the work of the 
first and second Expert Reports, published in 1997 and 2007 respectively [111,112]. Unlike 
Expert Reports, CUP is an ongoing review and captures new data, organ per organ, with the 
CUP report on the colon published in 2011 [1]. This report, focused on the associations 
between food, nutrition and physical activity and the risk of cancer, included 10 
recommendations on how the general public can prevent cancer: 
 Be as lean as possible within the normal range of body weight 
 Be physically active as part of everyday life 
 Limit consumption of energy-densed foods and avoid sugary drinks 
 Eat mostly foods of plant origin 
 Limit intake of red meat and avoid processed meat 
 Limit alcoholic drinks 
 Limit consumption of salt and avoid mouldy cereals (grains) or pulses (legumes) 
 Aim to meet nutritional needs through diet alone 
 Mothers to breastfeed; children to be breastfed 
 Cancer survivors should follow the recommendations for cancer prevention 
Concerning the risk of CRC, the expert panel of WCRF/AICR classified different types of 
factors (mostly foods) into 4 risk categories based on scientific evidence showing their role in 
increasing or decreasing CRC risk: convincing, probable, limited-suggestive and limited-no 
conclusion (Table 1). 
Table 1 shows that red meat is classified as a risk factor of CRC. Indeed, numerous 
scientific publications have reported a positive link between colorectal cancer and red meat 
intake, analyzed by cohort studies, case-control studies and meta-analysis. Cohort studies 
compare the incidence of a disease in two groups of people: exposed and not exposed to 
experimental factors. Case-control studies consist in identifying a group of people with a 
disease (“cases”) and a similar group without the disease (“controls”) and then comparing 
them with respect to exposure to experimental factors. Meta-analysis is a statistical technique 
for combining the findings from independent studies, allowing to propose a strong conclusion. 
The most recent meta-analysis study conducted by the expert panel of WCRF/AICR 
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regrouping cohort and case control studies revealed a statistically significant dose-response 
relationship between CRC and red meat intake, with a 17% increased risk of CRC (95% CI 
1.05-1.31), a 25% increased risk for colon cancer and a 31% increased risk for rectal cancer 
per 100 g per day of red meat [113]. WCRF also published a recommendation on limiting red 
meat intake of 500 g per week maximum and avoiding consumption of processed meat [1]. 
Red meat refers to beef, pork, lamb and goat from domesticated animals. Processed meat is 
meat that has been transformed through salting, curing, fermentation, smoking, or other 
processes aiming at enhancing flavor or improving preservation. Although it will not be 
detailed in this thesis, processed meat is also considered as risk factor of CRC with relative 
risk of 1.18 (95% CI 1.10-1.28) per 50 g per day of processed meat [113]. In addition, WCRF 
also expressed its public health goal encompassing population average of red meat 
consumption to be no more than 300 g a week [1]. In 2015, International Agency for Research 
on Cancer (IARC) under World Health Organization (WHO) categorized red meat in category 
2A (probably carcinogenic to humans) and processed meat in category 1 (carcinogenic to 
humans) [114].  
 Decreases risk Increases risk 
Convincing Physical activity 
Foods containing dietary fiber 
Red meat 
Processed meat 
Alcoholic drinks (men) 
Body fatness 
Abdominal fatness 
Adult attained height 
Probable Garlic 
Milk 
Calcium 
Alcoholic drinks (women) 
Limited-
suggestive 
Non-starchy vegetables 
Fruits 
Foods containing vitamin D 
Foods containing iron 
Cheese 
Foods containing animal fats 
Foods containing sugars 
Limited-no 
conclusion 
Fish, glycemic index; folate; vitamin C; vitamin E; selenium; low fat; dietary 
pattern 
 
Table 1. The role of food, nutrition and physical activity in colorectal cancer [1]. 
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1.2.1. Red meat 
Red meat refers to mammalian muscle meat — for example, beef, veal, pork, lamb, 
mutton, horse, or goat meat — including minced or frozen meat; it is usually consumed 
cooked [115]. Red meat contains high biological-value proteins and important micronutrients 
such as vitamin B, iron and zinc. Depending on the country, the proportion of the population 
consuming red meat varies worldwide from less than 5% to up to 100%. The global mean 
intake of red meat by those who consume it is about 50-100 g per person per day, with high 
consumption equaling more than 200 g per person per day [116].  
Meat processing, such as curing (with nitrite and nitrate) and smoking, can result in 
formation of carcinogenic chemicals, including N-nitroso-compounds (NOCs) and polycyclic 
aromatic hydrocarbons (PAHs). Cooking improves the digestibility and palatability of red 
meat, including prolongs its preservation, but can also produce known or suspected 
carcinogens, including heterocyclic amines (HCAs) and PAHs. High-temperature cooking by 
pan-frying, grilling, or barbecuing generally produces the highest amount of these chemicals 
[115].  
Myoglobin is the main responsible protein for red meat’s red color. It is a cytoplasmic 
hemoprotein consisting of a single polypeptide chain of 154 aa and solely expressed in 
cardiac myocytes and oxidative skeletal muscle fibers. Myoglobin contains heme (complex 
between porphyrin ring and iron ion) and globin protein (Figure 11A). The main function of 
myoglobin in muscle tissues is binding oxygen (O2) provided by hemoglobin in blood to be 
used in cellular activity. Myoglobin binds oxygen by its heme residue. The iron ion in the 
heme interacts with six ligands, four of which are provided by nitrogen atoms in the porphyrin 
ring (Figure 11B). Globin imidazole side chain of His93 provides the fifth ligand, stabilizing 
the heme group. The sixth ligand serves as binding site with O2 and is unoccupied in 
deoxymyoglobin. This ligand is stabilized by globin side chain of His64 [117].  
Myoglobin shares similarities with hemoglobin (red pigment of red blood cells) in 
terms of structure and function. Both molecules consist of globin protein and heme residue; 
and are important in O2 binding and transport. However, myoglobin has higher affinity to O2 
than hemoglobin despite the ability of hemoglobin to transport four O2 molecules (vs. one O2 
molecule per myoglobin) [118]. 
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Figure 11. Structure of A) myoglobin (red: heme, blue: globin) and                                                     
B) heme residue in myoglobin ([118] with modifications). 
 
1.2.2. Hypotheses on colorectal cancer and red meat intake 
Several hypotheses, which are mainly based on studies carried out on red meat, may 
explain the reasons for which red meat intake is linked to CRC risk: 1) high-fat diets could 
promote carcinogenesis via insulin resistance or fecal bile acids, 2) cooking meat at high 
temperature forms carcinogenic heterocyclic amines and polycyclic aromatic hydrocarbons, 
3) carcinogenic N-nitroso compounds are formed in meat and endogenously, 4) N-
glycolylneuraminic acid in red meat provokes colon inflammation and 5) heme iron in red 
meat can promote carcinogenesis because it increases cell proliferation in the mucosa, through 
lipoperoxidation and/or cytotoxicity of fecal water [119,120].  
1.2.2.1.  Fat 
The implication of fat as a possible etiologic factor is linked to the concept of the 
typical Western diet. Ingested fat increases secretion of bile acids in intestinal lumen and bile 
acids are known to be tumor promoters. Bile acids are abrasive towards colonocytes [121] and 
can be degraded into carcinogenic N-nitroso compounds (NOC) in the presence of certain 
bacterial flora [122]. High-fat diet also increases obesity risk, which is considered as a 
convincing risk factor of CRC [1]. Obesity can lead to insulin resistance, which is associated 
to the increase of glucose, free fatty acids, insulin and IGF-1 (insulin-like growth factor 1) in 
the blood. These factors have been shown to increase the proliferation and reduce the 
apoptosis of cancerous cells [123,124]. 
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Several in vivo experiments in rats have been done to show direct evidence between 
high-fat diet and the increase of carcinogen-induced tumors in the colon. Some of them 
prevailed [125-128] while some of them failed [129-134], leading to puzzling discrepancy. 
The latest meta-analysis study regrouping six cohort studies reported no effect of high-fat diet 
on colorectal carcinogenesis in humans [135]. 
1.2.2.2.  Heterocyclic amines and polycyclic aromatic hydrocarbons 
Heterocyclic amines (HCAs) and polycyclic aromatic hydrocarbons (PAHs) are 
carcinogenic molecules formed during the cooking of meat. HCAs are formed by pyrolysis of 
create(ni)ne with specific amino acids. Its formation during cooking depends on the 
temperature of cooking surface, the degree of browning and the length of cooking time. Since 
a high temperature is required, only fried, broiled, or barbecued meat contains significant 
amount of HCAs. The most abundant HCAs in meat are 2-amino-3,8-dimethylimidazo[4,5-
f]quinoxaline (MeIQx), 2-amino-3,4,9-trimethylimidazo[4,5-f]quinoxaline (DiMeIQx) and 2-
amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) [136-138]. In vivo, HCAs have been 
shown to induce colon, mammary and prostate tumors in rodents and monkeys [139]. 
However, the dose of HCAs used in the experiment that led to CRC in rodents and monkeys 
was 1,000 to 10,000 times as high as the dose found in cooked meat. 
 
 
 
Figure 12. Metabolic activation and DNA adduct formation of benzo[a]pyrene [140]. 
 
PAHs are produced from incomplete combustion of organic compounds. Many tested 
PAHs, like benzo[a]pyrene (BaP), are mutagens and animal carcinogens. In humans, BaP has 
been shown to form DNA adducts in colon mucosa [141]. Upon phase I detoxification system 
by cytochromes p450 (CYP1A1 and CYP1A2) and microsomal epoxide hydrolase (mEH), 
transformed BaP is able to form adducts with DNA and cause a further mutation through 
GC→TA transversion following mutations on the tumor suppressor p53 gene [140] (Figure 
12). The main sources of PAHs for humans are cooked and smoked fish and meat (notably 
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barbecued meat) and tobacco smoke [142]. In vivo studies reported that BaP could induce the 
development of preneoplastic lesions in the colon of mice [143,144].  
Some epidemiological studies showed the link between HCAs, PAHs and CRC in 
humans [145-147] while some did not [148,149]. The absence of meta-analysis makes it seem 
difficult to conclude the carcinogenicity of HCAs and PAHs in human CRC. Recently, 
specific human genotypes were shown to be critical in cooked meat-dependent colorectal 
carcinogenesis. They include polymorphisms on gene NTA1 (N-acetyl transferase, a phase II 
enzyme) and CYP1 A2 (cytochrome p450 1A2, a phase I enzyme) [150,151].  
1.2.2.3. N-nitroso compounds 
Nitrite (NO2) is added in processed meat to ensure pink color of meat, enhance flavor 
and improve shelf life. N-nitroso compounds (NOCs) are produced through the reaction of 
nitrite and nitrogen oxides with secondary amines and N-alkylamides. They can disturb 
normal DNA functions through alkylation of DNA bases. Figure 13 shows an example of 
nitrosation of methionine that gives rise to a sulfonium ion that can methylate DNA bases. 
Many NOCs, including nitrosamines, nitrosamides and nitrosoguanidines, are carcinogenic in 
laboratory animals [152]. Human exposure to NOCs can be exogenous and endogenous. The 
exogenous routes include the consumption of certain processed meats (such as grilled bacon), 
smoked fish, cheeses or beers [153]. Endogenously, NOCs can be formed in human body 
through decarboxylation of amino acids by gut bacteria yielding amines and amides [152]. 
Heme from meat facilitates NOCs formation in human gastrointestinal tract [154]. Ascorbic 
acid is often added to nitrite-containing processed meat as antioxidant to prevent NOCs 
formation in foods and in digestive tract [155]. 
Animal studies reported that the intake of processed meat led to fecal excretion of 
NOCs, but without any evidence of CRC initiation or promotion [156-158]. Among total fecal  
NOCs, nitrosylated iron (FeNO) constituted about 80-90% of total NOCs found in the feces of 
rats fed with diet enriched in heme and NO2 [159]. In human studies, the increase of fecal 
NOCs has also been observed following consumption of red meat and processed meat 
[152,160,161]. Furthermore, cohort studies showed that NOCs and consumption of nitrite 
were associated to the risk of rectal cancer [162,163]. International Agency for Research on 
Cancer (IARC) under World Health Organization (WHO) categorized ingested nitrite under 
conditions resulting in endogenous nitrosation in category 2A (probably carcinogenic to 
humans) [114,164]. 
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Figure 13. Nitrosation of methionine gives rise to a DNA alkylating agent [165]. 
 
1.2.2.4. N-glycolylneuraminic acid 
Sialic acids are common monosaccharides that are widely expressed as outer terminal 
units on all vertebrate cell surfaces. They play fundamental roles in cell-cell and cell-
microenvironment interactions. N-acetylneuraminic acid (NANA) and N-glycolylneuraminic 
acid (NGNA) are two derivatives of sialic acids. NANA can be converted to NGNA in the 
presence of enzyme CMP-N-acetylneuraminic acid hydroxylase (CMAH) [166,167].  
NGNA is not present in humans because the human gene expressing CMAH is 
irreversibly mutated. This loss of CMAH was estimated to have occurred two to three 
millions of years ago, just before the emergence of the genus Homo [168]. However, NGNA 
is present in cells of other mammals. Despite the fact that humans are genetically unable to 
produce NGNA, this molecule is detectable in human epithelia and endothelia, and in higher 
amount in malignant tissues. Dietary intake through ingestion of mammalian tissues (such as 
red meat) is suspected to be the source of NGNA incorporation in human tissues. As a 
xenobiotic, incorporated NGNA provokes the generation of anti-NGNA “xeno-
autoantibodies” that causes inflammation (called xenosialitis) [119,166]. In vivo studies using 
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human-like CMAH-KO mice showed that xenosialitis due to NGNA ingestion or injection of 
NGNA-expressing melanoma cell line was linked to tumor progression [119,169,170]. 
1.2.2.5. Heme iron 
The term “heme iron” refers to iron molecule complexed with a porphyrin ring (Figure 
11B). Heme iron represents 65% of total iron in human body and is present under the form of 
hemoglobin and myoglobin (also in certain enzymes such as cytochrome oxidase, catalase and 
ribonucleotide reductase) [171,172]. The role of heme iron in CRC started to be highlighted 
since several studies reported the cytotoxic and hyperproliferative effects of dietary heme on 
rat colonic epithelium [132,173]. Following the loss of APC gene in the colon, luminal iron 
level was also reported to govern intestinal tumorigenesis [174]. The latest meta-analysis 
study showed that a high intake of heme iron was associated with CRC risk with the relative 
risk of 1.15 (95% CI 1.04-1.26) [175].  
A study aiming at determining at nutritional doses the relative contributions of three 
mechanisms involved in CRC promotion by red and processed meat (heme iron, HCAs and 
NOCs) has been conducted in our team. The results showed that heme iron was the only 
experimental factor associated with the tumor promotion in rats and Min mice without any 
additive or synergistic effects with HCAs or NOCs [159]. This study highlights the central 
role of heme iron in CRC promotion by red meat. 
Three mechanisms may explain heme-mediated CRC promotion: 1) heme itself can 
have direct effects by generating oxidative stress, 2) heme induces lipid peroxidation in foods 
and in the gut, and the lipoperoxides would promote CRC, and 3) heme catalyzes the 
endogenous N-nitrosation that increases the formation of NOCs [120,175].  
1.2.2.5.1. Direct effects of heme on carcinogenesis 
Hemoglobin and hemin (heme with a chloride ligand) have been shown to be 
genotoxic towards human colorectal carcinoma SW480 and HT29 cells and primoculture of 
colonocytes [176,177]. This genotoxicity was associated with generation of free radicals 
[176]. In rats, cytotoxicity towards intestinal mucosa is compensated by cellular 
hyperproliferation that can be interpreted as a risk factor of cancer [178].  
Basically, the mechanism by which heme induces carcinogenesis involves the 
formation of reactive oxygen species (ROS) that generate oxidative stress (Figure 14). 
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Uptaken heme in cells is degraded by heme oxygenase-1 (HO-1) that opens the porphyrin 
ring, producing biliverdin and carbon monoxide (CO) and releasing Fe2+. Biliverdin is rapidly 
converted by cytosolic biliverdin reductase (BVR) to bilirubin that possesses powerful 
antioxidant activities to counteract ROS. Fe2+ induces the expedient production of ferritin, an 
antioxidant whose action is primarily mediated through the sequestration of reactive Fe2+ and 
its oxidation to less reactive ferrous ions Fe3+ by intrinsic ferroxidase activity. However, in 
case of insufficient antioxidant activity of bilirubin or ferritin, Fe2+ reacts with endogenous 
hydrogen peroxide (H2O2) through Fenton reaction resulting in the formation of potentially 
genotoxic ROS (including hydroxyl radicals •OH) that can provoke DNA damage and cell 
mutation [179-181]. This might be the mechanism of heme-induced CRC [182].  
 
 
 
 
 
 
 
 
 
Figure 14. Model for direct effects of heme on carcinogenesis involving oxidative stress 
(based on [179,181]). 
 
1.2.2.5.2. Indirect effects of heme on carcinogenesis 
The indirect effects of heme on colorectal carcinogenesis involve the role of heme in 
catalyzing lipid peroxidation and N-nitrosation in human body. In these mechanisms, 
prooxidant heme in red meat (also found under nitrosylated form in processed meat) catalyzes 
the oxidation of unsaturated fatty acids (in lipid peroxidation) or the formation of NOCs (in 
N-nitrosation), leading to the formation of cytotoxic and genotoxic molecules involved in 
colorectal carcinogenesis (Figure 15). In general, these catalytic effects can be inhibited by 
calcium and chlorophyll by heme-trapping mechanism [183-187]. 
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Figure 15. Indirect roles of heme iron in colorectal carcinogenesis involving                               
catalysis of lipid peroxidation and formation of N-nitroso compounds [175]. 
 
 Heme can catalyze the formation of endogenous NOCs following consumption of 
processed meat and this process can be inhibited by addition of vitamin C and vitamin E in 
processed meat [188-190]. These NOCs are also known as apparent total N-nitroso 
compounds (ATNCs) that include nitrosamines, nitrosamides, nitrosyl iron (FeNO) and S-
nitrosothiols [191]. ATNCs have been shown to be genotoxic. Firstly, most NOCs can yield 
alkylating agents during metabolism and cause DNA damage. For instance, N-methyl-N-
nitrosurea intrarectally perfused induced G→A transitions in oncogenic K-RAS in 30% of rat 
colon carcinoma [192]. In addition, nitrosated glycine derivatives are able to form adducts 
with DNA resulting in promutagenic and toxic adducts including O6-methylguanine and O6-
carboxymethylguanine [193]. Moreover, potassium diazoacetate, a stable form of nitrosated 
glycine, was shown to induce tumor suppressor p53 gene mutation in a functional yeast assay 
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[194]. These mutations on K-RAS and p53 are involved in chromosomal instability leading to 
CRC development (Figure 3 and 15). 
Heme also catalyzes the oxidation of polyunsaturated fatty acids (PUFAs) resulting in 
a variety of reactive compounds such as epoxides and aldehydes. The major aldehyde 
products of lipid peroxidation are malondialdehyde (MDA, derived from polyunsaturated 
fatty acids with two or more double bonds), 4-hydroxyhexenal (HHE, derived from n-3 fatty 
acids) and 4-hydroxynonenal (HNE, derived from n-6 fatty acids) [159,195,196]. An in vivo 
study investigating the role of heme iron and PUFA intake in colorectal carcinogenesis has 
demonstrated a 130-fold increase of urinary MDA in heme iron and fish oil-fed rats and a 
300-fold increase of urinary DHN-MA (mercapturic acid of dihydroxynonane, urinary 
metabolite of HNE detoxification) in heme iron and safflower oil-fed rats [197]. MDA exerts 
genotoxicity and can form DNA adduct [198-200]. HNE appears to be the main toxic 
products of lipid peroxidation [159]. HNE can conduct positive selection in favor of 
preneoplastic colon cells harboring APC mutation over normal colon cells, therefore favoring 
CRC promotion [61,159]. The catalytic effects of heme on lipid peroxidation can be inhibited 
by antioxidants such as α-tocopherol and several polyphenols (quercetin and red wine 
polyphenols) [201-203]. Colon microbiota was also suggested to be positively involved in 
heme-induced lipid peroxidation [204]. 
1.3. 4-Hydroxynonenal and carcinogenesis 
Lipid peroxidation  can be described generally as a process under which oxidants such 
as free radicals (R•) attack lipids containing carbon-carbon double bond(s), especially PUFAs 
[195]. These free radicals can be generated from the mitochondrial electron transport chain, 
the cytochrome P450 biotransformation activities, or inflammation. Iron, through Fenton 
reaction with hydrogen peroxide (H2O2), can also catalyzes the formation of free radicals in 
the forms of hydroxyl radicals (•OH) or hydroperoxyl radicals (•OOH), depending on its 
oxidative state [205] (Figure 16A). Furthermore, these radicals can provoke lipid peroxidation 
through three main phases: initiation, propagation and termination [195] (Figure 16B).  In the 
initiation phase, free radicals attack the lipids, thereby forming lipid radicals that tend to 
stabilize themselves by a molecular rearrangement to form a conjugated diene (step 1). In the 
propagation phase, lipid radicals rapidly react with oxygen to form lipid peroxy radicals (step 
2) which abstract a hydrogen from other lipid molecules, thus generating new lipid radicals 
and lipid hydroperoxides (step 3). In the termination reaction, antioxidants (such as β-
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carotene, vitamin C or vitamin E) donate a hydrogen atom to the lipid peroxy radical species 
resulting in the formation of nonradical products (step 4).  
 
A           Fe2+ + H2O2 → Fe
3+ + •OH + -OH 
               Fe3+ + H2O2 → Fe
2+ + •OOH + H+ 
B 
 
 
 
 
 
 
 
 
 
Figure 16. A) Fenton reaction involving ferrous (Fe2+) and ferric (Fe3+) ions resulting in 
hydroxyl (•OH) and hydroperoxyl (•OOH) radicals [205]. B) Lipid peroxidation consisting in 
initiation (step 1), propagation (steps 2-3) and termination (step 4) phases [195]. 
 
Lipid peroxidation and antioxidant status is an important parameter in CRC. 
Compared to healthy patients, CRC patients have been shown to exhibit higher lipid 
peroxidation status in their blood and lower level of serum antioxidants (vitamin C and E) 
[206].  Consumption of α-tocopherol was also reported to reduce biomarkers of lipid 
peroxidation in human stools following cured meat consumption [207].  However, the most 
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recent meta-analysis study found no sufficient evidence of vitamin E role for decreasing CRC 
[208].   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17. Formation of HNE from arachidonic acid trigerred by free radicals [209]. 
 
4-hydroxynonenal (HNE, C9H1602) is a major end product derived from the oxidation 
of n-6 PUFAs such as linoleic, γ-linolenic or arachidonic acids. The formation of HNE from 
arachidonic acid oxidation is presented in Figure 17. Following ROS attack that generates 
arachidonic acid hydroperoxides, ferrous (Fe2+) ion catalyzes the conversion of these 
molecules into arachidonic acid peroxyl radicals. The highly reactive peroxyl radicals cause a 
molecular arrangement which cyclizes these radicals. Further oxidation and Fenton reactions 
result in the β-scission of the cyclized intermediate, causing the eventual formation of HNE 
[209]. HNE can be formed endogenously under physiological conditions through the 
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production of free radicals that trigger lipid peroxidation. Exogenously, HNE can enter human 
body through consumption of foods containing HNE, for example HNE that is formed in red 
meat following PUFAs oxidation catalyzed by heme iron. In this case, intestinal cells are the 
most susceptible to HNE-containing food because they can be directly exposed to high 
concentrations of HNE [210-213]. 
HNE has been shown to be involved in numerous pathologies, such as Alzheimer’s 
disease, Parkinson’s disease, atherosclerosis, metabolic syndrome, liver diseases and cancer. 
Its action in exacerbating these diseases is focused on its ability to modify protein, induce 
inflammation, provoke oxidative stress, cause mutations on genes, or disturb homeostasis 
[210]. In cancer, HNE status remains unclear but its level has been observed to be higher or 
lower in tumor tissues compared to healthy tissues [214-219]. Blood profiling revealed higher 
HNE level in CRC patients compared to healthy patients and this phenomenon was inversely 
correlated with their blood antioxidant status [220]. The level of HNE-protein adducts seems 
to be positively correlated to progression in tumor malignancy [221,222]. HNE has also been 
reported to bind to guanosine moiety of DNA, induce G C to T A mutations on tumor 
suppressor gene p53 and inhibit DNA repair mechanisms, thereby exerting genotoxic and 
mutagenic potentials [223-225].  
1.3.1. Reactivity of 4-hydroxynonenal 
HNE possesses three reactive functions: a C2=C3 double bond, a C1=O carbonyl 
group and a hydroxyl group on C4 (Figure 18). Apart from possible oxidation or reduction of 
these reactive groups, several reactions can explain HNE ability to disrupt cellular physiology 
by forming adducts with DNA or protein. The C=C double bond is responsible for HNE 
genotoxicity through possibility of forming DNA adducts by epoxidation. The formation of 
protein adducts involves C2=C3 and C1=O groups. It is initiated by Michael addition that 
saturates C2=C3 group and enables the formation of covalent bond on C3 with amino acid 
residues (cysteine, histidine, or lysine). This reaction is also involved in Phase II HNE 
detoxification through conjugation with cysteine residue of glutathione. Following Michael 
addition, C1=O group reacts with lysine residue to form Schiff base to stabilize protein 
adducts. The formation of protein adducts can modify protein structure and activity (for 
instance, by forming protein cross-linking) or even inactivate it. It can also induce carbonyl 
stress [210,226]. 
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Figure 18. Reactivity of 4-hydroxynonenal                                                                                       
on the hydroxyl, carbonyl and C=C double bond groups [210]. 
 
1.3.2. Detoxification pathways of 4-hydroxynonenal 
The half-life of HNE is less than 2 minutes. This relatively short half-life underlines 
the importance of HNE detoxification as a cell defense system against HNE toxicity [210]. 
HNE detoxification depends on cellular type. For example, colonocytes metabolize 100% of 
40 µM HNE in 90 min [62] whereas hepatocytes metabolize 95% of 100 µM HNE in 3 min 
[227]. In radioactive HNE-fed rats, radioactivity distribution revealed that 48% of the 
administered radioactivity was excreted into urine and 15% into feces after 24h, while 3% 
were measured in intestinal contents and 2% in major organs, mostly in the liver [228]. In 
general, HNE detoxification pathways consist of reactivity modification of C2=C3 and C1=O 
groups by oxidation/reduction, saturation, or conjugation (Figure 19). 
The saturation and oxidation/reduction pathways consist in hydrogenyzing double 
bonds C1=O and C2=C3 bond. These pathways involve three main enzymes: aldehyde 
dehydrogenase (ALDH), aldo-keto reductase (AKR) and alkenal/one oxidoreductase (AOR). 
Once enters cellular cytoplasm, HNE may undergo some possible enzymatic reactions: (1) 
reduction of C1=O carbonyl group by AKR resulting in 1,4-dihydroxynon-2-ene (DHN), (2) 
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oxidation of C1=O carbonyl group by ALDH resulting in 4-hydroxynon-2-enoic acid (HNA) 
and (3) hydrogenation of C2=C3 double bond by AOR resulting in 4-hydroxynonanal 
hemiacetal (saturated HNE), which may further be oxidized by ALDH and form 4-
hydroxynonanoic acid (saturated HNA). These molecules are then released outside the cells 
[210]. 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                                                           
Figure 19. Putative pathways involved in the detoxification of 4-hydroxynonenal                                 
in mouse colonocytes [210]. 
 
The conjugation pathway enables detoxification of HNE through conjugation with 
glutathione (GSH), an antioxidant tri-peptide consisting of cysteine, glycine and glutamic 
acid. The production of GSH involves several proteins: (1) cystine/glutamate antiporter (xCT) 
embedded in cellular membrane which enables the influx of cystine (dimeric amino acid 
formed by two cysteine residues) into cytoplasm compensated with efflux of glutamate, (2) 
enzyme thioredoxin 1 (TRX1) which cleaves disulfide bond between two cysteine residues in 
cystine resulting in two separated cysteines and (3) enzyme glutamate cysteine ligase (GCL) 
which ligates cysteine and glutamate in order to form GSH. After the cleavage of disulfide 
bond in cystine by TRX1, cysteines can also be transferred outside the cells to capture and 
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inactivate extracellular HNE. Once GSH is formed, it can be conjugated with HNE in the 
presence of enzyme glutathione-S-transferase (GST), forming a complex HNE-GSH. This 
complex can be taken out directly outside the cells through membrane protein transporters 
such as multidrug resistance protein (MRP) and RalA-binding protein 16 encoded 76-kDa 
splice variant (RLIP76), or undergoes further modification catalyzed by ALDH or AKR 
resulting in HNA-lactone-GSH and DHN-GSH respectively before finally being released 
through transporters [210]. 
Mercapturic conjugate 1,4-dihydroxynonane mercapturic acid (DHN-MA) is known as 
the major urinary metabolite of HNE [213,229]. This highlights the importance of the GSH-
related conjugation pathway as the major HNE detoxification pathway. A dramatical increase 
of urinary DHN-MA has been observed in rats fed with diets containing high heme 
concentration [197]. However, ω-hydroxylated metabolite of HNE 4,9-dihydroxy-2-nonenoic 
acid and its oxidized form 4-hydroxy-2-nonene-1,9-dicarboxylic acid have also been detected 
in the urine of HNE-fed mice [228]. This shows the involvement of cytochrome P450 4A in 
HNE detoxification pathways [230]. Urinary metabolites of HNE as thiomethyl and 
glucuronide conjugates were also evidenced in the urine of HNE-fed rats [228].  
1.3.3. Red meat and colorectal cancer promotion: 4-hydroxynonenal in the balance 
As previously mentioned, tumor heterogeneity can explain the different sensitivity of 
tumor cells towards cytotoxic molecules (Chapter 1.1.4) and heme iron in the red meat can 
provoke the formation of HNE that exerts different cytotoxicity towards normal and 
preneoplastic colon cells (Chapter 1.2.2.5.2). Concerning the role of HNE in CRC, heme-
induced lipid peroxidation in the lumen is suggested to be  involved in the promotion of 
colorectal carcinogenesis by generating byproducts, including HNE that triggers the positive 
selection of preneoplastic cells to the detriment of normal cells (Figure 20) [61]. Regarding 
the theory of clonal evolution of cancer (Figure 4), HNE acts as the bottleneck or selective 
pressure that favors the survival of preneoplastic cells over normal cells. Thus, this 
phenomenon might contribute to the promotion of colorectal carcinogenesis by red meat 
intake by positively selecting preneoplastic cells. Further studies revealed that the resistance 
of preneoplastic colon cells to HNE and fecal water was due to higher level of HNE 
detoxification enzymes (Figure 19) in preneoplastic cells compared to normal cells [62]. 
Interestingly, these enzymes are regulated by Nrf2 (nuclear factor (erythroid-derived 2)-like 
2), a transcription factor responsible for the expression of antioxidant enzymes. 
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Figure 20. Model for colorectal carcinogenesis promotion based on Darwinian positive 
selection of preneoplastic cells over normal cells by HNE [231]. 
 
1.4. Nrf2-dependent antioxidant response 
Nrf2 is a ubiquitous cytoplasmic regulatory protein acting as a transcription factor that 
integrates cellular stress signals and responds by directing various transcriptional programs 
[232]. The Nrf2-dependent antioxidant response is known as the primary cellular defense 
against the harmful effects of extrinsic and intrinsic insults (e.g. xenobiotics and oxidative 
stress) owing to its ability to activate transcription of cytoprotective genes. These genes 
include those expressing primary internal cellular enzymatic antioxidants, such as superoxide 
dismutase (SOD), catalase, GSH peroxidase (GPX) and TRX (thioredoxin) peroxidase [233]. 
These enzymes, known as the most important in cellular antioxidant defense system,  allow to 
neutralize oxidative insults in the cells such as superoxide anion (O2-•) and H2O2 (Figure 21). 
As a result, Nrf2 has traditionally been regarded as cellular main defense mechanism and a 
major regulator of cell survival. Activation of Nrf2-dependent antioxidant response has been 
shown to protect against neurodegenerative diseases, aging, diabetes, photo-oxidative stress, 
cardiovascular diseases, inflammation, pulmonary fibrosis, acute pulmonary injury and cancer 
[234-236]. 
Beside Nrf2, other transcription factors that are involved in cellular antioxidant 
response do exist, among which the most well-studied are NF-κB (nuclear factor kappa-light-
chain-enhancer of activated B cells) and AP-1 (activator protein 1) composed of jun and fos 
gene products [237]. These transcription factors have been shown to be activated by oxidative 
stress and are dependent on each other [238-242]. Some antioxidant genes whose expression 
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is induced by these transcription factors are those expressing NQO1 (NAD(P)H quinine 
dehydrogenase 1), GSTs (glutathione S-transferases), SOD and mitochondrial PRX1 
(peroxiredoxin) [237]. Nevertheless, without any intention to disregard the role of NF-κB and 
AP-1 in cellular response following oxidative stress, only Nrf2-dependent antioxidant 
response is detailed in this chapter. 
 
 
 
 
 
 
 
 
Figure 21. Important cellular antioxidant defense system involving superoxide dismutase 
(SOD), catalase, GSH peroxidase and TRX peroxidase ([243] with modifications). 
 
1.4.1. Structure of Nrf2 
Nrf2 contains seven functional domains, known as Neh1-Neh 7 (Figure 22). Of these, 
Neh2 domain, located in the N terminus of Nrf2 is the major regulatory domain. Neh2 
contains seven lysine residues that are responsible for ubiquitin conjugation [244] as well as 
two binding sites (termed ETGE and DLG motifs) that help regulate Nrf2 stability. The ETGE 
and DLG motifs interact with Keap1 (Kelch-like erythroid cell-derived protein with CNC 
homology [ECH]-associated protein 1), which is a substrate adaptor protein for the Cullin 3 
(Cul3)-dependent E3 ubiquitin ligase complex that represses Nrf2 by promoting its 
ubiquitination and subsequent proteasomal degradation [244-247] (Chapter 1.4.2.1). 
The Neh1 and Neh6 domains are involved in the regulation of Nrf2 stability. Neh1 
allows Nrf2 to bind DNA and dimerize with other transcription factors [248]. The Neh6 
domain contains two binding sites (DSGIS and DSAGPS motifs) that are primordial for β-
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TrCP (β-transducin repeat-containing protein)-dependent Nrf2 regulation [249-251] (Chapter 
1.4.2.2).  
 
 
 
 
 
Figure 22. Structure of Nrf2 containing seven domains Neh1-Neh7 [234]. 
 
The Neh3, Neh4 and Neh5 domains interact with coactivators to enable the 
transactivation of Nrf2 target genes. The Neh3 domain binds to CHD6 (chromodomain 
helicase DNA-binding protein 6) which functions as Nrf2 transcriptional coactivator [252]. 
The Neh4 and Neh5 domains interact with CBP (C-AMP response element binding [CREB]-
binding protein) to facilitate the transactivation of Nrf2 target genes [253,254]. Finally, the 
Neh7 domain is involved in Nrf2 negative regulation by interacting with RXRα (retinoic X 
receptor alpha), an Nrf2 repressor, and repressing the transcription of Nrf2 target genes [255]. 
1.4.2. Regulation of Nrf2 
At the protein level, Nrf2 under basal conditions is negatively regulated by 
ubiquitination system aiming at degrading Nrf2. Indeed, mechanism of Nrf2 activation 
consists of the disruption of interaction between Nrf2 and the ubiquitination system. Before 
going further into details of different proteins that are involved in Nrf2 regulation by 
ubiquitination, the mechanism of protein degradation by ubiquitination is worth explaining 
(Figure 23).  
Ubiquitin (Ub) is a small 8-kDa which is first transferred to the ubiquitin-activating 
enzyme E1 in an ATP-dependent manner. This activated ubiquitin is then transferred to 
ubiquitin-conjugatin enzyme E2. Finally, the ubiquitin is covalently attached to the target 
protein by E3 ubiquitin ligase, leading to the formation of polyubiquitin chain. The 
polyubiquitinated protein is recognized by the 26S proteasome and is degraded in an ATP-
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dependent manner. The ubiquitins can then be recycled for other ubiquitination processes 
[256]. In terms of Nrf2 degradation by ubiquitination, the target protein is Nrf2 and the 
ubiquitination process varies in the E3 ubiquitin ligase complexes.  
 
 
 
 
 
 
 
Figure 23. General mechanism of protein degradation by ubiquitination [256]. 
 
Three E3 ubiquitin ligase complexes have been reported to regulate Nrf2: 1) Keap1-
Cul3-Rbx1 (ring-box 1), 2) GSK3β/β-TrCP-Skp1 (S-phase kinase-associated protein 1)-Cul1-
Rbx1 and 3) Synoviolin (SYVN1 or Hrd1) (Figure 24). The mechanisms by which these 
complexes regulate Nrf2 are discussed in the following chapters. In addition, another 
mechanism of Nrf2 regulation involving p62 has been elucidated. This pathway would allow 
us to highlight the role of p62 in autophagy and Nrf2 signaling. 
 
 
 
 
 
Figure 24. The three E3 ubiquitin ligase complexes regulating Nrf2 activation:                        
A) Keap1-Cul3-Rbx1, B) GSK3 β / β-TrCP-Skp1-Cul1-Rbx1 and C) Hrd1 [257]. 
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1.4.2.1. Regulation of Nrf2 by Keap1-Cul3-Rbx1 E3 ubiquitin ligase 
Nrf2 is primarily regulated by Keap1, a substrate adaptor that forms an E3 ubiquitin 
ligase with Cul3 and Rbx1. Keap1 possesses three functional domains, including a broad 
complex/tramtrack/bric-a-brac (BTB) domain, an intervening region (IVR, also known as 
linker region, LR) and a Kelch-repeat domain (Figure 25). The BTB domain is required for 
the formation of Keap1 homodimers as well as the recruitment of Cul3 or Rbx1 [258,259]. 
The Kelch-repeat domain is critical for maintaining the interaction between Keap1 and the 
Neh2 domain of Nrf2 [249,260]. The IVR/LR domain contains several cysteine residues that 
have been proposed to regulate Keap1 activity [246,261]. There are several cysteine residues 
functioning as sensors for electrophiles: Cys-151, Cys-226/Cys-613, Cys-273/Cys-288 and 
Cys-434. A disulfide bridge can be formed between Cys-226 and Cys-613 following 
oxidation [262]. 
 
 
 
 
 
Figure 25. Structure of Keap1 containg three domains: BTB, IVR/LR and Kelch-repeat 
domain (NTR: N terminal region, CTR: C terminal region) [262]. 
 
Under basal conditions, Nrf2 is primarily localized in the cytoplasm and bound to 
Keap1 via direct protein-protein interactions between the Kelch-repeat domain of Keap1 and 
the ETGE and DLG motifs in the Neh2 domain of Nrf2 (Figure 24A and 26). This binding to 
Keap1-Cul3-Rbx1 E3 ubiquitin ligase promotes Nrf2 polyubiquitination and its subsequent 
proteasomal degradation by proteasome [244,263,264].  
In response to a diverse array of stimuli, it has been proposed that the critical cysteine 
residues of Keap1, especially Cys-151, can be covalently modified, allowing Nrf2 to evade 
Keap1-mediated ubiquitination. The human Keap1 protein contains 27 cysteine residues that 
can be oxidized to sulfenic acid, form disulfides, or be covalently adducted by electrophiles 
[265-267]. The modification of cysteine residues on Keap1 alters its conformation and results 
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in the release of Nrf2 from the DLG motif to the nucleus. Another proposition for Nrf2 
liberation from Keap1 involves dissociation of Cul3 that blocks ubiquitination [232]. In the 
nucleus, Nrf2 dimerizes with members of the masculoaponeurotic fibrosarcoma (Maf) protein 
family that facilitates the binding of Nrf2 to ARE (antioxidant response element), a sequence 
in the promoter regions of a wide variety of genes involved in cytoprotection and metabolism 
[268-270]. The Nrf2-Maf heterodimer recruits transcriptional coactivators that promote the 
transcription of numerous cytoprotective enzymes (detailed in Chapter 1.4.3). By inducing the 
expression of this battery of genes, Nrf2 is able to augment a wide range of cell defense 
processes, thereby enhancing the overall capacity of cells to detoxify potentially harmful 
entities. As feedback mechanism, Keap1 translocates into the nucleus to bind to Nrf2 and 
deregulates it via ubiquitination in the cytoplasm [271,272]. Regulation of Nrf2 activity 
involving Keap1-Cul3-Rbx1 is known as canonical pathway of Nrf2 activation. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26. Nrf2-Keap1 signaling pathway ([257] with modifications). 
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1.4.2.2. Regulation of Nrf2 by GSK3β / β-TrCP-Skp1-Cul1-Rbx1 E3 ubiquitin ligase 
Beside Keap1-Cul3-Rbx1 E3 ubiquitin ligase that has been revealed as the primary 
redox-sensitive regulator of Nrf2 in the Neh2 domain, a redox-insensitive degron within the 
Neh6 domain of Nrf2 was also reported to regulate Nrf2 ubiquitination. Subsequently, the 
Neh6 domain of Nrf2 contains a group of serine residues that can be phosphorylated by 
GSK3, a serine/threonine kinase that is also involved in APC regulation by Wnt signaling (see 
Chapter 1.1.5.2.1). This phosphorylation event creates a phosphorylated destruction motif 
(phosphodegron) which can then be recognized by the β-TrCP-Skp1-Cul1-Rbx1 E3 ubiquitin 
ligase complex [250] (Figure 24B). This E3 ubiquitin ligase complex ubiquitylates Nrf2 and 
sends it to the protasome for degradation. Two distinct motifs in the Neh6 domain of Nrf2 
have been reported to be recognized by β-TrCP: DSAPGS and DSGIS. Between these two 
motifs, only DSGIS contains a GSK3β phosphorylation site [251].  
The regulation of Nrf2 by β-TrCP-Skp1-Cul1-Rbx1 E3 ubiquitin ligase complex 
bridges Nrf2 activation and Wnt signaling that is activated in CRCs following APC mutation. 
Recently, the activation of Wnt signaling was shown to lead to Nrf2 activation in hepatocytes 
[273] (Figure 27). The mechanism involves Nrf2 phosphorylation by GSK3β to form a 
phosphodegron that is followed by β-TrCP-dependent Nrf2 degradation when no Wnt signal 
is detected. Upon activation of Wnt signaling, GSK3β is recruited to the membrane, along 
with receptors LRP5/6 and Frizzled and therefore GSK3β becomes less available to 
phosphorylate Nrf2.  
1.4.2.3. Regulation of Nrf2 by Hrd1 E3 ubiquitin ligase 
Recently, in the case of liver cirrhosis, Nrf2-mediated protective response has been 
reported to be suppressed during liver carcinogenesis. This finding was somehow surprising 
because Keap1 should be likely to be inactivated by the high levels of ROS in cirrhotic livers, 
leading to Nrf2 signaling by canonical mechanism [274]. Subsequently, the phenomenon of 
endoplasmic reticulum stress (ER stress) was pointed out to cause the suppression of Nrf2 
activity during the pathogenesis of liver cirrhosis. 
ER stress occurs when misfolded proteins accumulate and the unfolded protein 
response (UPR) is initiated. Three sensors located on the ER membrane detect the 
accumulation of misfolded proteins and relays signaling cascades to correct the insults: 1) 
inositol-requiring enzymes 1 (IRE1), 2) protein kinase RNA-like ER kinase (PERK) and 3) 
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activating transcription factor 6 (ATF6) [275]. Concerning IRE1, ER stress is known to 
enable IRE1 to homodimerize and actively splice X-box-binding protein 1 (XBP1) mRNA 
into a mature mRNA encoding XBP1s, a transcription factor. Hrd1 (Synovial apoptosis 
inhibitor 1), one of XBPs target genes, is an E3 ubiquitin ligase that is able to ubiquitylate 
Nrf2, leading to its degradation by proteasome [274] (Figure 24C).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 27. Mechanism of Wnt-dependent activation of Nrf2 in hepatocytes [273]. 
 
1.4.2.4. Regulation of Nrf2 by p62 
Apart from negative regulation through ubiquitination involving E3 ubiquitin ligase 
complexes, Nrf2 is subjected to positive regulation through disruption of the Nrf2-Keap1 
interaction by other proteins. Numerous proteins containing ETGE motif of Nrf2 have been 
identified and shown to compete with Nrf2 for Keap1 binding, thus stabilizing Nrf2 [276]. 
Some examples of (E/S)TGE-containing proteins include dipeptidyl peptidase 3 (DPP3), 
partner and localizer of breast cancer 2 (PALB2) and p62. Among these proteins, p62 is 
perhaps the most recognized positive regulator of Nrf2. p62 is mostly well-known for its role 
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as a cargo protein in autophagy machinery (Chapter 1.5.2). It possesses a Keap1-interacting 
region (KIR) containing STGE motif that accounts for the direct interaction between p62 and 
Keap1 [277]. Phosphorylation of Serine 351 residue of p62 has been shown to increase the 
affinity between p62 and Keap1, which resulted in Nrf2 activation through sequestration of 
Keap1 onto the autophagosomes for lysosomal degradation [278] (Figure 28). Recently, this 
phosphorylation was known to be mediated by TAK1 (TGFβ-activated kinase 1) [279]. 
Interestingly, p62 is also a target gene of Nrf2 [280]. This Nrf2 activation pathway was 
observed in arsenic-induced human lung carcinogenesis [281,282].  
 
 
 
 
 
 
 
 
 
Figure 28. Regulation of Nrf2-Keap1 signaling pathway by p62 [278] 
 
1.4.2.5. Regulation of Nrf2 at the transcriptional level by oncogenes 
At the transcriptional level, Nrf2 has been reported to be up-regulated by oncogenic 
activation of K-RAS, B-RAF and MYC [283]. Colorectal carcinogenesis involves activation of 
these genes. K-RAS and B-RAF are mutated during transformation of early colon adenoma 
into intermediate adenoma, both based on chromosomal instability model and microsatellite 
instability model (Figure 3). MYC is a target gene of Wnt signaling that is continuously active 
following APC mutation in early colorectal carcinogenesis (Figure 6B). The activation of 
Nrf2 by the oncogenic K-RAS is facilitated through a TPA (12-O-Tetradecanoylphorbol-13-
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acetate)-responsive element (TRE) in the regulatory region of Nrf2 [284].  Nevertheless, the 
precise mechanisms by which B-RAF and MYC up-regulate the transcription of Nrf2 are 
currently unknown. 
1.4.3. Target genes of Nrf2 
In general, the target genes of Nrf2 include those that are involved in: 1) Phase I-III 
drug detoxification, 2) thioredoxin- and glutathione-based antioxidant system, 3) carboxylate 
metabolism and NADPH regeneration, 4) heme and iron metabolism, 5) transcription factors 
and associated proteins and 6) ubiquitin ligase substrate adaptors [234,285-287] (Table 2). 
Interestingly, Nrf2 may perform an autoregulation by promoting the transcription of Nrf2 
itself and other proteins associated in Nrf2 regulation such as Keap1 and p62 [280,287,288]. 
In addition, the enzymes that are involved in HNE detoxification (Figure 19) have been 
reported to be regulated by Nrf2 [289-292]. 
 
General biochemical 
function 
Symbol Name 
Detoxification: Phase I drug 
oxidation, reduction and 
hydrolysis 
AKR1B1 Aldo-keto reductase family 1, member B1 (and 
1B8 and 1B10) 
AKR1C1 Aldo-keto reductase family 1, member C1 (and 
1C2 and 1C3) 
ALDH3A1 Aldehyde dehydrogenase 3 family, member A1 
(and 3A2) 
CBR1 Carbonyl reductase 1 (and 3) 
EPHX1 Epoxide hydrolase 1, microsomal 
PTGR1 Prostaglandin reductase 1 (also called 
LTB4DH) 
NQO1 NAD(P)H quinone oxidoreductase 1 
Detoxification: Phase II drug 
conjugation 
MGST1 Microsomal glutathione S-tranferase 1 (and 2) 
GSTA4 Glutathione S-transferase A4 
SULT1A1 Sulfotransferase family, cytosolic, 1A, member 
1(2) 
UGT1A1 UDP glucuronosyltransferase 1 family, 
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polypeptide A1 (and 1A6) 
UGT2B7 UDP glucuronosyltransferase 2 family, 
polypeptide B7 (and 2B34) 
Detoxification: Phase III 
drug transport 
ABCB6 ATP-binding cassette, subfamily B 
(MDR/TAP), member 6 
ABCC2 ATP-binding cassette, subfamily C 
(CFTR/MRP), member 2 
ABCC3 ATP-binding cassette, subfamily C 
(CFTR/MRP), member 3 
Antioxidant: glutathione-
based system 
GCLC Glutamate-cysteine ligase, catalytic subunit 
GCLM Glutamate-cysteine ligase, modifier subunit 
GGT1 γ-glutamyltransferase 1 
GLRX Glutaredoxin 1 
GLS Glutaminase 
GPX2 Glutathione peroxidase 2 
GSR1 Glutathione reductase 
SLC7A11 Cystine/glutamate transporte (also called xCT) 
Antioxidant: thioredoxin-
based system 
PRDX1 Peroxiredoxin 1 
PRDX6 Peroxiredoxin 6 
SRXN1 Sulfiredoxin 1 
TXN1 Thioredoxin 1 
TXNRD1 Thioredoxin reductase 1 
Other antioxidant systems CAT Catalase 
SOD3 Superoxide dismutase 3 
Carboxylate metabolism and 
NADPH regeneration 
HDK1 Hexokinase domain containing 1 
ME1 Malic enzyme 1, NADP+-dependent 
PGD 6-phosphogluconate dehydrogenase 
TALDO1 Transaldolase 
TKT Transketolase isoform 1 
UGDH UDP-glucose dehydrogenase 
Heme and iron metabolism BLVRA Billiverdin reductase A 
BLVRB Billiverdin reductase B  
FECH Ferrochelatase 
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FTH1 Ferritin, heavy polypeptide 1 
FTHL12 Ferritin, heavy polypeptide-like 12 
FTHL17 Ferritin, heavy polypeptide-like 17 
FTL1 Ferritin, light polypeptide 
HMOX1 Heme oxygenase 1 (also called HO1) 
Transcription factors and 
associated proteins 
MAFG MafG protein 
NRF2 Nuclear factor (erythroid-derived 2)-like 2 
PPARG Peroxisome proliferator-activated receptor γ 
PPARGC1B Peroxisome proliferator-activated receptor γ 
coactivator 1β 
RXRA Retinoid X factor α 
Ubiquitin ligase substrate 
adaptor 
KEAP1 Kelch-like ECH-associated protein 1 
 
Table 2. List of genes positively regulated by Nrf2 in humans [233,287]. 
 
1.4.4. Activators and inhibitors of Nrf2 
Numerous dietary phytochemicals naturally existing in vegetables, fruits and spices 
are considered as chemopreventive (Figure 29). These phytochemicals have been proven to 
activate Nrf2 [293]. For example, exposure to green tea extract containing epigallocatechin-3-
gallate (EGCG) has been shown to induce and activate Phase II enzyme gene expression in 
HepG2 cells, as determined by the ARE reporter-gene assay [294,295]. Sulphoraphane and 
cinnamaldehyde, the two active phytochemicals found respectively in broccoli and cinnamon 
are the two well-studied Nrf2 activators. These phytochemicals are indeed electrophiles that 
react with Keap1-Cys151 and increase Nrf2 levels via the canonical mechanism [281,282]. 
Recently, rosemary extract and carnosic acid were also reported to significantly upregulate the 
expression of Nrf2 in colon cells and inhibit a xenograft tumor formation in mice [296]. 
Bardoxolone and dimethylfumarate (DMF) are two Keap1-dependent Nrf2 activators 
that have advanced to clinical trials for multiple sclerosis and chronic kidney diseases. 
Bardoxolone, a natural product derived from triterpenoid, interacts with the BTB domain of 
Keap1, disrupting the BTB/Cul3 interface, leading to Nrf2 activation [297]. DMF (also 
known as BG-12 and Tecfidera) is able to adduct Keap1 and therefore activates Nrf2 
64 
 
[298,299]. Recently, Keap1-independent Nrf2 activators have emerged. For example, 
nordihydroguaiaretic acid (NDGA) was shown to induce Nrf2 through inhibition of 
phosphorylation of Neh6 motif in Nrf2 by GSK3β [300]. Additionally, 4U8C and LS-102 
activate Nrf2 by inhibiting IRE1 and Hrd1 respectively, thereby preventing Hrd1-dependent 
Nrf2 regulation [274].   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 29. Representative Nrf2-activating chemopreventive phytochemicals                                 
and their dietary sources [293] 
 
HNE has been widely reported to activate Nrf2 and contribute to the prevention of 
diseases like atherosclerosis, acute gastric mucosal lesions and cardiac disease [301-305]. 
This activation has been shown to be coordinated by activation of mitogen-activated protein 
kinase (MAPK) pathways, leading to nuclear translocation of Nrf2 and subsequent expression 
of cytoprotective enzymes [303]. However, the direct mechanism by which HNE activates 
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Nrf2 is still unknown. The ability of HNE to form protein adducts is suspected to be involved 
in Nrf2 activation by HNE through disruption of Nrf2 stability with its associated proteins 
[231]. 
 Several natural phytochemicals that are present naturally in many plant extracts can 
exert inhibitory activities against Nrf2 activation. Trigonelline, a coffee alkaloid, efficiently 
decreased tertiary butylhydroquinon (tBHQ)-induced Nrf2 activity in chemoresistant 
pancreatic carcinoma cell lines [306]. Chrysin (5,7-dihydroxyflavone), apigenin (4’,5,7-
trihydroxyflavone) and luteolin (3’,4’,5,7-tetrahydroxyflavone) are natural flavones present in 
many fruits and vegetables that reduced Nrf2 expression in hepatocellular carcinoma cells 
[307-309]. Brusatol is a quassinoid extracted from Brucea javanica that reduced Nrf2 protein 
level in various cancer cells and sensitized them to chemotherapeutic agents [310]. 
Carcinogenic ochratoxin A also inhibits Nrf2 responses and this is involved in its 
nephrotoxicity and renal carcinogenicity [311].  
1.4.5. Tumor suppressor functions of Nrf2 
There are abundant evidences showing that Nrf2 activation is able to suppress 
carcinogenesis, especially in its early stages. Nrf2 is even considered as a major mechanism 
of protection against chemical and radiation capable of damaging DNA integrity and initiating 
carcinogenesis [312]. The role of Nrf2 in chemoprevention is mainly focused on its ability to 
regulate the expression and coordinated induction of genes encoding cytoprotective enzymes 
in reponse to chemical and radiation stress, therefore preventing further cellular damages that 
might occur. This leads to reduced cell death and enhanced cell survival. In addition, Nrf2 has 
also been reported to upregulate anti-apoptotic proteins BCL-2 (B-cell lymphoma 2) and 
BCL-xL (Chapter 1.5.1), favoring cell survival by preventing apoptosis [313,314]. 
Some diverse chemopreventive drugs, which act as Nrf2 activators, have been applied 
to human usage and proven to inhibit early-stage colon carcinogenesis such as sulphoraphane 
[315]. The same effect has also been exerted by the application of celecoxib and curcumin, 
other types of chemopreventive drugs [316]. In a prevention study using genetic models of 
carcinogenesis, synthetic oleanane triterpenoids have been reported to delay the onset of 
oncogene-driven tumorigenesis [317]. 
A study using Nrf2-knockout mice has shown that mice deficient in Nrf2 underwent 
increasing sensitivity to carcinogenesis and loss in chemoprotective efficacy of enzymes 
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inducers [318]. In addition, their susceptibility to carcinogenesis induced by colon 
inflammation was reported to increase [319]. These findings emphasize the potential of Nrf2 
as a target for chemoprevention. However, numerous publications have revealed the 
potentially oncogenic activity of Nrf2 that would lead to increasing concerns about the safety 
of a long-term increase in Nrf2 activity. 
1.4.6. Paradox of Nrf2: protective and oncogenic 
As Nrf2 promotes cell survival under oxidative stress, it is logical to argue that 
increased Nrf2 activity could be tumor promoting by being protective to cancer cells [320]. 
Mutations on Keap1 or Nrf2-encoding genes have been found in several types of human 
cancers. These mutations disrupt Nrf2-Keap1 complex stability, leading to Nrf2 hyperactivity 
[234]. In the case of CRC, the promoter region of Keap1 gene is often hypermethylated. This 
hypermethylation inhibits Keap1 gene expression, which results in the accumulation of Nrf2 
[321]. Moreover, the fact that the expression of Nrf2 is induced by oncogenes [283] provides 
an idea that Nrf2 is also a defense system of cancerous cells to protect themselves. 
Additionally, an increase in Nrf2 level has been shown in tumor cells, together with an 
increase in the expression of cytoprotective enzymes and in the hyperanabolism of glucose 
molecules [249,316]. These findings show that Nrf2 might also give protective effects 
favoring carcinogenesis and therefore explain the chemoresistance of tumor tissues towards 
chemotheraphy. 
The revelation of both favorable and adverse effects of Nrf2 in carcinogenesis has 
raised doubts related to its potential as a target for chemoprevention. The action of Nrf2 is 
likened as a double-edged sword. On one hand, Nrf2 is beneficial because it may protect 
normal cells from oxidative stress by inducing the expression of cytoprotective enzymes. On 
the other hand, this protective effect may also be beneficial to the survival of cancerous cells 
and favor their development. These two opposing roles of Nrf2 depend on the tumor stage 
(Figure 30). Nrf2 activity is desirable (for the host organism) in early stages of tumorigenesis 
in order to enhance the endurance of normal cells towards oxidative stress and to prevent 
further malignancy. However, in cancerous cells, the enhancement of Nrf2 activity (caused by 
mutations) may confer protumorigenic metabolic alterations. For example, in skin 
carcinogenesis,  Nrf2 activation in oncogenicly-mutated keratinocytes increased the level of 
NADPH, purine and glutathione levels that promoted tumor development [322]. Nrf2 
activation would also protect tumors from insults generated from chemotheraphy, resulting in 
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its inefficiency. The importance of Nrf2 in tumor resistance concerning chemotheraphy has 
been highlighted in several studies, including those regarding CRCs. Knockdown of Nrf2 by 
siRNA (small interfering RNA) or shRNA (small hairpin RNA) enhanced the sensitivity of 
colon cancer cells to chemotheraphy agent 5-fluorouracil (5-FU) [323]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 30. Model for the importance of the context of tumor stage for                                         
the biological consequences of Nrf2 activation [232] 
 
 
1.5. Apoptosis and autophagy in carcinogenesis 
According to cell morphological appearance, cell death can be generally classified into 
three types: apoptosis, autophagy and necrosis [324]. Apoptosis and autophagy (also known 
as Type I and Type II cell-death respectively) are both considered as programmed cell death 
since their enrollment is mediated by an intracellular program. Necrosis (Type III cell-death, 
not discussed in this manuscript) is caused by external factors such as trauma and infection, 
and therefore is accidental or unprogrammed. HNE has been reported to be involved in these 
types of cell death [210].  
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1.5.1. Apoptosis 
Apoptosis (Figure 31) is mainly characterized by massive activity of caspases 
(cysteine-dependent aspartate-directed proteases) followed by cell shrinkage and 
fragmentation into smaller membrane-bound apoptotic bodies (membrane blebbing) before 
they are rapidly removed by other healthy cells through phagocytosis. The nucleus undergoes 
characteristic changes, including chromatin condensation and DNA breaks. Generally, 
apoptosis is not associated with a subsequent inflammatory response [325-327].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 31. Apoptosis snapshots showing its characteristics including                                   
membrane blebbing and chromatin condensation [325]. 
 
 
 
Caspases (cysteine aspartate-specific proteases) are the main actors of apoptosis. Two 
types of caspases are involved in apoptosis mechanisms: 1) initiator caspases (such as in 
mammals, caspase-8 and -9) and 2) executioner caspases (in mammals, caspase-3, -6 and -7). 
Initiator caspases, activated by dimerization by adaptor protein, serves to activate executioner 
caspases that cleave cellular proteins in general, therefore conducting “cell death by thousands 
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of cuts”. Caspases show preferences for cleaving their substrates based on peptide constitution 
in proteins. They generally cleave proteins after aspartate residue (coded as D in single letter 
amino acid code). The preferences for cleavage site of caspase-3, -6, -7, -8 and -9 are DELD, 
(T/V)QVD, DEVD, LETD and LEHD respectively [325,328,329].  
 There are two known pathways of apoptosis: 1) mitochondrial pathway (intrinsic 
pathway) that involves formation of mitochondrial pores and 2) death receptors-dependant 
pathway (extrinsic pathway) that involves ligand-mediated activation of membrane death 
receptors (Figure 32) [325,330]. Both pathways lead to activation of executioner caspases and 
have been shown to be able to interact with each other or other cell death mechanisms.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 32. Model for intrinsic and extrinsic pathways of apoptosis [331]. 
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The intrinsic apoptotic pathway involves mitochondrial outer membrane 
permeabilization (MOMP) following internal stimuli such as irreparable genetic damage, 
hypoxia, high cytosolic Ca2+ or severe oxidative stress [332]. This pathway is regulated by 
BCL-2 (B-cell lymphoma 2) family proteins that regulate the integrity of mitochondrial 
membrane. There are two main groups of BCL-2 proteins, namely the anti-apoptotic proteins 
(such as BCL-2, BCL-xL, BCL-W, BFL-1, and MCL-1) and the pro-apoptotic proteins (such 
as BAX, BAK, BAD, BCL-X, BID, BIK, BIM and HRK). While the anti-apoptotic proteins 
regulate apoptosis by blocking MOMP, the pro-apoptotic proteins promote such a  
permeabilization. The balance between the pro- and anti-apoptotic proteins determines 
apoptosis initiation. MOMP results in the release of pro-apoptotic cytochrome-c and other 
apoptotic factors such as apoptosis-inducing factor (AIF), second mitochondria-derived 
activator of caspase (Smac), direct IAP binding protein with low pI (DIABLO) and Omi/high 
temperature requirement protein A (HTRA2) [333]. The released cytochrome-c activates 
caspase-3 via the formation of a complex called apoptosome made up of cytochrome-c, 
APAF-1 and caspase-9. Smac/DIABLO and Omi/HTRA2 promotes caspase activation by 
binding to inhibitor of apoptosis proteins (IAPs) which subsequently leads to disruption in the 
interaction of IAPs with caspase-3 or -9 [334].  
The extrinsic apoptotic pathway is triggered by the interaction of extracellular ligands 
with receptors on the cell surface. Although several death receptors have been described, the 
best known death receptors are tumor necrosis factor receptor 1 (TNFR1) and Fas (CD95) 
with TNF (tumor necrosis factor) and Fas ligand (FasL) as their ligands respectively [335]. 
These death receptors possess an intracellular death domain that recruits adapter proteins such 
as TNF receptor-associated death domain (TRADD) and Fas-associated death domain 
(FADD). Activated FADD or TRADD dimerizes and activates initiator caspase-8. The 
assembly of death receptor, death ligand, adapter protein and caspase-8 is called DISC (death-
inducing signaling complex) and in turn activates executioner caspase-3 to carry out apoptosis 
[325,336]. It is noteworthy that different adaptor caspases are involved in intrinsic and 
extrinsic apoptotic pathway: caspase-9 in intrinsic pathway and caspase-8 in extrinsic 
pathway). However, the executioner caspases in both processes are caspase-3, -6 and -7. 
1.5.1.1. Apoptosis and carcinogenesis 
In carcinogenesis, the balance between cell proliferation and cell death is a critical 
factor since the disruption of this balance would drive the tendency of carcinogenesis forward 
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or backward [337]. Plausibly, too little cell death by apoptosis accompanied by too much cell 
proliferation can promote tumor formation as well as tumor progression. It is therefore not 
surprising that one of the characteristic features of human cancers is the inability to undergo 
apoptosis in response to stimuli that otherwise would trigger apoptosis in normal or sensitive 
cells [338]. Indeed, defective apoptosis is an acquired hallmark of cancer cells [339]. 
Cancer can be viewed as the result of a succession of genetic changes during which a 
normal cell is transformed into a malignant one while evasion of cell death is one of the 
essential changes in a cell that cause this malignant transformation. The defective apoptosis, 
which is observed in most cancer cells, is acquired through the successive mutations 
occurring during the carcinogenesis [340]. Through this evolutionary process, the transformed 
cells gain a better resistance to a certain insult compared to normal untransformed cells and 
this difference of resistance would favor the survival of transformed cells over normal cells, 
allowing further mutations and carcinogenesis [341] (Figure 4, Chapter 1.1.4). There are 
many ways a malignant cell can acquire apoptosis resistance. Generally, the mechanisms by 
which evasion of apoptosis occurs during carcinogenesis can be broadly divided into: 1) 
disrupted balance of pro- and anti-apoptotic proteins, 2) increased expression of anti-apoptotic 
factors (such as IAPs) or reduced expression of pro-apoptotic factors (such as caspases), 3) 
defects or mutations in apoptosis-related genes (such as pro-apoptotic p53) and 4) impaired 
death receptor signaling [331] (Figure 33). 
1.5.1.2. APC and apoptosis  
The link between APC and apoptosis is defined by armadillo repeat binding domain 
at N-terminal of APC protein (Figure 5) that is considered as a pro-apoptotic domain. During 
apoptosis, effector caspases-3 cleave APC resulting in two fragments: a fragment containing 
Armadillo repeat binding domain and a fragment containing β-catenin binding site [342]. The 
fragment with armadillo repeat binding domain then migrates to the mitochondria where it 
can promote cell sensitivity to apoptosis, thus exerting pro-apoptotic activity. However, this 
pro-apoptotic activity can be inhibited by mitochondrial 40-kDa apoptotic suppressor protein 
hTID-1 (human tumorous imaginal disc 1), that binds to the armadillo repeat binding domain 
of the cleaved APC at aa 202-512. Binding to 43-kDa isoform of hTID-1 enhanced the pro-
apoptotic activity of APC fragment containing armadillo repeat binding domain [343]. 
Furthermore, apoptosis also allows the cleavage of β-catenin, a protein that is activated in 
Wnt signaling pathway (Figure 6) [342]. 
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Figure 33. Mechanisms contributing to evasion of apoptosis and carcinogenesis [331].  
 
1.5.1.3. 4-Hydroxynonenal and apoptosis 
The role of HNE in intrinsic apoptotic pathway involves mitochondrial membrane 
disturbance, oxidative stress, p53 activation and AKT inhibition (Figure 34). Mitochondrial 
membrane contains a critical phospholipid called cardiolipin. Cardiolipin oxidation can 
generate HNE and activate MOMP [344]. HNE can also directly affect cellular redox status 
by depleting GSH, which can in turn induce mitochondrial crisis with mitochondrial ROS 
production and subsequent caspases activation [345,346]. AKT (also called protein kinase B, 
PKB) is a serine/threonine kinase that plays a key role in multiple cellular processes, 
including apoptosis. AKT regulates BCL-2 positively and BAX negatively, therefore favoring 
cell survival through apoptosis inhibition. Recently, HNE was shown to inhibit AKT and this 
inhibitory activity was related to HNE-induced apoptosis [347]. Tumor suppressor p53 is a 
transcription factor that regulates gene expression related to cell cycle, DNA repair and 
apoptosis. p53 is activated upon DNA damage and oxidative stress to protect and repair the 
cell, but if the stress or damage reaches a threshold, p53 triggers cell death. DNA damage or 
oxidative stress triggered by HNE can activate p53 which in turn will induce the expression of 
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proteins targeting apoptotic pathways and specifically repress the transcription of several 
death-inhibiting genes [348]. Some of p53 target genes that are involved in apoptosis 
machinery are BAX, PUMA (p53 up-regulated modulator of apoptosis) and NOXA (also 
known as PMAIP1, phorbol-12-myristate-13-acetate-induced protein 1) that exert pro-
apoptotic activity [349-352]. 
 
 
 
 
 
 
 
Figure 34. Role of HNE in intrinsic apoptotic pathway includes mitochondrial membrane 
disturbances, oxidative stress, AKT inhibition and p53 activation ([210] with modifications). 
 
HNE has also been shown to be involved in the extrinsic apoptotic pathway (Figure 
35). It promotes the expression of Fas (CD95), allowing cell sensitization to apoptosis when 
Fas-L is present in the microenvironment [353]. This up-regulation of Fas expression is linked 
to DNA damage or oxidative stress induced by HNE that activates p53 (Figure 34). Fas is a 
target gene of p53 and p53 is also involved in post-expressed Fas relocation to the cell surface 
[354,355]. The main pathway of Fas-signaling activation by HNE appears to be DISC-
independent without caspase-8 and FADD. HNE can form adducts with cysteine residues of 
Fas resulting in Fas aggregation that could mimic ligand-cell surface receptor binding. This 
phenomenon results in the downstream activation of ASK1 (apoptosis signal-regulating 
kinase 1) and JNK (c-Jun N-terminal kinase) that can regulate apoptosis. JNK can translocate 
to the nucleus and phosphorylate c-Jun that will form AP-1 (activator protein 1) transcription 
factor with phosphorylated c-Fos. This transcription factor regulates the expression of pro-
apoptotic genes [356]. JNK can also translocate to mitochondria and provoke MOMP to 
trigger the intrinsic apoptotic pathway [357]. Lastly, in the nucleus, HNE can create covalent 
links with nuclear protein Daxx (death domain-associated protein) via histidine residues and 
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induce Daxx export to the cytosol. Subsequently, Daxx can form a complex with Fas that 
exerts apoptosis negative feedback by regulating negatively JNK [358,359].  
 
 
 
 
 
 
 
 
 
 
 
Figure 35. Role of HNE in extrinsic apoptotic pathway includes Fas aggregation-related               
JNK activation and induction of Daxx export to the cytosol [210]. 
 
1.5.2. Autophagy 
Autophagy is defined as a lysosomal-mediated degradation activity providing an 
essential mechanism for recycling cellular constituents and clearance of excess or damaged 
lipids, proteins and organelles [360].  Cells utilize autophagy to recycle basic molecules 
during nutrient deprivation, to scavenge harmful or damaged organelles and to eliminate 
intracellular pathogens. As such, the autophagic process plays a crucial role in maintaining 
cellular homeostasis and also contributes to cell survival during stress [361,362]. Depending 
on the route of delivery to the lysosomes, three different types of autophagy are defined: 1) 
microautophagy, 2) chaperone-mediated autophagy and 3) macroautophagy (Figure 36).  
Microautophagy describes extension and/or invagination of lysosomal membranes to 
engulf and degrade intracellular contents [363,364]. This process has been shown to be 
dependent on ATP and microfilaments and be facilitated by phospholipid-HSC70 (heat shock 
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cognate 70) interaction [365-367]. Chaperone-mediated autophagy involves chaperone protein 
HSC70 recognizing proteins with a consensus KFERQ sequence and bringing the proteins to 
the lysosomes via lysosome-associated membrane protein 2A (LAMP-2A) receptor [368]. 
Macroautophagy is characterized by formation of double-membrane vesicles that recognize 
and encircle intracellular excessive or damaged lipids, proteins and organelles. The 
autophagic vesicles (autophagosomes) then fuse with lysosomes (autophagolysosomes) and 
their contents are degraded by lysosomal enzymes [369,370]. These three types of autophagy 
have shared as well as independent machineries and their activities may compensate or 
regulate one another. This part will solely focus on macroautophagy, which is hereafter 
simply termed autophagy (Figure 37). 
 
 
 
 
 
 
 
 
 
 
Figure 36. Three types of autophagy:                                                             
microautophagy, chaperone-mediated autophagy and macroautophagy [360]. 
 
At the beginning of its discovery, autophagy was assumed to be a bulk degradation 
pathway for intracellular components and therefore, was considered as a non-selective 
process. Recent studies, however, have highlighted the capacity of this pathway to selectively 
eliminate specific intracellular structures and thus better fulfil the catabolic necessities of the 
cell. Non-selective bulk autophagy, characterized by indiscriminate sequestration of cytosolic 
cargos to autophagosomes, is believed to ensue as a response to nutrient deprivation. This 
process mediated the recycling and global turnover of cytoplasmic materials. In contrast, 
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selective autophagy consists of the removal of specific cargos (including unfolded or 
aggregated proteins, several organelles and intracellular pathogens). Several types of selective 
autophagy have been identified and these processes turn over specificly a type of organelles. 
Cargo-specific names have been given to distinguish the various selective pathways, 
including the ER (reticulophagy), peroxisomes (pexophagy), mitochondria (mitophagy), lipid 
droplets (lipophagy), secretory granules (zymophagy), parts of the nucleus (nucleophagy), 
pathogens (xenophagy) and ribosomes (ribophagy) [371,372]. 
 
 
 
 
 
 
 
Figure 37. Electron micrographs showing macroautophagy (autophagy) in harmol-treated 
U251MG human glioma cells (100 µM, 12 h). The white arrows point to autophagosomes and 
autolysosomes (scale bar, 2 µm) [373]. 
 
The  key players in selective autophagy are the so-called autophagy receptors. These 
latter play an important role in selective autophagy by allowing the recognition of cargos to be 
engulfed by the autophagosomes. Autophagy receptors connect the cargos to the 
autophagosomal membrane. The lipidated proteins light chain 3 (LC3)-II present in the inner 
and outer leaflets of autophagosomal membrane are the targets of autophagy receptors for 
cargo recognition (Figure 38). In general, autophagy receptors possess two important domains 
called LC3-interacting region (LIR) and ubiquitin-binding domain (UBD) that allow them to 
bridge LC3-II proteins in the autophagosomal membrane and the ubiquitylated cargos 
respectively [374]. p62/sequestosome 1 (SQSTM1) was the first selective autophagy receptor 
described in mammalian cells. So far, four human ubiquitin-binding autophagy receptors have 
been identified and are classified in a group named sequestosome 1-like receptors (SLRs): 
p62, NBR1 (neighbor of breast cancer early-onset 1 gene 1), NDP52 (nuclear dot protein 52) 
and OPTN (optineurin) [375].  
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Figure 38. Autophagy receptor recognizes cargos and allows their                             
recruitment to the autophagosomal membrane [375]. 
 
Autophagy machinery consists of more than 30 proteins and regulators that are 
involved in the signaling for autophagy stimulation and the formation of autophagosomes. 
The main regulatory pathway involves: 1) initiation of autophagy regulated by mTOR 
(mammalian target of rapamycin) inhibition, 2) nucleation of autophagic vesicles, 3) 
extension of autophagosomal membranes by ubiquitin-like conjugation pathways as well as 
LC3-II insertion into autophagosomal membranes and 4) cargo recognition, including p62 
binding to both ubiquitinated proteins and LC3-II (Figure 39).  
 
 
 
 
 
 
 
 
 
 
Figure 39. Proteins involved in autophagy machinery [360]. 
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mTOR (mammalian target of rapamycin) is the key regulator of autophagy and its 
activity depends on nutrient availability. When nutrients or amino acids are plentiful, mTOR 
is active; cells grow and autophagy is inhibited. However, when energy levels are low, AMP 
(adenosine monophosphate) accumulates and this activates a kinase, AMPK (AMP kinase), 
that inhibits mTOR, and therefore autophagy is engaged. mTOR is also inhibited in response 
to insulin receptor withdrawal. The drug rapamycin is a potent inhibitor of mTOR and the 
addition of this drug to cells induces autophagy [325].  
Autophagy in mammals is initiated by the ATG13 (AuTophaGy-related gene 13) 
complex containing a kinase called ULK1 (unc-51-like autophagy activating kinase 1), 
ATG13, ATG101 and FIP200. When autophagy is activated, this complex dissociates, ULK1 
activates ATG13 by phosphorylation and ATG13 recruits the next complex in the pathway for 
nucleation of vesicles. This complex contains Beclin-1, ATG14, VPS34 (vacuolar protein 
sorting 34) and VPS15. During the extension of autophagosomal membranes, ATG7 is 
brought in, binding ATG12 and passing it to ATG10, which then places it on another protein, 
ATG5 by ubiquitin-like conjugation pathways. The ATG5-ATG12 complex recruits another 
protein, ATG16 to form the platform for the next step in the process. This complex associates 
with the autophagosomal membrane at an early step and dissociates from the autophagosomes 
upon completion of autophagy [325,360]. The source of autophagosomal membrane has been 
proposed to be plasma membrane, endoplasmic reticulum, Golgi and mitochondrial 
membranes [376,377].  
The protease ATG4 cleaves pro-LC3 into LC3-I exposing a glycine residue at the C-
terminal. LC3-I is then conjugated with ATG7 then ATG3 via thioester bonds and with 
phosphatidylethanolamine (PE) through an amide bond, forming LC3-II and insertion into 
autophagosomal membrane. LC3-II association with the autophagosomes will be sustained 
until autophagosomes fuse with lysosomes. ATG4 is able to delipidate LC3-II back to LC3-I. 
The transfer of cargos into autophagosomes involves p62, an adaptor protein that recognizes 
ubiquitinated proteins [325,360]. The structure of p62 contains LC3-interacting regions (LIR) 
that enables it to bind to LC3-II embedded in the autophagosomal membrane, thus bridging 
the link between the autophagosomal membrane and to-be-degraded cargos [376,378,379]. 
1.5.2.1. Autophagy and oxidative stress 
It is commonly accepted that the principle source of endogenous oxidative stress in the 
cell is the mitochondrial respiratory chain that generates ROS. Indeed, oxidative stress has 
79 
 
been reported to induce autophagy and antioxidant supplementation partially or completely 
reverted the process [380-385]. The interplay between autophagy and oxidative stress is 
presented in Figure 40. Superoxide (O2-) and H2O2 are the principle ROS generated by 
mitochondria upon nutrient deprivation. They positively regulate autophagy by means of at 
least three different mechanisms: 1) S-glutathionylation (SH→S-SG) of cysteines located in 
the subunits of AMPK, 2) oxidation of Cys81 (SH→Sox) of ATG4 that in turn leads to the 
inactivation of its ‘delipidating’ activity on LC3 and to the accumulation of the pro-
autophagic LC3-II form and 3) wide alteration of thiol redox state (e.g., decrease of 
GSH/GSSG ratio and increase of oxidized thiols, Sox) that is facilitated by the release of GSH 
to the extracellular milieu through MRP1. Following its activation by ROS, autophagy is 
directed to degrade intracellular components damaged by ROS and to participate in p62-
regulated Nrf2 activation through the degradation of Keap1 (Chapter 1.4.2.4).  
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 40. Interplay between autophagy and oxidative stress [386]. 
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1.5.2.2. Autophagy and immune system 
The immune system exists as a protection mechanism against diseases or other 
potentially damaging foreign bodies towards human body. Autophagy has been reported to be 
involved in such a process. At least four scopes have been identified to explain the roles of 
autophagy in immunity: 1) elimination of microorganisms, 2) control of pro-inflammatory 
signaling, 3) adaptive immunity and 4) secretion of immune mediators (Figure 41). 
Autophagy is involved in the elimination of microorganisms present in the cell (Figure 
41A). An incoming bacterium can induce autophagy by competing for nutrient with the host 
cell, thereby inhibiting mTOR. Innate immune receptors such as Toll-like receptors (TLRs) 
can also detect the presence of a bacterium and induce a particular type of phagocytosis 
mediated by LC3 called LC3-associated phagocytosis (LAP). This process is dependent on 
TNF receptor-associated factor 6 (TRAF6) and the formation of ROS involving NAD(P)H 
oxidase (NOX). Xenophagy can also take place to degrade the invading bacterium, both non-
selectively (dependent on NOD2 (nucleotide-binding oligomerization domain-containing 
protein 2) and ATG16L1 (ATG16-like 1)) or selectively by involving autophagy receptors 
SLRs. Apart from detecting ubiquitins, some SLRs can also recognize galectins bound to 
pathogen-associated damaged vacuolar membranes. Genetic materials of a virus can also be 
degraded by xenophagy [387].  
Autophagy is also able to control pro-inflammatory signaling (Figure 41B). 
Autophagy can deliver cytoplasmic pathogen-associated molecular patterns (PAMPs) to 
pattern recognition receptors (PRRs) such as endolytic TLRs and stimulate pro-inflammatory 
mediators. Failure to remove SLRs by autophagy can also increase the levels of pro-
inflammatory signaling. Several phenomena can also incite inflammasome-mediated pro-
inflammatory signaling by activating interleukins (IL) IL-1β and IL-18, such as leak of 
lysosomal protease, potassium ion (K+) efflux and damaged mitochondria. Damaged 
mitochondria liberate ROS and mitochondrial DNAs into the cytoplasm that activate NLRP3 
(NOD-, leucine-rich repeats (LRR)- and pyrin domain-containing protein 3) and AIM2 
(absent in melanoma 2) inflammasomes. Autophagy can limit inflammasome activation by 
removing damaged mitochondria. In addition, autophagy proteins ATG5-ATG12 can inhibit 
inflammatory signaling by disrupting the interaction between RIG-I (retinoic acid-inducible 
gene I) and IPS1 (Interferon β promoter stimulator protein 1) that activates Type I IFN 
(interferon), a pro-inflammatory factor [387]. 
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Figure 41. Principal roles of autophagy in immunity consisting of                                                   
A) Elimination of microorganisms, B) Control of pro-inflammatory signaling,                            
C) Adaptive immunity and D) Secretion of immune mediators [387]. 
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In adaptive immunity, autophagy is involved in the antigen presentation and the 
homeostasis of B cells and T cells (Figure 41C). The major histocompatibility complex 
(MHC) is a set of cell surface proteins displaying fragments derived from pathogens (or 
particulate and citrullinated antigens) for recognition by T cells. Autophagy, along with 
NOD2 and LAP, mediate the activity of MHC class II. Autophagy affects MHC class I 
presentation by competing with proteasome for protein acquisition and, furthermore, by 
increasing the protein pools through the inhibition of micro RNA (miRNA) component 
machineries AGO (argonaute) and DICER. In addition, autophagy affects the self-renewal of 
hematopoietic stem cells (HSCs), B1 cell development, plasma cell survival and IgG 
secretion. Autophagy affects thymic selection of T cell repertoire, T cell maturation, T cell 
survival following T cell receptor (TCR) activation and immunological synapse 
destabilization. It also controls innate immune cell (such as macrophage) signaling through 
the release of IL-1α and IL-1β which influence the polarization of T cells into T helper 17 
(TH17) cells [387]. 
Autophagy also participates in the secretion of immune mediators (Figure 41D). Some 
of these mediators are stored as pre-made secretory granules that are secreted regulatedly, 
such as cathepsin K in osteoclasts and lysozyme in Paneth cells. Autophagy also affects the 
constitutive secretory pathway, which is the conventional pathway of protein secretion (such 
as IL-6 and IL-8) via the ER, Golgi apparatus and plasma membrane. Autophagy supports a 
form of unconventional pathway of protein secretion that captures cytoplasmic proteins for 
extracellular release independent on the ER and the Golgi apparatus. This process has been 
shown in the secretion of damage-associated molecular patterns (DAMPs) that promote pro-
inflammatory signaling such as IL-1β, IL-18 and HMGB1 (high mobility group box 1). 
However, this pathway is unclear and yet to be investigated [387]. 
The importance of the role of autophagy in immune system and inflammation is 
reflected in the case of Crohn’s disease. This latter is a complex and chronic disorder 
affecting primarily the digestive system and is characterized by abnormal inflammation in the 
walls of ileum and colon. It is one common form of inflammatory bowel disease (IBD) 
[388,389]. Genome wide association studies (GWAS) have revealed common mutations on 
autophagy genes found in people suffering from Crohn’s disease. These genes express NOD2, 
ATG16L1 and IRGM (immunity-associated GTPase family M) whose role is important in 
xenophagy of pathogens (Figure 40A) [390,391]. IRGM is a mitochondria-associated protein 
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which supports autophagosome biogenesis from mitochondrial membrane upon viral infection 
[392]. Indeed, Crohn’s disease is suggested to arise from a defective innate immune response 
to enteric bacteria, particularly adherent invasive Escherichia coli (AIEC) strains [393]. In 
transgenic mouse models, the invalidation of ATG16L1 and IRGM1 has been shown to lead to 
a constitutive expression of pro-inflammatory cytokines in the macrophages [394,395]. In 
relation to CRC, Crohn’s disease has been identified as a risk factor of CRC with a relative 
risk of 2.5 (95% CI 1.3-4.7) according to the most recent meta-anaysis study [14].  
1.5.2.3. APC and autophagy 
The link between APC and autophagy is established mostly through in vivo studies 
using Min mice. However, the studies on autophagy and intestinal tumorigenesis in Min mice 
showed different findings. In 2012, autophagy was thought to be not involved in intestinal 
tumorigenesis in Min mice [396]. Intestinal polyp regions in Min mice were reported to exert 
slightly higher autophagy than non-polyp regions and ATG7 invalidation in Min mice did not 
induce intestinal tumorigenesis. In 2015, ATG5 invalidation in Min mice was reported to 
induce intestinal adenoma growth [397]. Another study in 2015, that showed for the first time 
the status of autophagy in human CRC, proposed that autophagy was activated in intestinal 
tumorigenesis in Min mice and human CRC. An activation of ATG gene transcription was 
reported in 20% of human CRC samples [398]. Autophagy inhibition through ATG7 deletion 
was shown to prevent tumor initiation and suppress tumor growth in Min mice. The authors 
reported that autophagy inhibition in Min mice resulted in dysbiosis of gut microbiota, 
increasing intestinal permeability, activation of immune response via a greater production of 
IL-12 and infiltration of anti-tumor response mediated by cytotoxic CD8+ T cells [399]. These 
phenomena contributed to inhibit tumor initiation in the intestine of Min mice. 
Autophagy has been reported to negatively regulate Wnt signaling in eukaryotic cells 
through the degradation of disheveled (Dsh), a protein that is important in the uncoupling of 
β-catenin and its degradation complex (Figure 6). In human CRC, defective autophagy 
induced aberrant activity of Wnt signaling pathway resulting in enhanced colonic tumor 
formation [400]. Low-dose treatment of rapamycin, an inducer of autophagy, has been 
reported to inhibit intestinal tumorigenesis in Min mice [401].  
 
 
84 
 
1.5.2.4. 4-Hydroxynonenal and autophagy 
HNE has been shown to induce autophagy in vascular smooth muscle cells, SH-SY5Y 
neuroblastoma cells and rat aortic smooth muscle cells [402-404]. Exposure to substances that 
can mediate HNE formation through lipid peroxidation, such as ferritin or drug inhibitor for 
Parkinson’s disease GSK257815A, also provoked autophagy [405,406]. The mechanism by 
which HNE induces autophagy is believed to involve ER stress (discussed briefly in Chapter 
1.4.2.3).  HNE forms adducts and modifies proteins, and these HNE-modified proteins 
accumulate in the ER to trigger ER stress, which in turn is an important source of signals 
stimulating autophagy [407,408]. Ethanol exposure towards retinal pigment epithelium (RPE) 
cells induced the degradation of neoformed HNE aggresomes through autophagy [409]. 
Activation of autophagy following HNE-induced protein damages largely contributes to the 
elimination of these damaged proteins and also prevented cell death by apoptosis [403], 
thereby highlighting the protective role of autophagy as a cellular defense mechanism 
regarding HNE toxicity [410]. The liver of transgenic mice overexpressing LAMP-2A 
receptors accumulated fewer damaged proteins compared to wild type controls due to 
enhanced autophagy [411]. It also appears that inhibition of autophagy can trigger apoptosis, 
supporting the fact that autophagy is probably a defense system for survival. HNE-protein 
adducts were shown to reduce autophagy in RPE cells, leading to apoptosis induction [412].  
The HNE-induced autophagy activation is also modulated by HNE detoxification 
enzymes, such as ALDH2 or GSTA4. In the case of myocardial ischemia-reperfusion injury, 
ALDH2 has appeared to exert cardioprotective effects by inhibiting HNE reactivity and 
suppressing autophagy or mitophagy, a selective form of autophagy targeting the lysosomal 
degradation of mitochondria [413-415]. The role of GSTA4 has been shown to be pivotal in 
alleviating obstruction-induced tubule damage and renal fibrosis by preventing HNE-induced 
autophagy activation [416]. 
Finally, not all HNE intervention induces autophagy as a clearance mechanism of 
HNE-damaged proteins. Intracellular proteins that are severely damaged by HNE may 
become undegradable by autophagy due to their aberrant covalent modifications and their 
deposition is potentially cytotoxic. HNE can also interfere with lysosomal protease activities 
and impair their functions directly or through modifications of their subsrate peptides [417]. 
In human RPE cells, HNE-induced lysosomal dysfunctions have been reported to reduce 
autophagy in vitro [412]. 
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1.5.2.5. Link apoptosis-autophagy 
Apoptosis and autophagy are two distinct mechanisms regulating cell death and 
survival. However, they are not truly independent one on another and therefore, they are 
linked through interaction of apoptotic and autophagic components in the cell. The interaction 
between BCL-2 and Beclin-1 has been well known to explain the way in which cells balance 
and regulate apoptosis and autophagy (Figure 42). 
 
 
 
  
 
 
 
 
Figure 42. Interaction between BCL-2 and Beclin-1 regulates apoptosis and autophagy [362]. 
 
As previously described in Chapter 1.5.1, BCL-2 is an anti-apoptotic protein and 
Beclin-1 is involved in the nucleation of autophagosomes. At the endoplasmic reticulum, 
BCL-2 inhibits autophagy by binding to Beclin-1. This binding is regulated by several 
mechanisms, including competitive binding of the pro-apoptotic protein BIK to BCL-2 and 
phosphorylation of BCL-2 by a kinase JNK1 that will disrupt the binding and liberate Beclin-
1 [418,419]. Once Beclin-1 is free, it is phosphorylated by DAPK (death-associated protein 
kinase) and becomes active to be involved in the formation of autophagosomes. The link 
between BCL-2 and Beclin-1 has also been reported to involve p62. This latter is able to 
directly interact with BCL-2 and disrupt the association between BCL-2 and Beclin-1 [420]. 
In the mitochondria, BCL-2 inhibits apoptosis by interacting with pro-apoptotic proteins BAX 
and BAK. Other pro-apoptotic proteins (e.g. BAD, NOXA, BID and others) activate apoptosis 
by inhibiting BCL-2 and its related anti-apoptotic family members [421,422]. Nevertheless, it 
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has been suggested that mitochondria-localized BCL-2 is also involved in inhibition of 
autophagy by sequestering a mitochondrial pool of AMBRA1 (activating molecule in Beclin-
1 regulated autophagy protein 1), a positive regulator of Beclin-1 [423]. Caspases (caspase-3, 
-7 and -8) have also been reported to cleave Beclin-1, thereby destroying its pro-autophagic 
properties [424,425]. 
Another way by which apoptosis and autophagy are linked involves pro-apoptotic 
activity of ATG5, an autophagy protein. Following death stimuli, ATG5 is cleaved by calpain, 
a cytosolic calcium-activated cysteine protease, resulting in truncated ATG5 (tATG5). This 
latter is able to bind anti-apoptotic protein BCL-xL, leading to mitochondria-mediated 
apoptosis [426,427]. TNFα (tumor necrosis factor alpha), a ligand for extrinsic apoptosis 
pathway, has been shown to induce autophagy in cancer cell lines and this induction was 
repressed by activation of NF-κB (nuclear factor kappa-light-chain-enhancer of activated B 
cells), an important anti-apoptotic factor [428,429]. Pro-apoptotic transcription factor p53 has 
also been reported to regulate autophagy [430,431]. 
The functional relationship between apoptosis and autophagy (Figure 43) is complex 
in the sense that on one hand, autophagy allows a stress adaptation that avoids cell death 
(suppresses apoptosis) whereas on the other hand, autophagy constitutes an alternative 
pathway to cellular death. In general terms, it appears that similar stressors can induce either 
apoptosis or autophagy in a context-dependent setting. Different sensitivity thresholds would 
dictate whether apoptosis or autophagy will develop. The choice between apoptosis and 
autophagy is influenced by the fact that the two processes exhibit mutual inhibition. In some 
cases, a mixed phenotype of apoptosis and autophagy can be detected in a single cell. 
Although autophagy mostly allows cells to adapt to stress, massive autophagy can also kill 
cells. 
  
 
 
 
 
Figure 43. Relationship between apoptosis and autophagy [432]. 
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The mutual inhibition between apoptosis and autophagy has been observed in several 
studies: autophagy when apoptosis is inhibited or apoptosis due to inhibited autophagy. 
Mouse embryonic fibroblasts (MEFs) from apoptosis-defective double-knockout BAX-/- 
BAK-/- mice underwent autophagy upon exposure to apoptosis inducer etoposide [433]. In 
vitro, chemical inhibition of caspases by general caspase inhibitor Z-VAD-FMK 
(benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone) caused autophagy in selected 
cell types (such as L929 mouse fibrosarcoma and human Jurkat T cell lymphoma) [434]. 
Autophagy inhibition in nutrient-deprived HeLa or HCT116 cancer cells resulted in apoptosis. 
Interestingly, the phenotype of the dying cells was influenced by the stage at which autophagy 
was inhibited. When autophagy was blocked at an early stage, cells underwent a typical 
apoptosis. However, when the fusion of autophagosomes and lysosomes was blocked by 
lysosomal inhibitors (such as chloroquine or bafilomycin A), autophagic vacuoles cumulated 
and the cells manifested a mixed of apoptotic and autophagic morphology [435,436].   
1.5.2.6. Autophagy in cancer: good or bad? 
Since autophagy favors cell survival upon stress, nutrition deprivation and even 
apoptosis triggers, it is considered as “good” in normal cells. However, one can also imagine 
the “bad” side of autophagy when it protects cancer cells from stress or death triggers such as 
chemotherapy treatment. Because of this duality, autophagy is referred as a “double-edged 
sword”. Therefore, a question of whether the role of autophagy in cancer is good or bad 
submerges. The ideal condition would be to boost autophagy in normal cells to prevent cancer 
but inhibit it in cancer cells as part of a cancer treatment strategy [437]. The role of autophagy 
in cancer promotion and suppression is shown in Figure 44. 
Autophagy was originally thought to be a tumor suppression mechanism due to the 
reported allelic loss of Beclin-1 in 40% to 75% of human breast, ovarian and prostate cancers 
[438,439]. In the case of breast cancer, this loss might be linked to the subsequent allelic loss 
of an adjacent tumor suppressor gene BRCA1 (breast cancer 1) [440]. Indeed, Beclin-1 and 
ATG gene deletion has been shown to favor tumor development in vivo and in vitro [441-
445]. Based on these findings, autophagy deficiency is considered as a molecular event in 
tumor initiation (Figure 44A). Autophagy deficiency produces the accumulation of damaged 
proteins in the cells that causes oxidative stress, chronic inflammation, DNA damage, 
stem/progenitor expansion and tumor initiation [446,447].  
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Figure 44. Role of autophagy in tumor promotion.                                                                     
A) Autophagy deficiency favors tumor promotion by accumulating                                    
damaged proteins and organelles, B) Autophagy in cancer cells promotes                           
tumor promotion by favoring survival and growth, whereas loss of autophagy                                                    
restricts tumor promotion by provoking apoptosis ([447] with modifications). 
 
Like normal cells, cancer cells also rely on autophagy to survive. For instance, CRC 
cells exerted autophagy as a classical way to resist nutrient deprivation [448]. Chemical 
inhibition of autophagy has been shown to sensitize colon cancer cells to chemotherapy agent 
5-fluorouracil [449]. In many cases, cancer cells are more autophagy-dependent than normal 
cells. Some cancer cell lines even possess abnormally high levels of basal autophagy under 
fed conditions. This suggests that oncogenic events create inherent metabolic stress 
necessitating autophagy to sustain tumor cell survival [444,447,450,451]. Autophagy in 
cancer cells favors their survival, proliferation and malignancy (Figure 44B, left panel) and 
therefore is considered as “bad”. Impairing autophagy in cancer cells would be a plausible 
hypothetic way into tumor suppression. Autophagy deficiency might lead to stress caused by 
accumulation of defective proteins in cancer cells, growth arrest, senescence and facilitated 
apoptosis as cell death mechanism (Figure 44B, right panel). In the case of CRC, autophagy 
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impairment through inhibition of ATG7 in murine and human CRC epithelial cells prevented 
tumor initiation and suppressed tumor growth [398].  
However, a link seems missing between the early events of tumorigenesis where 
autophagy is impaired and the following events that require autophagy for progression from 
benign to malignant tumors. Possible mechanism involving oncogenic K-RAS or B-RAF has 
been developed (Figure 44B). K-RAS and B-RAF genes are mutated in numerous cancers. K-
RAS- and/or B-RAF-mutated cancer cells have a high dependence on autophagy and exert 
high level of autophagy. K-RAS and B-RAF impair acetyl-co A production and therefore 
prevent Krebs cycle and β-oxidation. Thus, they potentially leave cells dependent on 
autophagy to provide substrates, such as amino acids and fatty acids, for acetyl-co A 
biosynthesis.  
Since the realization that autophagy is a survival pathway for tumor cells, there has 
been a great interest in inhibiting autophagy for cancer therapy. Indeed, numerous autophagy 
inducers and inhibitors have been used for treatment of almost all types of cancer [452]. 
These substances are whether used alone or in combination with other chemotherapy drugs. 
For instance, inhibition of autophagy sensitized brain tumor cells to chemotherapy [453]. 
Nevertheless, autophagy inhibition, especially in combination therapy, may pose cytotoxicity 
issues, such as to the liver and brain. Stem cells may also be more sensitive to autophagy 
inhibition than differentiated tissues [454]. Despite still needing developing, targeting 
autophagy in cancer treatment is promising to improve cancer treatment [455]. 
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Chapter II 
OBJECTIVES 
 
My thesis was focused on mechanistic studies of the roles of heme-induced lipid 
peroxidation in promoting colorectal carcinogenesis, especially by provoking positive 
selection of preneoplastic colon cells to the detriment of normal colon cells. The base of these 
studies was that HNE, a product of heme-induced lipid peroxidation, induced higher mortality 
in mouse-origin normal cells than in preneoplastic cells harboring APC mutation and this 
phenomenon was also observed upon exposure to fecal water of heme-fed rats [61]. This 
difference of mortality between normal and preneoplastic cells would favor colorectal 
carcinogenesis promotion following the consumption heme-containing foods, such as red 
meat. 
HNE is a molecule generated by heme-induced lipid peroxidation. Surely, there are a 
plethora of other molecules derived from heme-induced lipid peroxidation apart from HNE, 
mainly aldehydes. To study the role of lipid peroxidation in the promotion of colorectal 
carcinogenesis by red meat  thoroughly, I used fecal water (aqueous fecal extract) of heme-fed 
rats obtained from in vivo experiments by feeding rats with standard diet supplemented with 
hemoglobin or beef as sources of heme iron. This fecal water represents the real biological 
matrix of molecules derived from luminal lipid peroxidation that are in direct contact with 
colon cells. Therefore, fecal water provides a complementary approach to study the effects of 
heme-induced lipid peroxidation on colorectal carcinogenesis promotion. 
The main objectives of my thesis are (1) to compare the toxicity of purified HNE and 
fecal water of rats fed with purified heme or red meat, (2) to prove that lipid peroxidation-
derived aldehydes are responsible for the different toxicity of fecal water of heme-fed rats in 
mouse-origin normal and preneoplastic cells, (3) to study the different fecal water toxicity in 
human colon cells and (4) to understand the mechanisms involved in this different toxicity. 
The hypothesis is that heme-induced lipid peroxidation is responsible for this different 
toxicity by preferentially inducing apoptosis in normal cells compared to preneoplastic cells. 
Three main questions were directed to reach the goals: 
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 Are lipid peroxidation-derived aldehydes the main compounds determining the 
different toxicity of fecal water of heme-fed rats in mouse-origin normal and 
preneoplastic cells? 
 In addition to mouse cells, is this different toxicity also observed in wild type and APC 
knockdown human colon cells? 
 What are the mechanisms involved in the resistance of preneoplastic cells upon 
exposure to fecal water of heme-fed rats? 
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Chapter III 
EXPERIMENTAL MODELS 
 
 Two experimental in vitro models for APC mutation were used in this study: 1) 
mouse-origine APC +/+ and APC Min/+ cells [61,100] and 2) human-origin CT and CTA 
cells [101,102]. Both models were established to study early changes in colorectal 
carcinogenesis. In addition, the use of fecal water in this study is also detailed in this chapter. 
3.1. Mouse-origin APC +/+ and APC Min/+ cells 
The use of cells carrying only APC mutation would allow to investigate early 
phenomena that take place at the beginning of colorectal carcinogenesis. APC mutation is one 
of the earliest events that transform normal wild-type cells into early adenomas representing 
precancerous or preneoplastic phenotype (Figure 3). Here, my team developed mouse-origin 
APC +/+ and APC Min/+ (called normal and preneoplastic cells respectively) in 2003 [100]. 
The establishment of these cell lines consisted of mating of a heterozygous female 
“Immortomouse” with a male C57BL/6J mouse or with a heterozygous APC-mutated Min 
mouse (Figure 45). Immortomouse is transgenic mouse harboring a temperature-sensitive 
mutation of the simian virus 40 large T antigen gene (for cell immortalization) under the 
control of interferon γ which induces the promoter MHCI (major histocompatibility complex 
I) [456]. Large T antigen inactivates p53 and favors cellular proliferation [457].  
 
 
 
 
 
 
 
Figure 45. Establishment of mouse-origin APC +/+ and APC Min/+ cells                             
(adapted from [100]). 
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The two cell lines (APC +/+ and APC Min/+) were isolated from the colon crypts of F1 
progeny mice. Cultured at 33°C in the presence of interferon γ, the cells proliferate while at 
37°C without interferon γ, they cease to proliferate, behaving like a primoculture. Several 
differences have been identified between APC +/+ and APC Min/+: 1) destructured actin 
network in APC Min/+ cells, 2) higher level of nuclear β-catenin in APC Min/+ cells and 3) 
aneuploidy in APC Min/+ cells (3n). These differences appear as the consequences of the lack 
of APC protein, which has substantial roles in the regulation of cytoskeletal integrity, Wnt 
signaling pathway and chromosome segregation.  
3.2. Human-origin CT and CTA cells 
The establishment of human-origin colon cells that represent APC mutation is very 
interesting in terms of early CRC-related in vitro studies. The precedent available human 
colonic epithelial cell (HCEC)  lines were only of malignant origin and/or contained multiple 
cytogenetic changes which do not represent early colorectal carcinogenesis. In addition, for 
my team, this human-origin experimental model allows to approach human physiology. 
Human-origin CT and CTA cells established in 2010 were obtained from biopsy 
samples of two healthy patients undergoing routine screening colonoscopy [101]. Following 
isolation and culture, these cells were immortalized by successive infections of non-oncogenic 
proteins CDK4 (cyclin-dependent kinase 4) and hTERT (human telomerase reverse 
transcriptase). CDK4 is a catalytic subunit of the protein kinase complex that is important for 
cell cycle G1 phase progression and the loss of CDK4 has been reported to cause cellular 
senescence in ARF (adenosine diphosphate ribosylation factor)/p53-independent manner 
[458,459]. hTERT is a catalytic unit of the enzyme telomerase that reverses telomere 
shortening during DNA replication [460]. Telomerase shortening is associated with ageing, 
mortality and ageing-related disease [461]. Indeed, CT stands for the initial of CDK4 and 
hTERT. Following introduction of shRNA against APC in CT to silence APC gene 
expression, CTA cells were obtained (CTA stands for CDK4, hTERT and APC) [102].  
3.3. Fecal water of heme-fed rats 
Fecal water is an aqueous extract of feces representing bioavailable parts of fecal 
matters. It is indeed a matrix complex containing numerous substances originated from 
indigested part of consumed foods, secreted molecules during digestion or neoformed 
compounds in the gastrointestinal tract. Components of fecal water, such as terminal 
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aldehydes of lipid peroxidation (MDA and HNE) or hydroperoxides (LOOH) have been 
demonstrated to induce apoptosis in colon normal and carcinoma cells in vitro [462,463]. In 
terms of CRC, fecal water has been widely used as a diet-related source of CRC risk 
biomarkers [464-468]. Red meat intake has been shown to increase the risk of CRC by 
increasing the fecal water activity and toxicity towards colon cells [465].  
In this study, fecal water was prepared from the feces of hemoglobin (Hb)- and beef 
(Bf)-fed rats. Both Hb and Bf are sources of heme iron. The rats’ diet was also enriched in 
safflower oil (rich in n-6 fatty acids) to provoke heme-catalyzed lipid peroxidation resulting in 
the formation of cytotoxic aldehydes. The lipid peroxidation-derived products in the fecal 
water  can be analyzed by TBARS (Thiobarbituric acid reactive species) assay. Free HNE in 
the fecal water can be analyzed by mass spectrometry coupled with gas chromatography (in 
collaboration with Plateforme d’Exploration du Métabolisme (Platform for Exploration of 
Metabolism), Clermont-Ferrant since 2014) . To assess whether fecal aldehydes determine in 
part the different fecal water toxicity towards normal (APC +/+) and preneoplastic (APC 
Min/+) cells in vitro, fecal water was treated with CTR (carbonyl-trapping resin) to deplete 
the carbonyl compounds present in the fecal water, including aldehydes. This CTR possesses 
hydrazine groups that readily react with carbonyl compounds. 
 
 
 
 
 
 
 
 
 
 
 
 
 
95 
 
Chapter IV 
RESULTS 
 
 The results obtained during my thesis are compiled in articles published in 
Carcinogenesis in June 2016 (Article 1), in Cancer Research in January 2015 (Article 2) and 
a manuscript in preparation for publication (Article 3). In this chapter, all articles are 
presented with a brief introduction resuming the principle results presented in the articles. 
Article 1: 
Red meat and colorectal cancer: 
Nrf2-dependent antioxidant response contributes to the resistance of 
preneoplastic colon cells to fecal water of hemoglobin- and beef-fed rats 
 
Surya et al. 2016. Carcinogenesis 37(6):635-645. 
  
In this study, mouse-origin APC +/+ and APC Min/+ cells (Chapter 3.1, later called 
normal and preneoplastic cells respectively) were used to study the effect of lipid peroxidation 
byproducts in early colorectal carcinogenesis in vitro. This study aimed at:  
1) Demonstrating that preneoplastic cells are more resistant to fecal water of heme-
fed rats than normal cells and characterizing cell death 
As previously reported [61], we observed that preneoplastic cells were more resistant 
to the toxicity of fecal water of heme-fed rats by executing lower level of apoptosis 
compared to normal cells. Following the exposure to fecal water of heme-fed rats, 
caspases activity appeared at a higher rate and higher final extent in normal cells than 
in preneoplastic cells. By analyzing apoptosis end points such as nuclear 
fragmentation, membrane phosphatidylserine translocation to the outer leaflet and cell 
membrane permeabilization after exposure to fecal water of heme-fed rats for 6 h, we 
generally observed higher level of apoptosis in normal cells than in preneoplastic cells. 
 
2) Determining the involvement of Nrf2 in such a resistance 
We confirmed that Nrf2 was involved in the resistance of preneoplastic cells to fecal 
water of heme-fed rats. Basal Nrf2 activity was found to be higher in preneoplastic 
cells than in normal cells, shown by its nuclear colocalization. Therefore, the 
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expression of HNE detoxification enzymes, known to be regulated by Nrf2, was 
higher in preneoplastic cells than in normal cells. These conditions might give 
preneoplastic cells better advantages to tackle fecal water toxicity compared to normal 
cells. Following exposure to fecal water of heme-fed rats, Nrf2 was active in both cell 
lines, but the level of HNE detoxification enzymes was constantly higher in 
preneoplastic cells than in normal cells, potentially explaining the resistance of 
preneoplastic cells to fecal water toxicity. Indeed, siRNA-mediated Nrf2 silencing in 
preneoplastic cells sensitized them to fecal water toxicity, underlining the importance 
of Nrf2 in such a resistance. 
 
3) Proving that fecal aldehydes determine in part the different toxicity of fecal water 
towards normal and preneoplastic cells. 
To analyze the role of fecal aldehydes in the different toxicity of fecal water towards 
normal and preneoplastic cells, we optimized the depletion of carbonyl compounds in 
the fecal water by using carbonyl-trapping resin (CTR). We observed that the 
depletion of carbonyl compounds in the fecal water abolished the different fecal water 
toxicity in normal and preneoplastic cells. This finding underlines in part the 
importance of fecal aldehydes in inducing different apoptosis between normal and 
preneoplastic cells upon exposure to fecal water of heme-fed rats. Furthermore, CTR-
treated fecal water did not induce Nrf2 activation both in normal and preneoplastic 
cells, leading to a constant level of HNE detoxification enzymes in normal and 
preneoplastic cells like under basal conditions. 
 
Taken together, our results highlight the important role of fecal aldehydes derived 
from heme-induced lipid peroxidation in promoting colorectal carcinogenesis by initiating 
positive selection of preneoplastic cells over normal cells.  
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Abstract
Epidemiological studies have associated red meat intake with risk of colorectal cancer. Experimental studies explain this 
positive association by the oxidative properties of heme iron released in the colon. This latter is a potent catalyst for lipid 
peroxidation, resulting in the neoformation of deleterious aldehydes in the fecal water of heme-fed rats. The toxicity of fecal 
water of heme-fed rats was associated to such lipid peroxidation. This study demonstrated that fecal water of hemoglobin- 
and beef-fed rats preferentially induced apoptosis in mouse normal colon epithelial cells than in those carrying mutation on 
Apc (Adenomatous polyposis coli) gene, considered as preneoplastic. Highlighting the importance of lipid peroxidation and 
neoformation of secondary aldehydes like 4-hydroxy-2-nonenal (HNE), we optimized the depletion of carbonyl compounds 
in the fecal water which turned out to abolish the differential apoptosis in both cell lines. To explain the resistance of 
preneoplastic cells towards fecal water toxicity, we focused on Nrf2, known to be activated by aldehydes, including HNE. Fecal 
water activated Nrf2 in both cell lines, associated with the induction of Nrf2-target genes related to aldehydes detoxification. 
However, the antioxidant defense appeared to be higher in preneoplastic cells, favoring their survival, as evidenced by Nrf2 
inactivation. Taken together, our results suggest that Nrf2-dependent antioxidant response was involved in the resistance of 
preneoplastic cells upon exposure to fecal water of hemoglobin- and beef-fed rats. This difference could explain the promoting 
effect of red meat and heme-enriched diet on colorectal cancer, by initiating positive selection of preneoplastic cells.
Introduction
Colorectal cancer is the first cause of global mortality by can-
cer in non-smokers in affluent countries (1). Epidemiological 
studies proposed that physical activity and diet are important 
factors for colorectal cancer development (2–4). Concerning the 
diet, based on epidemiological and experimental studies, the 
International Agency for Research on Cancer (IARC) monograph 
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working group concluded in October 2015 that red meat is prob-
ably carcinogenic to humans (Group  2A) (5–8). Following the 
convincing evidence that red meat intake increases the risk of 
colorectal cancer, American Institute for Cancer Research (AICR) 
and World Cancer Research Fund (WCRF) recommended limit-
ing red meat consumption to 300 g/week (4).
Three major mechanisms could explain the association 
between red meat and colorectal cancer. Firstly, potentially car-
cinogenic N-nitroso compounds can be formed in the gastroin-
testinal tract by N-nitrosation or nitrosylation. Secondly, cooking 
meat at high temperature could generate mutagenic heterocy-
clic amines such as 2-amino-1-methyl-6-phenylimidazo(4,5-b)
pyridine (PhIP) and 2-amino-3,8-dimethylimidazo-(4,5-f)qui-
noxaline (MeIQx). Thirdly, epidemiological and experimen-
tal data support the hypothesis that heme iron present in red 
meat promotes colorectal carcinogenesis (9). In a recent study, 
we examined the relative contribution of these three mecha-
nisms in vivo and we demonstrated that heme iron was the only 
experimental factor associated with the promotion of colorectal 
carcinogenesis in rats or mice without any additive or synergic 
effects with N-nitroso compound or heterocyclic amines (10). 
Furthermore, we showed that heme iron contributed to lipid 
peroxidation occurring in the lumen, leading to the formation of 
cytotoxic and genotoxic aldehydes, one of which is 4-hydroxy-
2-nonenal (HNE), a secondary product of linoleic and arachi-
donic acid oxidation (11–13). This molecule has been reported 
to induce apoptosis in healthy colon cells (14). In hemoglobin 
(Hb)- and red meat-fed rats, we observed a significant increase 
of fecal thiobarbituric acid reactive species (TBARS) and urinary 
DHN-MA (1,4-dihydroxynonane mercapturic acid; metabolite of 
HNE), both are known as biomarkers of lipid peroxidation (9,15).
Numerous studies emphasized the role of fecal water and 
lipid peroxidation in colorectal cancer as diet-related factors 
(16–18). Fecal water is an aqueous extract of feces representing 
bioavailable parts of fecal matters. Components of fecal water, 
such as terminal aldehydes of lipoperoxidation (malondialde-
hyde and HNE) or hydroperoxides (LOOH) have been shown to 
induce apoptosis in colon normal and carcinoma cells in vitro 
(19,20). We previously tested in vitro the toxicity of fecal water 
of Hb- and Bf-fed rats in normal and preneoplastic immortal-
ized mouse colonic epithelial cells derived from wild-type and 
Min mice (21). Preneoplastic cells are derived from Min mice and 
bear a mutation on the Apc (adenomatous polyposis coli) gene, 
which is a frequent and early event in human colorectal can-
cer (22–24). Preneoplastic cells were more resistant than normal 
cells upon exposure to fecal water of Hb- and Bf-fed rats (14). 
We thus suggest that the resistance of preneoplastic cells to the 
detriment of normal cells, which was associated to lipid peroxi-
dation of fecal water, could explain the promotion of colorectal 
cancer following heme iron intake.
Nrf2 [nuclear factor (erythroid derived 2)-like  2] is a tran-
scription factor that has been shown to regulate the expres-
sion of cellular detoxifying and antioxidant enzymes (including 
those involved in HNE detoxification) through Nrf2-Keap1-ARE 
signaling pathway, thus exerting cytoprotective properties 
against oxidative stress (25). HNE has been shown to activate 
Nrf2 and antioxidant genes expression (26). Our previous study 
revealed that different resistance between normal and preneo-
plastic cells upon exposure to HNE could be due to higher basal 
expression of HNE detoxification enzymes in preneoplastic cells 
compared with normal cells (27), giving preneoplastic cells a 
better antioxidant shield to tackle toxic effects of HNE. As the 
cytotoxicity of fecal water of heme-fed rats was associated to 
lipid peroxidation, Nrf2 could be involved in the resistance of 
preneoplastic cells upon exposure to fecal water.
In this study, we firstly characterized cell death type as apop-
tosis and compared its induction in normal and preneoplastic 
cells regarding fecal water of Hb- and Bf-fed rats, in comparison 
to HNE. After treatment with fecal water or HNE, preneoplastic 
cells appeared to exhibit lower level of apoptosis compared with 
normal cells. Moreover, HNE and fecal water activated Nrf2 in 
both cell lines and the depletion of carbonyl compounds in fecal 
water prevented this event. The resistance of preneoplastic cells 
was correlated to a higher Nrf2-dependent response compared 
with normal cells, as evidenced by Nrf2 invalidation. Thus, this 
study demonstrated the importance of fecal carbonylated sec-
ondary lipoperoxidation products in explaining the differential 
apoptosis between normal and preneoplastic cells following 
exposure to fecal water of Hb- and Bf-fed rats.
Materials and methods
Cell culture
Normal wild-type and Apc-mutated colon epithelial cells (later called nor-
mal and preneoplastic cells) were established as described previously (21). 
Both cell lines express the heat-labile simian virus 40 large tumor antigen 
gene (AgT tsA58) under the control of interferon γ and are ‘immortalized’, 
that is, they expressed active SV40 at permissive temperature (33°C). They 
have been tested (as published in 2014 (10)) through the characteriza-
tion of Apc genotype (presence of Min mutation in preneoplastic cells), 
Apc phenotype (destructurized actin network in preneoplastic cells) and 
epithelial phenotype (expression of cytokeratin 18 in normal and preneo-
plastic cells).
Cells were cultured (approximate density 6.0 × 105 cells/cm2) at permis-
sive temperature of 33°C in Dulbecco-modified essential medium (DMEM) 
supplemented with 10% fetal calf sera, 1% penicillin/streptomycin, 2% 
glutamine, 10 U/ml interferon γ and 10 U/ml epidermal growth factor. 
All experiments were performed at non-permissive temperature of 37°C 
without interferon γ and epidermal growth factor to inhibit the SV40 
transgene and to reach differentiated state. The treatments with HNE and 
fecal water were performed in serum-free DMEM containing 2% glutamine 
to avoid any reaction between serum and fecal water or HNE.
HNE synthesis
HNE was synthesized as described previously (28). Briefly, Grignard reac-
tion between fumaraldehyde monoacetal and 1-pentylmagnesium bro-
mide afforded HNE-dimethylacetal. HNE was obtained by acid hydrolysis.
Fecal samples
Feces used to generate the fecal water were obtained from two animal 
studies set up to explore, respectively, the effect of dietary Hb (10) and 
Bf on colorectal carcinogenesis (not published). Briefly, 7 days following 
Abbreviations 
ALDH3A1 aldehyde dehydrogenase 3A1
Apc adenomatous polyposis coli 
ARE antioxidant response element 
Bf beef 
CTR carbonyl-trapping resin
GSTA4 glutathione S-transferase A4
Hb hemoglobin
HNE 4-hydroxy-2-nonenal
HO1 heme oxygenase 1
Keap1 Kelch-like ECH-associated protein 1 
MDF mucin-depleted foci 
Nrf2 nuclear factor (erythroid derived 2)-like 2 
PBS phosphate-buffered saline
TBARS thiobarbituric acid reactive species 
xCT x-C-type cystine/glutamate antiporter
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an injection with the carcinogen azoxymethane [Sigma Aldrich, 20 mg/kg 
body wt in NaCl (9 g/l)], F344 male rats were allowed free access to their 
respective diets for 100 days. In the first experiment, rats were fed with 
modified AIN-76 diet [low calcium with addition of 5% (v/w) safflower 
oil; control group] or with modified AIN-76 diet containing 1% (w/w) Hb 
(Hb-fed group) (10). In the second experiment, rats were fed with modified 
AIN-76 diet (control group) or with 50% modified AIN-76 diet containing 
50% raw Bf sirloin. Feces were collected on the 88th and 95th day of experi-
ment for Hb-fed and Bf-fed rats, respectively. The two studies resulted in 
four groups of collected feces: standard diet for Hb-fed rats, Hb-fed rats, 
standard diet for Bf-fed rats and Bf-fed rats. All experiment protocols were 
approved by the Local Animal Care and Use Committee of Institut National 
de la Recherche Agronomique (TOXCOM), and were conducted in accord-
ance with the European directive 2010/63/UE and ARRIVE guidelines.
Fecal water preparation and depletion of carbonyl 
compounds in fecal water
Fecal water was prepared as described previously (10). Briefly, 2 g of feces 
was diluted with 5 ml of distilled water, ground and centrifuged. The 
supernatant was collected, diluted 10 times in DMEM containing glu-
tamine 2% and sterilized by microfiltration (pore size 0.2 µm).
4-Fmoc-hydrazinobenzoyl AM NovaGelTM (Novabiochem®) is a poly-
meric resin grafted with fmoc-protected hydrazine functionality. Carbonyl 
compounds are known to readily react with hydrazine groups to yield 
hydrazones. Therefore, this resin, named carbonyl-trapping resin (CTR) in 
this work was used for carbonyl compounds depletion as described previ-
ously (10). Briefly, following activation of the resin using 500 μL of piperi-
dine 20% (v/v) in DMSO for 5 mg of resin and repeated washes, fecal water 
was treated with the activated resin at 4°C for 2 h under agitation.
TBARS and free HNE assay
TBARS value was used as a global analysis of lipid peroxidation endprod-
ucts. TBARS in fecal water were analyzed as described previously (29). 
For free HNE assay, sample preparation was realized as described previ-
ously (30) and adapted for free HNE in fecal water. Briefly, HNE present 
in fecal water (400 µl) was labeled and reduced into [2H1]DHN by NaB[
2H4] 
(0.2 mmol) in EDTA (50 mM)/Hepes (2 mM). [2H11]DHN (0.8 nmol) was added 
as internal standard. Following reduction of double bonds in the presence 
of Raney nickel, HNE was extracted with ethyl acetate and dried with 
Na2SO4. Analyses (31,32) were carried out on a triple quadrupole Quattro 
Micro mass spectrometer (Waters Corporation, UK) coupled with a gas 
chromatography Agilent 6890N system (Agilent Technologies, USA).
Apoptosis detection: nuclei fragmentation, caspase 
activation by time-lapse microscopy and annexin 
V-propidium iodide (PI) staining by flow cytometry
For nuclei fragmentation assay, cells seeded in 24-well plates were incu-
bated for 6 h of contact with HNE 40  µM and fecal water (dilution 10×) 
at 37°C. Cells were then fixed in paraformaldehyde 4% and stained using 
fluorescent dye Hoechst 33342 [Life Technologies, 0.5 ng/ml in phosphate-
buffered saline (PBS)]. Apoptotic (fragmented and/or condensed) and 
alive nuclei were counted using fluorescence microscope (Evos fl digital 
inverted microscope, AMG) and expressed as percentage of total popula-
tion (n > 500 nuclei).
For time-lapse microscopy, cells seeded in Labtek 8-well chamber 1.5 
borosilicate coverglass slides were incubated under confocal microscope 
Leica SP8 (with micro-incubator at 37°C, 5% CO2) with HNE 40  µM and 
fecal water (dilution 10×) containing Hoechst 33342 (5 µg/ml), CellEventTM 
Caspase-3/7 Green Detection Reagent (Life Technologies, 2  µM) and 
TO-PRO®-3 Iodide (Life Technologies, 1 µM). Images were acquired using 
lasers 405, 488 and 638 nm under 20× magnification every 30 min for 12 h. 
Image analysis was performed using ImageJ software.
For flow cytometry, cells seeded in 12-well plates were incubated for 
6 and 24 h in the presence of HNE 40 µM or fecal water (dilution 10×) at 
37°C. Cells were then harvested and stained using APC Annexin V apopto-
sis detection kit with PI (BioLegend, 50 ng/ml) according to manufacturer’s 
procedure. The flow cytometry was done using MACSQuant® Analyzer 
10 and the data were analyzed using VenturiOne software (Applied 
Cytometry).
siRNA transfection
siRNAs were provided by Thermo Scientific Dharmacon (Courtaboeuf, 
France). At 37°C, medium was replaced by OptiMEM and cells were trans-
fected overnight with 100 pmole Nrf2-specific siRNA (ON-TARGET plus 
SMART pool, mix of four siRNA), 100 pmole lamin-specific siRNA (siGLO 
LamineA/C control siRNA) as control of transfection rate or 100 pmole 
negative control siRNA (ON-TARGET plus siRNA Smart pool Non targeting 
control pool) according to manufacturer’s instructions. The transfection 
rate was more than 75% in each cell type after 18 h of transfection. The 
medium was then replaced by non-permissive medium and the cells were 
incubated at 37°C for 24 h prior to treatments.
Immunofluorescence staining of Nrf2
Cells seeded on round coverslips (diameter 18 mm) in 12-well plates were 
incubated for 1 h of contact with HNE 40 µM or fecal water (dilution 10×) at 
37°C. Following saturation (PBS, 0.1% Triton, 0.5% bovine serum albumin), 
each coverslip was incubated with primary antibodies directed against 
Nrf2 (Santa Cruz rabbit polyclonal IgG (33), 2.5 µg/ml in PBS, 0.1% Triton, 
0.5% bovine serum albumin) for 1 h at room temperature. After washing 
with PBS, the cells were incubated with secondary fluorophore-labeled 
antibodies (Invitrogen Alexa Fluor 488 (green) donkey anti-rabbit IgG, 
10 µg/ml in PBS, 0.1% Triton, 0.5% bovine serum albumin) for 1 h at room 
temperature. All cover slips were then sealed on microscope slides using 
anti-fading solution (Invitrogen Prolong Gold antifade reagent with DAPI). 
The slides were analyzed using confocal microscope Leica SP8 with lasers 
488 nm (Alexa 488) and 405 nm (DAPI) under 63x oil immersion objective. 
The colocalization of Nrf2 and nuclei was observed by using fluorescence 
intensity graphs presenting the intensity of blue (nuclei) and green (Nrf2) 
fluorescence detected along determined regions of interest (ROI). Nuclear 
localization of Nrf2 was deduced from blue and green fluorescence pattern.
RT-qPCR
Cells were incubated for 4 h of contact with HNE 40 µM or fecal water (dilu-
tion 10×) at 37°C. RNA was isolated using Tri Reagent (Eurogenetec) according 
to manufacturer’s instructions. Two-step RT-qPCR was performed using TBP 
(TATA binding protein) as the housekeeping gene. cDNA synthesis was done 
using the iScript cDNA Synthesis kit (Bio-Rad) with 1 µg RNA. Quantitative 
PCR was conducted using ViiATM 7 Real-Time PCR System (Life Technologies), 
with final reaction volume of 5 µl (1 µl cDNA, 1.5 µl primers and 2.5 µL iQ SYBR 
Green Supermix (Bio-Rad)). Thermocycling conditions were set as following: 
initial denaturation at 95°C (10 min), denaturation at 95°C (15 s), annealing at 
60°C (30 s) and extension at 72°C (30 s). The sequences of the primers (5′–3′) 
used are listed below: HO1 (F-CAA CCC CAC CAA GTT CAA ACA, R-AGG CGG 
TCT TAG CCT CTT CTG A), ALDH3A1 (F-AAA GTA GCC CAT GGA GGC AC, 
R-GTC ATT GGC TGT CAC TCC AC), xCT (F-CCT GGC ATT TGG ACG CTA CAT, 
R-TCA GAA TTG CTG TGA GGT TGC A), GSTA4 (F-GAA GTT CTA GTG ACA 
GCG TGC TTT A, R-TGT AGC TGC TGC TGT GAT TGG), TBP (F-AGA ACA ATC 
CAG ACT AGC AGC A, R-GGG AAC TTC ACA TCA CAG CTC).
Western blot of Nrf2
Cells were incubated for 1 h with HNE 40 µM or fecal water (dilution 10×) 
at 37°C. Whole cell extracts were fractionated using Nuclear Extraction 
kit (Active Motif). Western blot of nuclear extracts (10 µg) was performed 
by SDS-PAGE and blots were transferred to nitrocellulose membranes. 
Membranes were then saturated and incubated with primary antibodies 
against Nrf2 (Cell Signaling rabbit polyclonal IgG (34), dilution 1:1000) and 
lamin A/C (Sigma Aldrich mouse monoclonal IgG (35), dilution 1:5000) at 
4oC for a night under agitation. Fluorescent secondary antibodies (Thermo 
Scientific Pierce DyLight 700 donkey anti-rabbit IgG and Thermo Scientific 
Pierce DyLight 800 donkey anti-mouse IgG, 0.25 µg/ml) were incubated for 
1 h and membranes were revealed using Odyssey® CLx Li-Cor Infrared 
Imaging System at wavelengths of 700 and 800 nm.
Detection of HNE adducts
Cells were incubated for 6 h of contact with HNE 40 µM at 37°C. Whole 
cell extracts were fractionated using Nuclear Extraction kit (Active Motif). 
HNE-histidine adducts in cytoplasmic fraction were measured as previ-
ously described (36) using anti-HNE-his mouse monoclonal primary anti-
body generously given by Drs G.  Waeg and N.  Zarkovic (Laboratory for 
Oxidative Stress, Zagreb, Croatia) (37,38).
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Figure 1. Fecal water of Hb- and Bf-fed rats (Hb and Bf) exerted higher toxicity towards normal cells compared with preneoplastic cells. Cells were treated with HNE 
40 µM and fecal water. Control Hb and Control Bf (respective controls for Hb and Bf) were fecal water issued from standard diet-fed rats. Apoptosis was observed by 
detecting caspase-3/7 activity and membrane permeability using time-lapse microscopy and by APC Annexin V/propidium iodide (PI) flow cytometry. (A) Measures of 
the percentage of cells exhibiting caspase-3/7 activity upon exposure to fecal water recorded over time. (B) Percentage of cells with positive caspase-3/7 activity and 
(C) permeable membrane upon treatments with HNE 40 μM and fecal water (t = 6 h). (D) Repartition of cell population exhibiting positive and negative staining of APC 
Annexin V and PI upon treatments with HNE 40 μM and fecal water (t = 6 and 24 h). *Significant difference between normal and preneoplastic cells (P < 0.05). #Significant 
difference between a treatment (HNE, Hb, Bf) and its respective control (Control, Control Hb, Control Bf) (P < 0.05). †Significant difference between unstained (Annexin 
V (-) PI (-)) normal and preneoplastic cells (P < 0.05). Data are expressed as mean ± SD (n = 3).
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Cystine uptake assay
L-[14C]-Cystine (PerkinElmer, 100 mCi/mmol) uptake was measured 
according to Giraudi et al. with some modifications (39). Cells were seeded 
in a 12-well plate and incubated for 6 h of contact with fecal water (dilu-
tion 10×) at 37°C. The cells were then rinsed with warmed uptake buffer 
(NaCl 140 mM, HEPES 25 mM, KCl 5.4 mM, CaCl2 1.8 mM, MgSO4 0.8 mM, glu-
cose 5 mM, pH = 7.5). Cystine uptake was started by incubating the cells in 
uptake buffer containing L-[14C]-Cystine 0.1 µCi at room temperature for 
10 min, and stopped by rinsing with ice-cold unlabelled uptake buffer. The 
cells were then lysed by adding NaOH 0.1 N. Lysate was mixed with scintil-
lation cocktail (UltimaGold, PerkinElmer), protein quantification was done 
(Pierce bicinchoninic acid enzymatic kit) and the radioactivity was deter-
mined using a scintillation counter (Hewlett Packard). The results were 
expressed as nmol of incorporated cystine reported to protein content.
Statistical analysis
The results (n ≥ 3)  were analyzed using software GraphPad Prism 4 for 
Windows. Different responses of treatments and genotype effect were 
analyzed by two-way ANOVA and student’s t-test, respectively. When 
ANOVA showed a statistically significant effect (P  <  0.05), comparison 
among data was done using Tukey’s HSD Post-hoc test. Pearson correla-
tion test was done to analyze the correlation between the percentage of 
apoptotic nuclei and TBARS or free HNE concentration in fecal water.
Results
Fecal water of Hb- and Bf-fed rats induced cell death 
by apoptosis and preneoplastic cells exhibited 
higher resistance compared with normal cells
To characterize cell death, we analyzed caspase-3/7 activa-
tion, membrane phosphatidylserine translocation to the outer 
leaflet and cell membrane permeabilization (Figure  1A–D; 
Supplementary Movies 1–4, available at Carcinogenesis Online) 
in normal and preneoplastic cells following exposure to fecal 
water, according to the guidelines of apoptosis identification 
(40). Fecal water induced apoptosis in both cell lines (Figure 1A) 
but at a much higher extend when diets were supplemented 
with Hb or Bf. The differential of apoptosis in normal and pre-
neoplastic cells was observed only upon exposure to fecal water 
of Hb- and Bf-fed rats, but not to the fecal water control issued 
from rats fed with standard diet. Compared to preneoplastic 
cells, normal cells exhibited earlier and higher apoptosis upon 
exposure to fecal water of Hb- and Bf-fed rats.
Following 6 h of exposure to fecal water of Hb- and Bf-fed 
rats, approximately 50% of normal cells population exhibited 
caspase-3/7 activation and membrane permeabilization while 
only approximately 30% of preneoplastic cells population exhib-
ited the same phenomena (Figure  1B and C). The number of 
unstained living cells was higher in preneoplastic cells than in 
normal cells even at a longer incubation time of 24 h (Figure 1D). 
HNE was used in our experiments as positive control for apop-
tosis induction by lipid peroxidation byproducts. Like HNE, fecal 
water of Hb- and Bf-fed rats induced significantly higher apopto-
sis in normal cells than in preneoplastic cells (P < 0.05). This dif-
ference was not observed upon exposure to fecal water control.
Depletion of carbonyl compounds in fecal water of 
Hb- and Bf-fed rats abolished differential apoptosis 
in normal and preneoplastic cells
To support the fact that lipid peroxidation byproducts are 
involved in fecal water toxicity towards normal and preneoplas-
tic cells, we used CTR to deplete carbonyl compounds (including 
Figure 2. Carbonyl-trapping resin (CTR) was shown to be effective in depleting carbonyl compounds (including aldehydes) in fecal water of Hb- and Bf-fed rats (Hb 
and Bf). (A) HNE-histidine adducts in protein extract of cells treated with HNE 40 µM treated or not with CTR (t = 6h). (B) Concentration of lipid peroxidation byproducts 
TBARS and (C) free HNE in fecal water (Hb and Bf) and the respective controls (Control Hb and Control Bf) treated or not by CTR. # Significant difference between a treat-
ment (HNE, Hb, Bf) and its respective control (Control, Control Hb, Control Bf) (P < 0.05). •Significant difference between a treatment using untreated and CTR-treated 
HNE or fecal water (P < 0.05). Data are expressed as mean ± SD (n = 3).
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aldehydes) in fecal water. Figure 2A shows the efficacy of CTR 
in scavenging HNE, leading to omitted HNE-histidine adducts in 
the cells exposed to CTR-treated HNE. In Figure 2B and C, diet 
enriched in n-6 fatty acid and heme iron (under the form of Hb 
and Bf) led to a significant increase in fecal lipid peroxidation 
compared with standard diet (P < 0.05). Treatment by CTR was 
effective in reducing fecal TBARS and free HNE significantly to a 
concentration observed in fecal water control (P < 0.05).
We incubated normal and preneoplastic cells in untreated 
and CTR-treated fecal water to assess apoptosis by ana-
lyzing the percentage of nuclei with apoptotic appearance 
(fragmented or condensed) (Figure 3A), cells with positive cas-
pase-3/7 activity (Figure  3B) and cells with permeable mem-
brane (Figure  3C). The depletion of carbonyl compounds was 
shown to decrease significantly fecal water-induced apoptosis 
in both cell lines and abolish the differential apoptosis in nor-
mal and preneoplastic cells.
Exposure to fecal water of Hb- and Bf-fed rats induced 
Nrf2 activation in normal and preneoplastic cells
To analyze Nrf2 activation in normal and preneoplastic cells 
induced by exposure to fecal water, we investigated the nuclear 
localization of Nrf2. Figure 4A displays the fluorescence inten-
sity graphs representing the localization of nuclei (blue chan-
nel) and Nrf2 (green channel) in normal and preneoplastic cells 
under basal conditions and upon exposure to fecal water of 
Hb- and Bf-fed rats. Figure 4A shows that Nrf2 was active in pre-
neoplastic cells under basal conditions, indicated by its nuclear 
localization. In contrast, Nrf2 in normal cells tended to display 
less nuclear accumulation than preneoplastic cells. Following 
exposure to HNE and to fecal water of Hb- and Bf-fed rats, both 
normal and preneoplastic cells exhibited Nrf2 activation.
Our blot analysis of nuclear Nrf2 shows Nrf2 activation in 
normal and preneoplastic cells following exposure to HNE and 
fecal water of Hb- and Bf-fed rats, but not to fecal water control 
(Figure 4B and Supplementary Figure 5, available at Carcinogenesis 
Online). Interestingly, CTR-treated HNE or fecal water did not 
trigger Nrf2 nuclear translocation, showing the importance of 
carbonyl compounds in such an activation.
We analyzed the expression of heme oxygenase 1 (HO1), an 
Nrf2 target gene following exposure to HNE and fecal water for 
4 h. Figure 4C shows higher HO1 induction in normal cells than 
in preneoplastic cells upon exposure to HNE and fecal water of 
Hb- and Bf-fed rats (P < 0.05). Depletion of carbonyl compounds 
was shown to block the upregulation of HO1 expression carried 
out by untreated fecal water in both cell lines.
Nrf2 was involved in the resistance of preneoplastic 
cells towards fecal water toxicity
To analyze whether Nrf2 is involved in the resistance of preneo-
plastic cells towards fecal water toxicity, we downregulated Nrf2 
expression by transfecting control Nrf2-specific siRNA (siNrf2). 
Figure 3. Depletion of carbonyl compounds (including aldehydes) in fecal water of Hb- and Bf-fed rats (Hb and Bf) abolished their differential toxicity towards normal 
and preneoplastic cells. (A) Percentage of cells exhibiting apoptotic nuclei appearance (condensed and fragmented) following exposure to HNE 40 μM and fecal water 
treated or not with carbonyl-trapping resin (CTR) (t = 6 h). (B) Percentage of cells with positive caspase-3/7 activity and (C) permeable membrane upon treatments with 
HNE 40 μM and fecal water treated or not with CTR (t = 6 h). *Significant difference between normal and preneoplastic cells (P < 0.05). #Significant difference between 
a treatment (HNE, Hb, Bf) and its respective control (Control, Control Hb, Control Bf) (P < 0.05). •Significant difference between a treatment using untreated and CTR-
treated HNE or fecal water (P < 0.05). Data are expressed as mean ± SD (n = 3).
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Figure 4. Nrf2 was activated in normal and preneoplastic cells upon exposure to fecal water of Hb- and Bf-fed rats (Hb and Bf). Following treatments with fecal water 
(t = 1 h), Nrf2 detection in cells was done by immunofluorescence and western blot. (A) Images of immunofluorescence analysis of fecal water-treated normal and pre-
neoplastic cells. Blue channels indicate nuclei and green channels indicate Nrf2. The fluorescence intensity graphs represent the colocalization of blue signal (nuclei) 
and green signal (Nrf2) along regions of interest (ROI). The presented images are representative of three independent experiments. (B) Western blotting analysis of 
nuclear Nrf2 following exposure to HNE 40 μM and fecal water treated or not with carbonyl-trapping resin (CTR). Lamin A/C was used as loading control. The presented 
blots are representative of three independent experiments. (C) Relative mRNA expression of HO1 following exposure to HNE 40 μM and fecal water treated or not with 
CTR. Significant difference between normal and preneoplastic cells (*P < 0.05). Significant difference between a treatment in a cell line (HNE, Hb, Bf) and its respective 
control (Control, Control Hb, Control Bf) (#P < 0.05). Significant difference between a treatment using untreated and CTR-treated HNE or fecal water (•P < 0.05). Data are 
expressed as mean ± SD (n = 3).
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This down-regulation diminished the level of nuclear Nrf2 in 
preneoplastic cells both under basal conditions and upon expo-
sure to HNE (Figure 5A). In preneoplastic cells, siNrf2 transfec-
tion reduced cell viability and increased apoptosis following 
6 h of exposure to HNE and fecal water of Hb- and Bf-fed rats 
(Figure 5B), highlighting the importance of Nrf2 in their resist-
ance towards fecal water toxicity. In normal cells, probably 
because of their high sensitivity to HNE and fecal water, no 
enhancement of apoptosis induction following Nrf2 invalidation 
was observed (Figure S6).
Exposure to fecal water of Hb- and Bf-fed rats 
induced higher expression of HNE detoxification 
enzymes in preneoplastic cells
To further investigate the role of Nrf2 in cellular response to 
fecal water toxicity, we analyzed the expression of three Nrf2 
target genes involved in HNE detoxification: aldehyde dehydro-
genase 3A1 (ALDH3A1), glutathione S-transferase A4 (GSTA4) 
and x-C-type cystine/glutamate antiporter (xCT). Figure  6A 
(left panel) shows that these genes were more expressed in 
preneoplastic cells than in normal cells, both under basal con-
ditions and following exposure to HNE and fecal water of Hb- 
and Bf-fed rats (P  <  0.05). Treatment with CTR set down and 
normalized the effects of HNE and fecal water on the expres-
sion of these genes, resulting in gene expression profiles which 
resemble basal conditions. Despite higher final genes expres-
sion in preneoplastic cells, we found that these genes were 
more upregulated in normal cells than in preneoplastic cells 
upon exposure to HNE and fecal water of Hb- and Bf-fed rats 
(Figure 6A right panel).
In accordance with the upregulation of xCT expression, we 
analyzed the level of cystine uptake in normal and preneoplas-
tic cells following exposure to fecal water. Exposure to fecal 
water of Hb- and Bf-fed rats resulted in higher final uptake in 
preneoplastic cells than in normal cells (Figure 6B). Depletion of 
carbonyl compounds abolished the differential cystine uptake 
due to fecal water exposure.
Discussion
The aim of this study was to understand the mechanisms 
involved in the differential of fecal water toxicity prepared from 
Hb- or Bf-fed rats towards normal and preneoplastic mouse 
colonocytes. Here, we show that Nrf2 activity, via a higher 
expression of HNE-detoxification enzymes in preneoplastic 
cells, explains at least in part this difference. We also demon-
strate that carbonyl compounds (including aldehydes) are the 
main agents of fecal water toxicity determining differential 
susceptibility of normal and preneoplastic cells.
Fecal water from Hb- and Bf-fed rats were associated 
to high lipid peroxidation and colorectal cancer 
promotion in vivo
Fecal water of Hb- and Bf-fed rats is a complex matrix derived 
from real luminal contents which is relevant for studying 
the effects of heme on luminal neoformation of aldehydes. 
In comparison with Hb- and Bf-fecal water, HNE was used as 
pure model molecule representative of lipid peroxidation-
derived aldehydes since fecal waters were obtained from 
feces of rats fed with diets rich in n − 6 fatty acids. Indeed, 
HNE is an important lipoperoxidation endproduct of n − 6 
fatty acid by heme iron, both in terms of presence and toxic-
ity (10). The HNE concentration used in this study (40 µM) was 
deduced from TBARS concentration in the feces of Hb-fed rats 
(Figure 2B) to mimic the global level of lipoperoxidation end-
products in fecal water.
Our hypothesis on the role of lipid peroxidation in the pro-
motion of colorectal carcinogenesis by red meat emphasizes the 
importance of lipid peroxidation-derived aldehydes in generat-
ing a selection of colon cells. During our in vivo experiments, rats 
were fed with standard diet enriched in safflower oil and heme 
under the form of Hb or raw Bf. Heme contained in Hb and raw 
Bf is a potent catalyst of lipid peroxidation (41,42).
As observed in Figure 2B and C, supplementation of heme under 
the form of Hb and Bf in rats increased fecal lipid peroxidation 
Figure 5. Nrf2 was involved in the resistance of preneoplastic cells towards the toxicity of fecal water of Hb- and Bf-fed rats (Hb and Bf). (A) Western blotting analysis 
of nuclear Nrf2 in siNeg- and siNrf2-transfected preneoplastic cells treated or not with HNE 40 µM (t = 2 h) (B) Repartition of siNeg- and siNrf2-transfected preneoplastic 
cell population exhibiting positive and negative staining of APC Annexin V and propidium iodide (PI) upon treatments with HNE 40 μM and fecal water (t = 6 h). Signifi-
cant difference between unstained (Annexin V (-) PI (-)) siNeg- and siNrf2-treated preneoplastic cells (#P < 0.05). Data are expressed as mean ± SD (n = 3).
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and HNE level correlating positively with increasing fecal toxicity 
towards colon cells (Figure 1). Indeed, Hb (10) and Bf supplemen-
tation (not published) increased significantly number or size of 
preneoplatic lesions in the colon of azoxymethane-induced rats. 
These lesions are mucin-depleted foci (MDF) with absent or scant 
mucus production (43). After 100 days, we found that the Hb-fed 
Figure 6. Preneoplastic cells expressed higher level of HNE detoxification enzymes compared with normal cells under basal conditions and upon exposure to fecal 
water of Hb- and Bf-fed rats (Hb and Bf). (A) Left panel shows the relative mRNA expression of Nrf2 downstream genes implicated in HNE detoxification (ALDH3A1, 
GSTA4 and xCT) in nomal and preneoplastic cells following exposure to HNE 40 μM and fecal water treated or not with carbonyl-trapping resin (CTR) (t = 4 h). Right 
panel shows the fold induction of mRNA expression of the genes upon exposure to HNE, Hb and Bf reported to their respective controls (Control, Control Hb and 
Control Bf). (B) Incorporated cystine reported to protein mass upon exposure to fecal water treated or not with CTR (t = 6 h). Significant difference between normal and 
preneoplastic cells (*P < 0.05). Significant difference between a treatment in a cell line (HNE, Hb, Bf) and its respective control (Control, Control Hb, Control Bf) (#P < 0.05). 
Significant difference between a treatment using untreated and CTR-treated (•P < 0.05). Data are expressed as mean ± SD (n = 3).
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rats developed significantly higher amount of MDF compared 
with standard diet-fed rats meat (3.4 ± 1.2 versus 2.2 ± 1.5 MDF per 
colon, respectively; P  <  0.01) (10). Rats consuming Bf-based diet 
had significantly larger MDF in their colon compared with those 
not consuming red meat (2.6 ± 0.6 versus 2.2 ± 0.3 crypts by MDF, 
respectively; P = 0.03). Taken together, these results indicate that 
Hb or Bf consumption promoted colorectal carcinogenesis.
Higher Nrf2 activitiy in preneoplastic cells led to 
resistance to apoptosis towards exposure to fecal 
water of Hb- and Bf-fed rats
We showed that fecal water induced apoptosis in normal and 
preneoplastic cells through caspase-3/7 activation, membrane 
phosphatidylserine translocation, membrane permeabilization 
and finally DNA fragmentation (Figures 1 and 3). These end-
points prompted us to classify the cell death as apoptosis (40). 
Exposure to fecal water of Hb- and Bf-fed rats activated Nrf2 
in both normal and preneoplastic cells (Figure 4). Normal cells 
appeared to be more responsive in upregulating HNE detoxi-
fication genes expression compared with preneoplastic cells 
(Figure 6A right panel). However, final expression of cytoprotec-
tive enzymes in preneoplastic cells remained higher than in 
normal cells, asserting that preneoplastic cells had better cel-
lular defense towards fecal water toxicity (Figure 6A left panel). 
These enzymes (ALDH3A1, xCT and GSTA4) are implicated in 
HNE detoxification (44) and regulated by Nrf2 (45–48). Thus, pre-
neoplastic cells were more resistant to pro-apoptotic effects 
of HNE and fecal water than normal cells (Figure  1). Down-
regulation of Nrf2 in preneoplastic cells reduced their resistance 
to fecal water toxicity, confirming its protective role (Figure 5).
The mechanisms by which preneoplastic cells exert higher 
resistance towards fecal water of Hb- and Bf-fed rats than nor-
mal cells implicate conjugation pathway with glutathione. The 
expression of xCT and GSTA4, two enzymes involved in glu-
tathione conjugation pathway and cystine uptake, was higher 
in preneoplastic cells than in normal cells towards exposure to 
fecal water of Hb- and Bf-fed rats (Figure 6).
Fecal carbonyl compounds were responsible for Nrf2 
activation in colon cells
We proposed that the promotion of colorectal carcinogenesis was 
linked to the increase of fecal lipid peroxidation level and the 
toxicity of fecal water. In this study, the importance of carbonyl 
compounds, including aldehydes derived from lipid peroxidation 
in fecal toxicity was clearly shown in all our results using CTR. 
Under activation, this latter contains reactive hydrazine deriva-
tives which are able to scavenge carbonyl groups. Regarding its 
chemical specificity towards carbonyl groups under the present 
reaction conditions, activated CTR is very unlikely to bind other 
potentially cytotoxic molecules which are possibly present in 
fecal water such as bile acid, bilirubin and lysophospholipids.
CTR was shown to reduce the content of fecal lipid peroxida-
tion byproducts (TBARS) and free HNE (Figure 2A–C). The percent-
age of apoptotic nuclei (Figure 3) was significantly correlated with 
the concentration of fecal TBARS (r = 0.95, P < 0.01 for normal cells; 
r = 0.90, P < 0.01 for preneoplastic cells) and the concentration of 
fecal free HNE (r = 0.96, P < 0.01 for normal cells; r = 0.93, P < 0.01 
for preneoplastic cells). In our previous in vivo studies, we demon-
strated that the limitation of lipid peroxidation was correlated to 
the promoting effect of heme on colorectal carcinogenesis (29,49). 
This protection was associated to a decrease of fecal water toxic-
ity without causative link between lipid peroxidation and toxicity. 
Here, we proposed that heme-induced lipid peroxidation was at 
least in part responsible for the toxicity of fecal water of heme-fed 
rats. Indeed, as indicated above, CTR traps carbonyl compounds, 
including aldehydes derived from lipid peroxidation. However, 
other carbonyl compounds such as ketones and endogenous alde-
hydes can also be trapped by CTR. Therefore, our study with CTR 
does not demonstrate that lipid peroxidation-derived aldehydes 
are solely responsible for the effects of fecal water towards cells. 
Nevertheless, the results of free HNE trapping (Figure 2C) corre-
lating positively with cytotoxic activity and the kinetically slower 
reaction of ketones towards hydrazine compounds compared to 
aldehydes (50) encouraged us to propose that lipid peroxidation-
derived aldehydes are the main agents of fecal water toxicity.
In this study, we showed that the presence of carbonyl com-
pounds in fecal water was potentially fundamental in determin-
ing Nrf2 activation in normal and preneoplastic cells following 
exposure to fecal water of Hb- and Bf-fed rats. Figure 4B indicates 
that Nrf2 activation stimulated by fecal water of Hb- and Bf-fed 
rats was nullified by depletion of carbonyl compounds. These phe-
nomena were also observed in the expression of Nrf2 downstream 
genes reported in Figure 6A. In addition, we also reported that all 
profiles induced by treatments with HNE showed similar tendency 
with those induced by treatments with fecal water of Hb- and 
Bf-fed rats. Based on these findings, we highlight the central role 
of carbonyl compounds (including aldehydes) in Nrf2 activation 
in colon cells and in the toxicity of fecal water of heme-fed rats.
The different resistance between normal and preneoplastic 
cells towards exposure to fecal water of Hb- and Bf-fed rats led 
us to propose a mechanism of colorectal carcinogenesis through 
positive selection of preneoplastic cells. This phenomenon 
would favor the survival of preneoplastic cells and thus promote 
colorectal carcinogenesis.
Supplementary material
Supplementary Movies S1–S4 and Supplementary Figures 5 and 
6 can be found at http://carcin.oxfordjournals.org/
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Supplementary Figures integrated in Article 1: 
 
 
 
 
 
 
 
 
 
 
Figure S5: Exposure to HNE and fecal water of hemoglobin- and beef-fed rats (Hb and Bf) 
activated Nrf2 response in normal and preneoplastic cells. Uncropped full-length image with 
molecular weight marker of nuclear Nrf2 western blotting analysis following exposure to HNE 40 μM 
and fecal water treated or not with carbonyl-trapping resin (CTR) (t=1h). Lamin A/C was used as 
loading control. The cropped images are presented in Figure 5 in the article. The presented blots are 
representative of three independent experiments. 
 
 
 
 
 
 
 
Figure S6: Normal cells did not exhibit sensitization to the toxicity of hemoglobin- and beef-fed 
rats (Hb and Bf) following Nrf2 inactivation. Repartition of siNeg- and siNrf2-transfected normal cell 
population exhibiting positive and negative staining of APC Annexin V and propidium iodide (PI) upon 
treatments with HNE 40 μM and fecal water (t=6 h). No significant difference was observed between 
unstained (Annexin V (-) PI (-)) siNeg- and siNrf2-transfected normal cells in each treatment (P>0.05).  
Data are expressed as Mean ± SD (n=3). 
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The synthesis of Article 1 is presented in Figure 46. Nrf2 activity was found to be 
higher in preneoplastic (APC Min/+) cells than in normal (APC +/+) cells and this resulted in 
higher expression of HNE detoxification enzymes in preneoplastic cells. This condition 
rendered preneoplastic cells more resistant than normal cells upon exposure to fecal water of 
heme-fed rats. Even though the expression of HNE detoxification enzymes was improved in 
normal cells upon exposure to fecal water of heme-fed rats, the final level of these enzymes 
remained higher in preneoplastic cells than in normal cells. Because of this lack of HNE 
detoxification enzymes in normal cells, they underwent higher level of apoptosis than 
preneoplastic cells following exposure to fecal water of heme-fed rats. Depletion of carbonyl 
compounds in the fecal water by using carbony-trapping resine (CTR) abolished the different 
toxicity of fecal water towards normal and preneoplastic cells. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 46. Schema for the role of Nrf2 in the resistance of                                                            
APC Min/+ cells upon exposure to fecal water of heme-fed rats 
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Article 2: 
A central role of heme iron in colon carcinogenesia associated with red 
meat intake 
 
Bastide et al. 2015. Cancer Research 75(5):870-879. 
  
This study, conducted by previous PhD students in the team, was focused on 
investigating the relative contributions of three main hypotheses on CRC and red meat intake: 
heme iron (Chapter 1.2.2.5), NOCs (Chapter 1.2.2.3) and HCAs (Chapter 1.2.2.2) by a 2x2x2 
factorial designs in an in vivo experiment using azoxymethane-injected rats. I was a co-author 
in this study. My participation consisted in assessing the central role of aldehydes in the 
toxicity of fecal water of hemoglobin (Hb)-fed rats towards normal (APC +/+) and 
preneoplastic (APC Min/+) cells in vitro (results are presented in Figure 2A in the article). 
Briefly, the main findings presented in the article are: 
1) Heme iron played a major role in the formation of colon preneoplastic lesions  
In this study, to assess the relative contributions of the three potential mechanisms 
(heme iron, NOCs and HCAs), a 2x2x2 protocol was conducted on azoxymethane-
injected rats fed with hemoglobin, HCAs (PhIP+MeIQx), or both with or without the 
presence of nitrite (NaNO2) and nitrate (NaNO3) in the drinking water to induce 
endogenous NOCs formation. The results showed that heme iron was the only 
experimental factor associated with the formation of preneoplastic lesions in the rat 
colon (MDF, mucin-depleted foci) without any additive or synergic effects with NOCs 
or HCAs. The intake of Hb-containing diet was associated with increasing formation 
of lipid peroxidation terminal products in the fecal water, as evidenced by the dosage 
of TBARS. 
2) Heme iron intake induced intestinal carcinogenesis in Min mice and genotoxicity 
in normal mice 
Hb-fed Min mice developed significantly higher load of tumor polyps compared to 
standard diet-fed Min mice and this phenomenon was associated to increasing TBARS 
in the feces and small intestine contents. In non-mutated C57BL/6J mice, Hb intake 
induced genotoxicity in small intestinal epithelium, indicating potential mutagenic 
effects of heme iron that might lead to carcinogenesis. 
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3) Preneoplastic cells were more resistant to fecal water of Hb-fed rats than normal 
cells: the central role of aldehydes 
I participated in this part of the study. Fecal water of Hb-fed rats exerted higher 
cytotoxicity towards normal cells than preneoplatic cells. Depletion of carbonyl 
compounds in the fecal water of Hb- fed rats by carbonyl-trapping resin (CTR) 
appeared to reduce more than 90% of fecal TBARS and about 75% of fecal water 
toxicity towards normal and preneoplastic cells without any significant different 
toxicity observed between both cell lines (p>0.05). Among the three major lipid 
peroxidation-derived aldehydes, HNE was found to be more cytotoxic than HHE and 
MDA towards normal and preneoplastic cells. 
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Abstract
Epidemiology shows that red and processed meat intake is
associated with an increased risk of colorectal cancer. Heme iron,
heterocyclic amines, and endogenous N-nitroso compounds
(NOC) are proposed to explain this effect, but their relative
contribution is unknown. Our study aimed at determining, at
nutritional doses, which is the main factor involved and pro-
posing a mechanism of cancer promotion by red meat. The
relative part of heme iron (1% in diet), heterocyclic amines
(PhIP þ MeIQx, 50 þ 25 mg/kg in diet), and NOC (induced by
NaNO2 þ NaNO3; 0.17 þ 0.23 g/L of drinking water) was
determined by a factorial design and preneoplastic endpoints
in chemically induced rats and validated on tumors inMinmice.
The molecular mechanisms (genotoxicity, cytotoxicity) were
analyzed in vitro in normal and Apc-deﬁcient cell lines and
conﬁrmed on colon mucosa. Heme iron increased the number
of preneoplastic lesions, but dietary heterocyclic amines and
NOC had no effect on carcinogenesis in rats. Dietary hemoglo-
bin increased tumor load in Min mice (control diet: 67  39
mm2; 2.5% hemoglobin diet: 114 47mm2, P¼ 0.004). In vitro,
fecal water from rats given hemoglobin was rich in aldehydes
and was cytotoxic to normal cells, but not to premalignant cells.
The aldehydes 4-hydroxynonenal and 4-hydroxyhexenal were
more toxic to normal versus mutated cells and were only geno-
toxic to normal cells. Genotoxicity was also observed in colon
mucosa of mice given hemoglobin. These results highlight the
role of heme iron in the promotion of colon cancer by red meat
and suggest that heme iron could initiate carcinogenesis through
lipid peroxidation. Cancer Res; 75(5); 870–9. 2015 AACR.
Introduction
Colorectal cancer is the third most common type of cancer
worldwide after lung and prostate cancer in men and after lung
and breast cancer in women (1). Environmental factors, partic-
ularly diet, play roles in the development of colorectal cancer
(2, 3). On the basis of epidemiologic studies, the World Cancer
Research Fund panel considers the colorectal cancer risk associ-
ated with red and processed meat intake to be convincing and
recommends limiting the consumption of redmeat and avoiding
the consumption of processed meat (2, 3). Our previous works
showed that red and processed meats promote precancerous
lesions (aberrant crypt foci, ACF, and mucin-depleted foci, MDF)
in the colons of rats fed a low-calcium diet (4–6). These data
strongly support the results from epidemiologic studies.
Three major mechanisms may explain the association between
meat and colorectal cancer (7). First, potentially carcinogenic
N-nitroso compounds can form in the gastrointestinal tract by
N-nitrosation of peptide-derived amine or by nitrosylation yield-
ing S-nitrosothiols and nitrosyl iron (FeNO). Collectively, these
aremeasured as the apparent totalN-nitroso compounds (ATNC;
ref. 8). Second, meat cooked at high temperatures contains
mutagenic heterocyclic amines (HCA) like 2-amino-1-methyl-
6-phenylimidazo(4,5-b)pyridine (PhIP) and 2-amino-3,8-dim-
ethylimidazo [4,5-f]quinoxaline (MeIQx); ref. 9]. Third, epide-
miologic and experimental data support the hypothesis that heme
iron present in red and processed meats promotes colorectal
cancer (5–7, 10). This effect can be explained by the direct
cytotoxic, genotoxic effects of heme on epithelial cells and by
the catalytic effect of heme iron on the formation of ATNC and
lipid peroxidation end-products like 4-hydroxynonenal (4-HNE;
refs. 4, 5, 7, 11–14). Cross and colleagues investigated these 3
hypotheses in a cohort study and found a signiﬁcant association
between colorectal cancer and the intake of heme iron, nitrate
from processed meat, and HCA (15). Nevertheless, numerous
biases are possible in the determination of risk factors using
epidemiologic approach, and contribution of each of these factors
has never been evaluated experimentally in the same study.
The present study aimed at investigating the roles of these 3
potential mechanisms, namely heme iron, NOC, and HCA, in
colorectal cancer in vivo at a precancerous lesion stage (MDF) in
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carcinogen-induced rats (see a ﬂowchart in Supplementary Fig.
S1). Doses were chosen to mimic red meat consumption. Sub-
sequently, the results were conﬁrmed at the tumor stage using
C57BL/6J ApcMin/þmice, a geneticmodel of colorectal cancer. The
tumor incidence was associated with genotoxicity endpoints in
mucosa as gH2AX and anaphase bridges. Like tumors in the
majority of human colorectal cancer cases and in ApcMin/þ mice,
the preneoplastic lesion MDF in rats show activation of the Wnt
signaling pathway driven by mutations in Apc and/or in the
b-catenin gene. We also used an intestinal cellular model with
normal and premalignant cells (Apcþ/þ and Apc/þ cells) to
complement the in vivo studies. In combination with animal
models, such cellular models allowed us (i) to understand the
effect of dietary compoundson cancer promotion at early stages of
carcinogenesis and (ii) to explain and further investigate the
effects observed in vivo.
Materials and Methods
Animals and diets
Male 4-week-old F344 rats (n ¼ 80; Charles Rivers), male and
female 4-week-old C57BL/6J ApcMin/þmice (Jackson, Laboratory,
n ¼ 35) and Apcþ/þ mice (Charles River, n ¼ 33), and male and
female C57BL/6Jmice (n¼ 10)were housed (2 rats per cage and 2
to 3mice per cage) under standard laboratory conditionswith free
access to food and water. After acclimatization with AIN76 diet,
rats were fed experimental diets for 100 days, ApcMin/þ andApcþ/þ
mice were fed experimental diets for 49 days, and C57BL/6J mice
were fed experimental diets for 14 days. Rats were killed by CO2
asphyxiation, andmicewere killed by cervical dislocation. Animal
care was in accordance with the European Council and ARRIVE
guidelines.
To assess the relative contributions of the 3 potential mechan-
isms (heme iron, NOC, and HCA), we conducted a 2  2  2
protocol on azoxymethane-induced F344 rats fed a diet contain-
ing 1% hemoglobin, HCA (PhIP, 50 mg/kg; MeIQx, 25 mg/kg), or
both. To induce a strong endogenous NOC formation, drinking
water was supplementedwith sodiumnitrate and nitrite (0.17 g/L
of NaNO2 and 0.23 g/L of NaNO3) and compared with a nitrate-
free water, according to the experimental groups described
in Table 1A (16). Mice were fed a control diet or a 2.5% hemo-
globin diet (Table 1B).
Azoxymethane-induced colon carcinogenesis in rat
After 1 week on the experimental diet, rats received intraper-
itoneal injection of azoxymethane (Sigma; 20 mg/kg body
weight).
Neoplastic lesions
The large intestines of rats and large and small intestines ofmice
were removed and ﬁxed in 0.05% buffered formalin (Sigma).
MDF scoring in colon of rats. MDF were scored in duplicate by 2
readers who were blinded to the origin of the colon following the
high-iron diamine Alcian blue procedure (17) described by San-
tarelli and colleagues (4).
Tumor scoring in small intestine and colon of mice. At sacriﬁce, the
intestinal tract fromduodenum to colonwas removed. Sections of
duodenum, jejunum, and ileum were harvested, opened along
the longitudinal axis, and washed in PBS. After ﬁxation in 10%
formalin, mouse colons were stained for 6 minutes in a 0.05%
ﬁltered methylene blue solution, and small intestines were
stained for 48 hours in a 300 ppm solution of methylene blue
in formalin. One reader who was blinded to the origin of the
sample scored tumors and determined their diameters using a
binocular microscope at 25 magniﬁcation. All tumors in each
section of the intestines were counted, the smallest tumors that
could be counted were approximately 0.5 mm in diameter.
Fecal assays in rat and mice
Feces were collected during the last 10 days and frozen at
20C. Urine was collected on days 67 to 70 for rats and on
days 44 to 45 formice and frozen at20CbeforeDHN-MA assay
(Supplementary Materials and Methods).
Fecal water preparation. Feces of 24 hours were collected. To
prepare fecal water, distilled water (1 mL for rats or 0.85 mL for
mice) was added to 0.3 g of dried feces. Fecal water was prepared
as described by Pierre and colleagues (5).
Heme, TBARS in fecal water of rats and mice. The heme concen-
tration in the fecal water was measured by ﬂuorescence according
toVandenBerg and colleagues (18) andas describedbyPierre and
colleagues (5). To determine the lipid peroxides in the lumen,
thiobarbituric acid reactive substances (TBARS)were quantiﬁed in
fecal water according to the technique of Ohkawa and colleagues
(19) as described previously (20). The results are expressed as the
MDA equivalent.
ATNCs in fecal water of rats. ATNCs include N-nitroso com-
pounds, S-nitrosothiols, and FeNO nitrosyl heme. They were
analyzed as described previously (11) with an Ecomedics CLD
Exhalyzer (Ecomedics). The values measured in 100 mL of the
sample are expressed as concentration (in mmol/L).
Table 1. Experimental diets (g/100 g): study in F344 rats and in Min mice
Study in F344 rats Study in Min mice
Control Heme HCA Heme þ HCA Control Hemoglobin
AIN76 base 89 89 89 89 65.2 65.3
Sucrose 5.7 4.7 5.7 4.7 29.7 27.2
Casein 0.33 0.33 — —
Hemoglobin — 1 — 1 — 2.5
Ferric citrate 0.015 — 0.015 — 0.035 —
PhIP þ MeIQx — — 7.5  106 7.5  106
Safﬂower oil 5 5 5 5 5 5
NOTE: HCA: PhIP and MeIQx were obtained from Toronto Research Chemicals. All other chemicals were analytical grade and were obtained from either Merck or
Sigma. For their drinkingwater, each dietary group of rats was split in two subgroups. Half of them received tapwater in their drinking bottle. The other half received
NaNO2 and NaNO3 solutions in tap water. The NaNO2 and NaNO3 solutions were prepared with 170 mg NaNO2/L water and 230 mg NaNO3/L water. Water was
replaced twice a week.
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Cell lines
Apcþ/þ (derived fromC57BL/6Jmice) andApc/þ (derived from
C57BL/6J ApcMin/þ mice) colon epithelial cells (21) express the
heat-labile SV40 largeT antigen (AgT tsa58)under the controlof an
IFNg-inducible promoter. Both cell lines expressed cytokeratin 18,
a marker of their epithelial phenotype (Forest 2003). Conse-
quences of the Apc mutation were also detected in the Apc/þ cell
line. As expected, actin network was disorganized in Apc/þ cells
(Supplementary Fig. S2A; refs. 21, 22), accumulation of multinu-
cleated cells was observed in Apc/þ cells (Supplementary Fig.
S2A). As expected, the culture conditions affected cell proliferation
due to the thermolabile tsA58T antigen,which confers conditional
immortalization: at 33C with IFNg , the large T antigen is active
and drives cellular proliferation, and at 37C, the temperature-
sensitive mutation yields an inactive protein and cells act like
nonproliferating epithelial cells (Supplementary Fig. S2B).
Aldehydes for cytotoxicity and genotoxicity assays
4-HNE derived from the oxidation of n-6 polyunsaturated fatty
acids and 4-hydroxy-2-hexenal (4-HHE) derived n-3 polyunsat-
urated fatty acids were synthesized as described by Chandra and
Srivastava (23). Malondialdehyde (MDA) derived from polyun-
saturated fatty acids with 3 ormore double bondswas prepared as
described by Fenaille and colleagues (24).
Aldehyde trapping of fecal water from hemoglobin fed rats for
cytotoxicity assay
Polymer resin (4-Fmoc-hydrazinobenzoyl AMNovaGel,Noba-
biochemMerckChemicals) contains hydrazine functional groups
protected by Fmoc groups. To unprotect them, the resin was
washed with 0.8 mL DMSO þ 0.2 mL piperidine, vortexed for
1 minute, and allowed to settle for 15 minutes. The settled resin
was washed twice with DMSO, 4 times with ethanol, and with
distilledwater. The amount of polymer resin used for each sample
was based onusing 100 the amount ofMDA equivalents present
in the fecal water sample. Polymer resin was added to fecal water,
and the samples were agitated for 2 hours at 4C. After letting the
resin settle for 15 minutes, supernatant was transferred to a new
tube with polymer resin and agitated for 2 hours at 4C. After
settling, the supernatantwas diluted into culturemediumwithout
FCS and used for the MTT assay.
Cytotoxicity and genotoxicity assays on cell lines treated with
fecal water, heme, or aldehydes
To determine cytotoxic activity of fecal water, of HNE (20
mmol/L), and of hemin (100 mmol/L), the MTT assay on Apcþ/þ
and Apc/þ cells was used, as described previously (5). H2AX
phosphorylation (gH2AX) is a rapidandsensitive cellular response
to genotoxicity (25, 26). Genotoxicity and cytotoxicity of alde-
hydes were measured after 24 hours of treatment of Apcþ/þ and
Apc/þ cells using a gH2AX in-cell Western blot assay according to
Audebert and colleagues (27, 28). Graillot and colleagues (28)
demonstrated that this assay can be used to measure cell viability
via DNA quantiﬁcation. Cells were seeded into 96-well plates at 5
 103 cells per well in DMEM supplemented with 10% (v/v) FCS,
1% (v/v) penicillin/streptomycin, and 10 U/mL IFNg at the per-
missive temperature of 33C. After 72 hours, cells were transferred
to 37Cwithout IFNg for 24 hours and then treated with aldehyde
(5, 10, and20mmol/L) induplicate.Culturemediumwithout IFNg
and FCS was used for untreated control wells. This assay was
repeated 4 times.
Apoptosis assay on cell lines treated with aldehydes
Apoptosis was measured in Apcþ/þ and Apc/þ cells using a
luminescent assay (Caspase-Glo3/7; Promega). Cells were treated
with aldehydes for 6hours. After cell lysis, plateswere incubated at
room temperature for 2 hours, and the luminescence intensity of
each well was determined using an INFINITEM200 plate reader
(TECAN). This measure was performed in triplicate with alde-
hydes at 2.5, 5, 10, 20, 40, and 80 mmol/L.
Histologic analyses of the small intestine of mice
Immunohistochemistry H2AX. Four-micrometer parafﬁn-embed-
ded sections from formalin-ﬁxed mouse small intestine (Swiss
rolls) specimens were de-waxed in toluene and rehydrated.
Sections were incubated in Dako peroxidase blocking solution
(Dako S2023) and in goat serum (1:10, Dako X0907) for 20
minutes at room temperature. Sections were incubated with the
rabbit polyclonal anti-gH2AX antibody (1:400, Cell Signaling
Technology #9718) for 50 minutes at room temperature. The
secondary antibody (biotinylated goat anti-rabbit, Thermo
Scientiﬁc TR-060-BN) was applied for 30 minutes at room
temperature followed by horseradish peroxidase (HRP)–strep-
tavidin solution (DAB, Dako K0675) for 25 minutes. Peroxi-
dase activity was revealed by DAB substrate (DAKO, K3468).
Sections were counterstained with Harris hematoxylin, dehy-
drated, and coverslipped.
Enterocytes with nuclear gH2AX-positive foci or complete
nuclear labelingwere consideredpositive cells. Cellswere assessed
by counting the positive nuclei in segments of the small intestine
specimen that were at least 200 glands long. The positive counts
were expressed as counts per one villi-gland unit.
Anaphase bridges.Chromosomal or mitotic alterations can arise
from numerous events, including errors during cell division or
repair of damaged DNA. As a consequence, the separating
sister chromatids are often connected by DNA bridges in
anaphase. Anaphase bridges (AB) were evaluated on 4-mm
parafﬁn-embedded sections from formalin-ﬁxed mouse small
intestine (Swiss rolls). Sections were stained with hematoxylin
and eosin and AB were evaluated under light microscope using
400 magniﬁcation. Four segments from the duodenum,
jejunum, and ileum that were at least 100 consecutive glands
long were selected for counting. Criteria for ABs included
having a well-separated parallel anaphase plate displaying a
perpendicularly aligned amphophilic (stretched) connecting
ﬁlament (29). The scores were expressed as number of AB per
villi-gland unit.
Statistical analysis
Results were analyzed using Systat 10 software for Windows,
and all data are reported as mean  SEM. For the in vivo experi-
ments on chemically induced rats, the importance of each factor
was tested independently of the experimental groups (ANOVAper
factor). If a signiﬁcant difference was found between groups (P <
0.05), each experimental group was compared with the control
using Dunnett test, the difference between control and hemoglo-
bin diets effect on Min mice tumors was analyzed using the
Student t test. For the in vitro study, the dose effect of aldehydes
was analyzed using one-way ANOVA. If a signiﬁcant difference
was found between groups (P < 0.05), each experimental group
was compared with the control treatment using Dunnett test.
Second, the effect of the mutation effect at each concentration of
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aldehyde was analyzed with the comparison between the Apcþ/þ
and Apc/þ cell lines using the Student t test.
Results
Heme iron plays amajor role inmucin-depleted foci formation
Only diets containing hemoglobin signiﬁcantly increased the
number of MDF per colon (P < 0.001) independent of the 2 other
factors (Fig. 1A). Indeed, although nitrates/nitrites in drinking
water induced a considerable increase in fecal ATNCs in all
groups, they failed to increase the number of MDF per colon
(Fig. 1A and D). Nevertheless, we noticed that the ATNC com-
position was different between groups, containing 30% to 80%
FeNO and no S-nitrosothiols in the hemoglobin-fed groups
compared with no FeNO and about 30% of S-nitrosothiols in
other groups.
Diets containing hemoglobin signiﬁcantly increase the amount
of TBARS in fecal water (Fig. 1B) and the amount of urinary 1,4-
dihydroxynonemercapturic acid (DHN-MA), a metabolite of the
lipid oxidation product 4-HNE (Supplementary Fig. S3B). These
oxidation biomarkers depended only on dietary and fecal heme
(Supplementary Fig. S3A) and remainedunchangedwhen thediet
contained nitrates/nitrites or HCA without hemoglobin (Fig. 1B
and Supplementary Fig. S3B).
Premalignant epithelial cells resist cytotoxicity induced by fecal
water from heme-fed rats: the central role of aldehydes
Fecal water from rats fed hemoglobin-containing diets was
more cytotoxic to the nonmutated Apcþ/þ cells than to prema-
lignant Apc/þ cells (Fig. 1C). These data are consistent with
previous results (20). Fecal water from rats fed HCA or nitrites/
nitrates without hemoglobin was not cytotoxic to these cells (Fig.
1C).
With the trappingof aldehydes from fecalwater of rats fedheme
with a polymer resin with hydrazine functional groups, we found
that in Apcþ/þ and Apc/þ cells, a 95% reduction in fecal water
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Figure 1.
Heme iron plays a major role in MDF formation in rats and is associated with fecal water lipid peroxidation biomarkers independent of the fecal concentration
of ATNCs. A, the number of MDF per rat colon. A 3-factor ANOVA was used and showed only an effect of heme. B, lipid peroxidation in fecal water [measured
as TBARs (MDA equivalents)]. C, fecal water cytotoxicity. The cytotoxic effects of fecal water from the 8 groups of rats on Apcþ/þ cells (gray bars) and on Apc/þ
cells (black bars). Viability was measured by MTT assay after 24 hours of incubation with a 1:50 dilution of fecal water. D, ATNCs in fecal water shown as nitrosyl
iron (FeNO), S-nitrosothiols (RSNO), and other ATNCs. TEM, control diet; HCA, diet with PhIP (50 mg/kg) and MeIQx (25 mg/kg); Heme, diet containing 1%
hemoglobin; Hemeþ HCA, diet containing 1% hemoglobin, PhIP, and MeIQx: 50þ 25 mg/kg; 0, drinking water control; N, drinking water with nitrites and nitrates at
0.4 g/L. Values are means  SEM, n ¼ 10.  , signiﬁcantly different from TEM and HCA, P < 0.001;  , signiﬁcantly different from Apc/þ cells, P < 0.01.
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peroxidation was associated with a 75% reduction in cytotoxicity
(Fig. 2A). Furthermore, we observed that only 4-HNE, but not
heme, had differential cytotoxic effects in Apcþ/þ and Apc/þ cells
that was similar to that observed with fecal water of rats fed heme
(Fig. 2B).
We thenmeasured the cytotoxic and genotoxic effects of 3main
lipid peroxidation end products (4-HNE, 4-HHE and MDA) on
Apcþ/þ and Apc/þ cells using a gH2AX in-cell Western blot assay.
HNE and HHE were more cytotoxic and more genotoxic to
normal Apcþ/þ cells than to premalignant Apc/þ ones (Fig. 2C,
P < 0.05). HNE at 10 and 20 mmol/L and HHE at 20 mmol/L were
signiﬁcantly more genotoxic to Apcþ/þ cells than to Apc/þ ones
(Fig. 2C,P<0.05).MDAwasneither cytotoxic nor genotoxic in the
tested cell lines (Fig. 2C).We conﬁrmed these viability results with
the MTT assay and with the CellTiter-Glo assay (Supplementary
Fig. S4), and we used an expanded range of treatment concentra-
tions (from 0 to 80 mmol/L) in these assays. We conﬁrmed that
HNE and HHE were more cytotoxic (from 10 to 80 mmol/L and
from 40 to 80 mmol/L, respectively) to normal cells than to
premalignant ones, whereas MDA had no effect (Supplementary
Fig. S4).
We determined the caspase-3/7 activity and again found a
signiﬁcant difference between Apcþ/þ and Apc/þ cells after
HNE and HHE treatment at 80 and 40 mmol/L, respectively
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Figure 2.
The central role of aldehydes in the cytotoxic effect of fecal water of hemoglobin fed rats and the cytotoxic, genotoxic, and proapoptotic dose-dependent
effects of HNE, HHE, and MDA in Apcþ/þ and Apc/þ cells. A, TBARS and cytotoxicity on Apcþ/þ and Apc/þ cells of fecal water of hemoglobin fed rats
treated or not with trapping aldehydes resin. Solid bars, fecal water of hemoglobin group; hatched bars, fecal water of hemoglobin group treated with resin.
Values are means  SEM, n ¼ 3. B, cytotoxicity on Apcþ/þ (gray bars) and Apc/þ (black bars) cells of HNE (20 mmol/L) and hemin (100 mmol/L). Values
are means  SEM, n ¼ 3. C, genotoxic and cytotoxic effects of aldehydes on Apcþ/þ and Apc/þ cells. Values are means  SEM, n ¼ 4. D, proapoptotic
dose-dependent effects of aldehydes on Apcþ/þ and Apc/þ cells. Values are means  SEM, n ¼ 3.  , signiﬁcant difference between fecal water treated or
not with resin using the Student t test ( , P < 0.05).  , signiﬁcant difference between Apcþ/þ and Apc/þ using Student t test ( , P < 0.05;  , P < 0.01;
 , P < 0.001).
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(Fig. 2D, P < 0.05). Speciﬁcally, caspase-3/7 activity was higher in
Apcþ/þ cells than inApc/þ cells, andMDA treatment hadno effect
(Fig. 2D).
Heme iron and tumoral promotion: hemoglobin increases
intestinal tumorigenesis in ApcMin/þ mice
A diet containing 2.5% hemoglobin given to ApcMin/þ mice
signiﬁcantly increased the intestinal tumor load (control diet: 67
 39mm2; hemoglobin diet: 114 47mm2, P¼ 0.004; Fig. 3A).
These mice develop polyps mainly in the small intestine, and in
our study,wedidnot observe any effects of hemoglobin diet in the
colon. The hemoglobin diet also signiﬁcantly increased the num-
ber of all tumors in the jejunum (Supplementary Fig. S5A). In the
entire small intestine, the hemoglobin diet signiﬁcantly increased
the number of tumorswith a diameter greater than 1mm(1mm <
tumor size  2 mm, P ¼ 0.04; 2 mm < tumor size, P ¼ 0.006;
Supplementary Fig. S5B). Giving the same hemoglobin diet to
normal C57BL/6J Apcþ/þmice induced no neoplasia. As observed
in rats, the effect of dietary heme on mice tumors was associated
with a signiﬁcant increase in fecal heme (from2022 to19829
mmol/L) and with increases in lipoperoxidation biomarkers: fecal
TBARS (Fig. 3B) and urinary DHN-MA (Supplementary Fig. S5C).
We also assessed TBARS and the cytotoxicity of fecal water in the
small intestine to measure biomarkers at the same location as
tumors. As Minmice have amutation in the Apc gene, we decided
to use themouseApc/þmodel to investigate the cytotoxic activity
of fecal water in vivo. Heme diet was associated with a signiﬁcant
increase in fecal TBARS and cytotoxicity in the small intestine
(Fig. 3C).
A heme diet is genotoxic in vivo in the epithelium of C57BL/6J
Apcþ/þ mice
The induction of luminal lipid peroxidation by the hemoglobin
diet (Fig. 3B andC)was associatedwith increased genotoxicity only
innonmutatedC57BL/6JApcþ/þmicewith ahigher AB index in the
epithelium (Fig. 4A and B). As expected the AB index was higher in
C57BL/6JApcMin/þmice than inC57BL/6JApcþ/þmice feda control
diet (Fig. 4A) because of the Apc mutation. In ApcMin/þ mice, the
hemoglobin diet had no additional genotoxic effect (Fig. 4A). The
genotoxic effect of the hemoglobin diet in C57BL/6J Apcþ/þ was
conﬁrmed by gH2AX induction (Fig. 4C and D).
Discussion
This study examines in vivo the relative contributions of the 3
main factors that may explain how consumption of red and
0
20
40
60
80
100
***
B
HemoglobinControl
0
20
40
60
80
100
120
140
160
TB
A
R
s 
eq
ui
va
le
nt
 M
DA
 (m
m
o
l/L
)
A
Hemoglobin
0
50
100
150
200
250
Tu
m
or
 lo
ad
 (m
m2
)
**
Control
0
20
40
60
80
100
TB
A
R
s 
eq
ui
va
le
nt
 M
DA
 (m
m
o
l/L
)
HemoglobinControl
C
***
Cy
to
to
xi
ci
ty
 (%
)   
    
 
Control
Mean control
Hemoglobin
Mean hemoglobin
Cytotoxicity
TBARs
***
Figure 3.
The effect of hemoglobin on intestinal
tumorigenesis in Min mice and changes in
fecal and luminal biomarkers associatedwith
this effect. A, intestinal tumor load (mm2 per
intestine). Values are means  SEM, n ¼ 14
for the control diet and n ¼ 21 for the
hemoglobin diet. B, lipid peroxidation in
fecal water from feces [measured as TBARs
(MDAequivalents)].n¼ 5 for the control diet
and n ¼ 7 for the hemoglobin diet. C,
cytotoxic activity and peroxidation in small
intestine contents from mouse. Cytotoxicity
was measured in the Apc/þ cell line (fecal
water diluted 1:50, MTT assay). n ¼ 5 for the
control diet and n ¼ 7 for the hemoglobin
diet.  and  , signiﬁcantly different from
control diet ( , P < 0.01;  , P < 0.001).
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processed meat promotes colorectal cancer. Cross and colleagues
showed that these factors, that is, heme, HCA, and NOC, were
associated with colorectal cancer in a prospective cohort study in
humans (15). However, the identiﬁcation of risk factors using an
epidemiologic approach has to be correlated with the experimen-
tal approach to establish the causative effect of such factors. Here,
heme iron was the only experimental factor associated with a
signiﬁcant increase in precancerous lesions (MDF) in rats. Heme
iron showedno additive or synergic effectswith nitrates/nitrites or
with HCA. Using a complementary approach that included 2
animal models and a cellular model, we found that heme is the
determining factor in the promotion of colorectal carcinogenesis
and that the selective toxicity of heme-induced alkenals to non-
mutated cells seemed to play an important role in this
mechanism.
HCA are complete carcinogens that induce colon, mammary,
and prostate tumors in rodents and monkeys (30). The absence
of effects of HCA in this study could be explained by the dose
we chose, which was based on the estimated dietary exposure
to HCA in a diet that is high in red meat and was relevant of the
human food exposure. Indeed, carcinogenic doses of HCAs in
rodents are 1,000 to 100,000 times higher than levels found in
human foods (31). Nitrite undergoes an enterosalivary cycle in
humans but not in rats. We hypothesized that the addition of
sodium nitrates/nitrites to the rodents' drinking water, which
mimics human saliva, would increase the effects of heme iron
in rats by boosting nitrosation in the gut. In humans, red meat
consumption increases fecal ATNC concentrations (11), as in
our study with rats. Nevertheless, we could not detect any
association between the ATNC level (Fig. 1D) and carcinogen-
esis (Fig. 1A). The highest level of ATNC was seen in the control
group given nitrates/nitrites-supplemented water; this group
had the fewest MDF. The lack of a relationship between ATNCs
and the number of MDF does not support a strong role
for ATNCs in the promotion of colon carcinogenesis by red
meat.
The present results strongly suggest that at concentrations
that are in line with human red meat consumption, heme iron
is associated with the promotion of colon carcinogenesis at a
preneoplastic stage. Most human colon cancers have an Apc
mutation, as do MDF in humans and rats (32). To unravel the
mechanisms, we used a cellular model that represented the
colorectal cancer stages that we investigated in vivo. We chose a
cellular model that mimicked the early steps of carcinogenesis.
This conditionally immortalized intestinal cellular model uses
premalignant Apc/þ cells derived from C57BL/6J ApcMin/þmice
and "normal" Apcþ/þ cells from C57BL/6J mice (33). Charac-
terization of both cell lines showed the expected consequences
of Apc mutation, such as actin network disassembly, aneuploi-
dy, and multinucleated cells (Supplementary Fig. S2). These
cell lines can therefore be used to study the mechanisms
involved in the early steps of colorectal cancer and thus com-
prise a cellular model that is a relevant complement to our in
vivo model.
In rats, promotion of colon carcinogenesis by dietary hemo-
globin was associated with changes in noninvasive biomarkers:
fecal water heme iron, TBARS, and cytotoxic activity. Only the
hemoglobin diet increased TBARS levels in fecal water (Fig. 1B).
A
na
ph
as
e 
br
id
ge
/g
la
nd
Apc+/+ mice
ApcMin/+ mice
A
*
*
gH
2A
X 
N
um
be
r o
f p
os
iti
ve
 c
el
ls
/g
la
nd
C
Hemoglobin
HemoglobinControl
Control
0.025
0.02
0.015
0.01
0.005
0
0.35
0.3
0.25
0.2
0.15
0.1
0.05
0
B
D
Figure 4.
The effect of a hemoglobin-containing
diet on ABs and on the induction of
gH2AX in the small intestinal
epithelium in mice. A, the number of
ABs per gland in ApcMin/þ and Apcþ/þ
mice after 50 days of the indicated
experimental diet.  , signiﬁcantly
different from the control diet in the
same genetic context;  , signiﬁcantly
different from Apcþ/þ mice on the
same diet. B, an AB (arrow) in an
Apcþ/þ mouse fed a hemoglobin diet.
Scale bar, 2 mm. C, the number of
gH2AX-positive cells per gland in
C57BL/6J mice after 14 days on the
experimental diet. D, gH2AX-positive
cells (arrows) in Apcþ/þ mice fed the
heme diet. Scale bar, 4 mm.
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We speculated that the cytotoxic effects of fecal water on
normal and premalignant colonic cells in vitro mimic the in
vivo situation with normal epithelium (Apcþ/þ) and with Apc-
mutated MDF. In this study, only fecal water from hemoglobin-
fed rats was more cytotoxic to Apcþ/þ cells than to mutated cells
(Fig. 1C). We propose that premalignant cell selection explains
the heme-induced promotion of MDF. Aldehydes or heme iron
itself, both present at high concentration in feces from hemo-
globin-fed rats, might be responsible for this differential cyto-
toxicity. Using a resin to speciﬁcally trap fecal aldehydes, we
showed that aldehydes alone are responsible for fecal water
cytotoxicity. In addition, we observed that 4-HNE, but not
heme iron, induced differential cytotoxicity in Apcþ/þ and
Apc/þ cells similar to that observed with fecal water (Fig.
2B). Therefore, we propose that heme-induced lipid peroxida-
tion in the gut explains the observed differential cytotoxicity
and the colorectal cancer–promoting effects of heme that are
observed in vivo.
To explore the link between aldehydes and the promotion of
colon carcinogenesis, we tested the effects of 3 relevant alde-
hydes, 4-HNE, HHE, and MDA, in Apcþ/þ and Apc/þ cells.
These a,b-unsaturated hydroxyalkenals are highly reactive
compounds with proteins and nucleic acids (34), and they
are potentially cytotoxic and genotoxic. In our cellular model,
4-HNE and HHE were more cytotoxic to normal cells than to
premalignant cells and induced higher levels of apoptosis in
normal cells than in premalignant cells. HNE was more cyto-
toxic than HHE, as reported previously (35). Furthermore,
HNE, like HHE, was more genotoxic to normal cells than to
premalignant ones (Fig. 2C), with a higher index of DNA
double-strand breaks as revealed by the phosphorylation
of histone H2AX. DNA double-strand breaks pose a critical
hazard to the genome, and erroneous rejoining of DNA dou-
ble-strand breaks can lead to mutation. These results thus
suggest that at concentrations higher than 20 mmol/L, HNE
and HHE will kill normal cells, whereas at lower concentra-
tion, they could create mutations in Apcþ/þ cells and might
thus initiate carcinogenesis. Therefore, Apc-mutated cells are
resistant to apoptosis and can survive to contact with cytotoxic
and genotoxic aldehydes, which allows them to undergo
further mutation and to become more malignant. Surprisingly,
MDA was not toxic to the cells tested in this study but others
found also that MDA had little or no toxicity in cells (35, 36).
The results obtained by aldehyde trapping and in vitro with
HNE and HHE conﬁrmed our hypothesis that aldehydes are
responsible for the differential cytotoxic effects of fecal water
from heme-fed rats. Heme iron catalyzes the formation of
aldehydes in the gastrointestinal tract, which would "select"
premalignant cells and also increase the mutation frequency in
normal cells (22).
This study shows that a hemoglobin-rich diet signiﬁcantly
increased the tumor load in the small intestine of ApcMin/þ
mice. In contrast, tumor load was not changed by heme diet in
the colon of mice, despite the expected modulation of bio-
chemical markers. The number of tumors in the colon of Min
mice is low (<0.5 tumors per mouse), which reduces statistical
power (37). These mice have a truncated Apc gene as in human
familial adenomatous polyposis (FAP; ref. 38). Moreover,
sporadic colorectal cancer tumors have the same early Apc
mutation in 50% to 80% of cases (37). This mutation is also
present in MDF (39). Our nutritional experiments in rats and
mice were thus conducted in the deﬁned genetic context of the
Apc mutation. Promotion of carcinogenesis in rats and in
ApcMin/þ mice (Fig. 3A) was associated with 2 noninvasive
biomarkers, fecal water TBARS and cytotoxic activity, in colon
and in small intestine (Fig. 3B and C).
Furthermore, aswe found thatHNE ismore genotoxic in vitro to
wild-type cells than to Apc/þ cells (Fig. 2C), we decided to
investigate the genotoxicity of dietary heme in vivo by measuring
(i) the AB index in the epithelium of C57BL/6J Apcþ/þ mice and
C57BL/6J ApcMin/þmice and (ii) by assessing gH2AX induction in
the epithelium of C57BL/6J Apcþ/þ mice (Fig. 4). In these 2
studies, the induction of lipid peroxidation in the gut by heme
(Fig. 3B and C) was associated with increased epithelial geno-
toxicity in Apcþ/þmice but not in ApcMin/þmice. Together with in
vitro data, these data show that dietary hemoglobin can induce
DNA damage. We also observed ABs, which are biomarkers of
chromosomal instability and a major consequence of Apc muta-
tion. As expected, inmice fed the control diet, more ABswere seen
in ApcMin/þ mice than in Apcþ/þ mice (Fig. 4A). Moreover, the
hemoglobin diet increased the AB index in Apcþ/þmice (Fig. 4A).
The hemoglobin diet induced the same number of ABs as the Apc
mutation, suggesting that dietary hemoglobin generates strong
initiators. Taken together, these data suggest that heme-induced
aldehydes can induce mutations in vitro and in vivo and may
initiate carcinogenesis.
In conclusion, we identiﬁed heme iron as the main factor
responsible for the promotion of colorectal cancer by red meat
and showed that aldehydes such as 4-HNE or HHE play roles in
the underlying mechanism of action. Furthermore, we suggest
that dietary heme could result in initiating agents in the gut.
Improved dietary recommendations should focus (i) on the
amount of heme iron in meat-based diets rather than on the
modes of cooking or preparation and (ii) on dietary changes that
could reduce the heme effect in the gut (i.e., on changes that limit
the bioavailability of heme and of heme-induced peroxidation;
ref. 40).
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Article 3: 
Red meat and colorectal cancer: 
4-Hydroxy-2-nonenal (HNE) induces different apoptosis, autophagy and 
Nrf-2-related responses in normal and APC knockdown human colon 
epithelial cells 
 
Surya et al. 2016. Manuscript to be submitted 
 
In this study, we used human-origin experimental models HCECs (human colonic 
epithelial cells): CT and CTA cells to approach human physiology (Chapter 3.2). This study 
was directed to investigate whether APC invalidation in HCECs led to better detoxifying and 
survival ability upon exposure to HNE and fecal water of heme-fed rats. The main results 
obtained in this study are:  
1) CTA cells are more resistant to HNE and fecal water of heme-fed rats than CT 
cells 
We observed that CTA cells exhibited lower level of apoptosis than CT cells upon 
exposure to HNE and fecal water of heme-fed rats, highlighting the better resistance of 
CTA cells to such an exposure. Following the exposure to HNE or fecal water of 
heme-fed rats, caspases activity appeared at a higher rate and higher final extent in CT 
cells than in CTA cells. By analyzing apoptosis end points such as nuclear 
fragmentation, cleavage of caspase-3 and PARP and cell membrane permeabilization 
after exposure to HNE or fecal water of heme-fed rats for 6 h, we observed higher 
level of apoptosis in CT cells than in CTA cells. 
 
2) Autophagy is involved in such a resistance. 
CTA cells exhibited autophagy under basal conditions, shown by the formation of 
LC3 puncta and the lipidation of LC3-I. Following exposure to HNE and fecal water 
of heme-fed rats, CTA cells underwent autophagy at higher rate and extent than CT 
cells, probably as a defense mechanism against HNE and fecal water-induced 
apoptosis. To analyze the importance of autophagy in the resistance of CTA cells 
towards HNE or fecal water of heme-fed rats, we modulated autophagy in CT and 
CTA cells by using rapamycin or wortmannin to induce and inhibit autophagy 
respectively. Indeed, chemical inhibition of autophagy sensitized CTA cells to HNE 
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whereas chemical stimulation of autophagy improved the resistance of CT cells to 
HNE. These findings highlighted the potentially protective role of autophagy in CTA 
cells towards the toxicity of HNE and fecal water of heme-fed rats.  
 
3) Nrf2, mediated by p62, is involved in such a resistance 
Nrf2 was present at a higher basal activity in CTA cells than in CT cells and this led to 
higher expression of HNE detoxification enzymes (AKR1B1, AKR1B10 and GCLM) 
in CTA cells compared to CT cells. Basal Nrf2 activity in CTA cells was mediated by 
autophagic protein p62. We suggested that the higher p62 level in CTA cells would 
allow them to evacuate autophagy and activate Nrf2 more responsively than CT cells 
upon exposure to HNE or fecal water of heme-fed rats. 
 
Prior to this study, the studies within the team using mouse-origin APC +/+ and APC 
Min/+ cells showed that APC mutation improved cell resistance towards HNE and fecal water 
of heme-fed rats (Article 1 and 2). In this study, we reported for the first time the 
extrapolation of cell resistance regarding APC invalidation to human cells. Taken together, 
our results revealed autophagy and Nrf2 as potential mechanisms underlying the resistance of 
CTA cells to the toxicity of HNE or fecal water of heme-fed rats. This study opens a 
perspective to modulate autophagy and Nrf2 responses during early colorectal carcinogenesis 
by improving the resistance of normal cells or sensitizing preneoplastic cells to the toxicity of 
HNE or fecal water of heme-fed rats. 
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Abbreviations 
3-MA  : 3-methyladenine 
AKR1B1 : Aldo-keto reductase family 1 member B1 
AKR1B10 : Aldo-keto reductase family 1 member B10 
Apc  : Adenomatous polyposis coli 
ARE  : Antioxidant response element 
BCL-2  : B-cell lymphoma 2 
Bf  : Beef 
Caspase : Cysteine aspartate-specific protease 
CDK4  : Cyclin-dependent kinase 4 
CRC  : Colorectal cancer 
CypA  : Cyclophilin A 
DHN-MA : 1,4-dihydroxynonane mercapturic acid 
GCLM : Glutamate-cysteine ligase, modifier subunit 
Hb  : Hemoglobin 
HCEC  : Human colon epithelial cell 
HNE  : 4-hydroxy-2-nonenal 
HO-1  : Heme oxygenase 1 
HPRT  : Hypoxanthine-guanine phosphoribosyltransferase 
Keap1  : Kelch-like ECH-associated protein 1 
LC3  : Light chain 3 
Nrf2  : Nuclear factor (erythroid derived 2)-like 2 
PARP  : Poly (ADP-ribose) polymerase 1 
PI3K  : Phosphoinositide 3-kinase 
RPLP0 : Large ribosomal protein 
Ser  : Serine 
TBARS : Thiobarbituric acid reactive species 
Z-VAD-FMK : Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone 
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Abstract 
 
Red meat is a factor risk for colorectal cancer, considered as probably carcinogenic to human. 
Experimental studies explain the association between red meat and colorectal cancer by the 
oxidative properties of heme iron released in the colon. This latter is a potent catalyst for lipid 
peroxidation, resulting in the neoformation of cytotoxic aldehydes present in the fecal water 
of heme-fed rats, including 4-hydroxy-2-nonenal (HNE). In this study, we compared two 
isogenic non-transformed human colonic epithelial cell (HCEC) lines termed CT (normal 
HCECs) and CTA (HCECs with shRNA-mediated invalidation of APC gene, representing 
preneoplastic phenotype). This study demonstrates that HNE and fecal water of heme-fed rats 
preferentially induced apoptosis in CT cells than in CTA cells. CTA cells exerted autophagy 
at higher rate and extent than CT cells. Indeed, chemical inhibition of autophagy sensitized 
CTA cells to HNE whereas chemical stimulation of autophagy rendered CT cells more 
resistant to HNE, suggesting that autophagy would be a defense mechanism against HNE and 
fecal water-induced apoptosis. To further study the resistance of CTA cells to HNE and fecal 
water, we focused on Nrf2, known to be activated by HNE and promote the expression of 
HNE detoxification enzymes (AKR1B1, AKR1B10 and GCLM). Nrf2 was present at a higher 
basal activity in CTA cells than in CT cells and this activity was mediated by autophagic 
protein p62. The higher level of p62 in CTA cells also allowed them to evacuate autophagy 
and activate Nrf2 more responsively than CT cells. Taken together, our results suggest that 
different apoptosis, autophagy and Nrf2 responses may explain the different resistance of CT 
and CTA cells upon exposure to HNE or fecal water of heme-fed rats. This difference could 
explain the promoting effect of red meat on colorectal cancer, by initiating positive selection 
of cells with preneoplastic phenotypes. 
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Introduction 
Colorectal cancer (CRC) is a major worldwide heath problem, being the third most commonly 
diagnosed cancer in the world and the fourth cause of cancer death worldwide. Although most 
of CRC cases occurred in the developed countries, the incidence rates have been rising in 
developing countries [1-3]. There was convincing evidence that diet and physical activity are 
risk factors for CRC development [4-6]. Concerning the diet, red meat consumption has been 
demonstrated to increase the risk of colorectal cancer with a relative risk of 1.17 (95% CI 
1.05-1.31) per 100 g/day of red meat [7]. American Institute for Cancer Research (AICR) and 
World Cancer Research Fund (WCRF) proposed that red meat was a convincing cause of 
CRC and recommended limiting red meat consumption to 300 g/week [5]. Later, The 
International Agency for Research on Cancer (IARC) concluded in October 2015 that red 
meat is probably carcinogenic to humans (Group 2A) [8].  
Several carcinogenic compounds that are present in or derived from red meat have been 
hypothesized as culprits for CRC development, such as heme iron present in the red meat, N-
nitroso compounds that can be formed in the gastrointestinal tract by N-nitrosation or 
nitrosylation and heterocyclic amines that can be generated from cooking red meat at high 
temperature [9]. Our team previously examined in vivo the relative contribution of heme iron, 
N-nitroso compounds and heterocyclic amines in CRC development and we showed that 
heme iron was the only experimental factor associated with the promotion of colorectal 
carcinogenesis in rats and Min mice (harboring a mutation on adenomatous polyposis coli 
(APC) gene, a frequent and early event in human CRC development [10-12]) without any 
additive or synergic interaction with N-nitroso compounds or heterocyclic amines [13]. 
Furthermore, we showed that heme iron exerts its carcinogenic activity by catalyzing lipid 
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peroxidation in the lumen that results in the formation of cytotoxic and genotoxic aldehydes, 
one of which is 4-hydroxy-2-nonenal (HNE), a secondary product of linoleic and arachidonic 
acid oxidation [14-16]. In hemoglobin (Hb)- and beef (Bf)-fed rats, we observed a significant 
increase of fecal thiobarbituric acid reactive species (TBARS) and urinary 1,4-
dihydroxynonane mercapturic acid (DHN-MA); metabolite of HNE), both are biomarkers of 
lipid peroxidation [17-19].  
We previously assessed HNE toxicity in vitro in normal and preneoplastic immortalized 
mouse colon epithelial cells. Preneoplastic cells were derived from Min mice. Interestingly, 
preneoplastic cells appeared to be more resistant than normal cells upon exposure to HNE 
[19] and this phenomenon was also observed using fecal water of Hb- and Bf-fed rats [20]. 
Fecal water, a bioavailable aqueous extract of feces, hereby represents a complex biological 
matrix containing numerous neoformed substances in gastrointestinal tract including terminal 
aldehydes of lipid peroxidation such as malondialdehyde and HNE [21-23]. Recently, we 
showed that fecal aldehydes were in part responsible for the different resistance between 
normal and preneoplastic cells to fecal water of Hb- and Bf-fed rats, since the depletion of 
carbonyl compounds in this fecal water abolished the different toxicity of fecal water 
observed in normal and preneoplastic cells [20]. We thus suggested that heme iron intake 
yields lipid peroxidation-derived cytotoxic aldehydes that generate a positive selection of 
preneoplastic cells over normal cells, explaining the mechanism by which heme iron intake 
promotes CRC. 
Nuclear factor (erythroid derived 2)-like 2 (Nrf2) is a transcription factor that regulates the 
expression of antioxidant enzymes (including those involved in HNE detoxification) through 
Nrf2-Keap1-ARE signaling pathway, thus exerting cytoprotective properties against oxidative 
stress [24]. HNE has been shown to activate Nrf2 and antioxidant genes expression [25]. Our 
previous study revealed that the resistance of preneoplastic cells upon exposure to fecal water 
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of Hb- and Bf-fed rats is due to higher basal Nrf2 activity in preneoplastic cells compared to 
normal cells, thus bestowing preneoplastic cells with higher level of basal HNE detoxification 
enzymes that protect them from HNE toxicity [20,26].  
Autophagy (macroautophagy) is an intracellular degradation system that delivers cytoplasmic 
constituents to the lysosomes. It is mediated by the formation of autophagosomes that engulf a  
to-be-degraded portion of cytoplasm [27]. Autophagy is considered as a protective 
mechanism in response to stress. It allows the clearance and recycling of damaged proteins 
and organelles following the stress [28]. It has also been shown to block cellular apoptotic 
responses, thus favoring cell survival [29,30]. p62/SQSTM1 (sequestosome), a cargo receptor 
protein for autophagic degradation, is an Nrf2 target gene and can create a positive feedback 
loop for Nrf2 activation following its phosphorylation at Serine 351 (Ser 351) residue by 
TAK1 (transforming growth factor beta-activated kinase 1) [31]. Phosphorylated p62 at Ser 
351 then binds to Keap1, the Nrf2 inhibitor, for further lysosomal degradation [32,33]. 
Indeed, autophagy was reported to be up-regulated during colorectal carcinogenesis and this 
up-regulation was linked to the increasing resistance of CRC cells towards chemotherapy 
intervention [34-37]. As autophagy may exert protective properties to cells, it could also be 
involved in the different resistance of normal and preneoplastic cells upon exposure to fecal 
water. 
In this study, we analyzed the resistance of normal and Apc knockdown human colonic 
epithelial cells (HCECs) [38,39] upon exposure to HNE. These isogenic cell lines represent 
normal and preneoplastic phenotypes of human colon cells respectively, thereby allowing the 
studies on different cell resistance during early events in colorectal carcinogenesis. We 
consider that the use of human colon cancer cell lines is not pertinent to assess early 
colorectal carcinogenesis since their phenotypes represent advanced or late stages of 
colorectal carcinogenesis. Similar to our previous findings using normal and preneoplastic 
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mouse colon epithelial cells [19,20], Apc knockdown cells (termed CTA), which represent 
preneoplastic phenotype, appeared to be more resistant towards HNE toxicity compared to 
normal cells (termed CT) by exhibiting lower level of apoptosis. Exposure to fecal water of 
Hb- and Bf-fed rats showed the same phenomenon. This higher resistance of Apc knockdown 
cells was linked to their higher basal Nrf2 activity. Interestingly, we observed a higher level 
of autophagy in Apc knockdown cells following exposure to HNE and fecal water compared 
to normal cells. Indeed, chemical inhibition of autophagy in Apc knockdown cells sensitized 
them to HNE toxicity while chemical induction of autophagy in normal cells improved their 
resistance towards HNE toxicity. We suggest that Apc knockdown cells relied on autophagy 
as a protective mechanism against HNE and fecal water toxicity. Finally, we demonstrated 
that higher Nrf2 activity in Apc knockdown cells implicated autophagic protein p62. Thus, 
this study deciphered the plausible link among apoptosis, autophagy and Nrf2-related 
antioxidant responses in the early stages of CRC development. 
Materials and Methods 
Chemicals 
All chemicals used in culture cell treatment were provided by Sigma Aldrich: Z-VAD-FMK 
(10 µM), staurosporin (1 µM), rapamycin (500 nM), wortmannin (1 mM), E64d (5 µg/mL) 
and pepstatin A (5 µg/mL). All chemicals were diluted in DMSO in stock solution (maximum 
DMSO dilution in final solution 1/1000). 
Antibodies 
For immunofluorescence analysis, primary and secondary fluorophore-labeled antibodies 
were diluted 1:100 and 1:200 respectively in PBS containing 0.1% Triton and 0.5% BSA. The 
primary antibodies used were anti-LC3A (Cell Signaling, rabbit) and anti-Nrf2-C20 (Santa 
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Cruz, rabbit). The secondary fluorophore-labeled antibody used was Alexa Fluor 488 donkey 
anti-rabbit IgG (Life Technologies). 
For western blot analysis, primary and fluorescent secondary antibodies were diluted 1:1000 
in TBS containg 3% BSA and 0.1% Tween. The primary antibodies used were anti-PARP 
(Cell Signaling, rabbit), anti-cleaved caspase-3 (Asp175) (Cell Signaling, rabbit), anti-BCL-2 
(Cell Signaling, rabbit), anti-Beclin 1 (Cell Signaling, rabbit), anti-p62 (Santa Cruz, goat), 
anti-LC3A (Cell Signaling, rabbit), anti-Nrf2 (Cell Signaling, rabbit), anti-HO-1 (Santa Cruz, 
goat), anti-phosphorylated p62 (Ser351) (MBL, rabbit), anti-Keap1 (Santa Cruz, goat) and 
anti-β-actin (Santa Cruz, mouse). The fluorescent secondary antibodies used Pierce DyLight 
700 donkey anti-rabbit IgG, Pierce DyLight 800 donkey anti-goat IgG and Pierce DyLight 
800 donkey anti-mouse IgG (Thermo Scientific). 
Cell culture 
Immortalized non-transformed human colonic epithelial cells (HCECs) termed CT (“C” for 
CDK4 and “T” for telomerase) were established and provided by Pr. Jerry W. Shay [39]. An 
isogenic cell line derived from CT (termed CTA, the additional “A” for APC) was obtained 
by shRNA-mediated downregulation of Apc [38]. Cells were cultured (approximate density 
2.5x104 cells/cm2) on PrimariaTM flasks in a humidified atmosphere with 5% CO2 at 37 °C, in 
4:1 Dulbecco-modified Eagle medium (DMEM)/medium 199 supplemented with fetal bovine 
serum (FBS 2%), epidermal growth factor (EGF 20 ng/mL), hydrocortisone (1 mg/mL), 
insulin (10 mg/mL), transferrin (2 mg/mL), sodium selenite (5 nM) and gentamycin sulfate 
(50 µg/mL). All supplements for cell culture media were provided by Sigma-Aldrich. CTA 
cells were selected by puromycin (1 µg/mL). All treatments with HNE and fecal water were 
performed in complete medium without FBS to avoid any reaction between serum and fecal 
water or HNE. 
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HNE synthesis 
HNE was synthesized as previously described [40]. Briefly, Grignard reaction between 
fumaraldehyde monoacetal and 1-pentylmagnesium bromide afforded HNE-dimethylacetal. 
HNE was obtained by acid hydrolysis.  
Fecal samples 
Feces used to generate the fecal water were obtained from two animal studies set up to 
explore respectively the effect of dietary hemoglobin [13] and beef on colorectal 
carcinogenesis (not published). Briefly, seven days following an injection with the carcinogen 
azoxymethane (Sigma Aldrich, 20 mg/kg body wt in NaCl (9 g/L)), F344 male rats were 
allowed free access to their respective diets for 100 days. In the first experiment, rats were fed 
with modified AIN (American Institute of Nutrition)-76 diet (low calcium with addition of 
5% (v/w) safflower oil; control group) or with modified AIN-76 diet containing 1% (w/w) Hb 
(Hb-fed group) [13]. In the second experiment, rats were fed with modified AIN-76 diet 
(control group) or with 50% modified AIN-76 diet containing 50% raw beef sirloin. Feces 
were collected on the 88th and 95th day of experiment for Hb-fed and beef-fed rats 
respectively. The two studies resulted in four groups of collected feces: standard diet for Hb-
fed rats (Control Hb), Hb-fed rats (Hb), standard diet for beef-fed rats (Control Bf) and beef-
fed rats (Bf). All experiment protocols were approved by the Local Animal Care and Use 
Committee of Institut National de la Recherche Agronomique (TOXCOM), and were 
conducted in accordance with the European directive 2010/63/UE and ARRIVE guidelines. 
Fecal water preparation 
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Fecal water was prepared as previously described [13]. Briefly, 2 g of feces was diluted in 5 
mL of distilled water, ground and centrifuged. The supernatant was collected, diluted 20 times 
in complete medium without FBS and sterilized by microfiltration (pore size 0.2 µm).  
Viability assay 
Cell viability assay was done by using cell proliferation reagent WST-1 (Roche Life Science) 
according to manufacturer’s protocol. Briefly, cells were seeded in 96-well microtiter plates. 
Following treatments with HNE or fecal water, cells were incubated in WST-1 reagent for 1 h 
in the dark. The absorbance of each well was measured by colorimetric at measurement and 
reference wavelengths of 440 nm and 690 nm respectively. 
Apoptosis detection: nuclei fragmentation and caspase activation by time-lapse microscopy  
For nuclei fragmentation assay, cells seeded in 24-well plates were incubated for 6 h of 
contact with HNE 40 µM and fecal water (dilution 20x) at 37 °C. Cells were then fixed in 
paraformaldehyde 4% and stained using fluorescent dye Hoechst 33342 (Life Technologies, 
0.5 ng/mL in PBS). Apoptotic (fragmented and/or condensed) and alive nuclei were counted 
using fluorescence microscope (Evos fl digital inverted microscope, AMG) and expressed as 
percentage of total population (n>500 nuclei). 
For time-lapse microscopy, cells seeded in Labtek 8-well chamber 1.5 borosilicate coverglass 
slides were incubated under confocal microscope Leica SP8 (with micro-incubator at 37 °C, 
5% CO2) with HNE 20 µM and fecal water (dilution 20x) containing Hoechst 33342 (5 
µg/mL), CellEventTM Caspase-3/7 Green Detection Reagent (Life Technologies, 2 µM) and 
TO-PRO®-3 Iodide (Life Technologies, 1 µM). Images were acquired using lasers 405, 488 
and 638 nm under 20x magnification every 30 min for 12 h. Image analysis was performed 
using ImageJ software. 
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Immunofluorescence 
Cells seeded on round coverslips (diameter 18 mm) in 12-well plates were incubated for 1 or 
2 h of contact with HNE 20 µM or fecal water (dilution 20x) at 37 °C. Following saturation 
(PBS, 0.1% Triton, 0.5% BSA), each coverslip was incubated with primary antibodies 
directed against LC3A or Nrf2 (dilution 100x in PBS, 0.1% Triton, 0.5% BSA) for 1 h at 
room temperature. After washing with PBS, the cells were incubated with secondary 
fluorophore-labeled antibodies (Alexa Fluor 488 donkey anti-rabbit IgG, dilution 200x in 
PBS, 0.1% Triton, 0.5% BSA) for 1 h at room temperature. All cover slips were then sealed 
on microscope slides using anti-fading solution (Invitrogen Prolong Gold antifade reagent 
with DAPI). The slides were analyzed using confocal microscope Leica SP8 with lasers 488 
nm (Alexa 488) and 405 nm (DAPI) under 63x oil immersion objective. The formation of 
LC3 puncta was observed and counted (n>50 nuclei). The colocalization of Nrf2 and nuclei 
was observed by using fluorescence intensity graphs presenting the intensity of blue (nuclei) 
and green (Nrf2) fluorescence detected along determined regions of interest (ROI). Nuclear 
localization of Nrf2 was deduced from blue and green fluorescence pattern. Image analyses 
were done using Leica LAS AF software. 
RT-qPCR 
Cells were incubated for 5 h of contact with HNE 40 µM at 37 °C. RNA was isolated using 
Tri Reagent (Eurogenetec) according to manufacturer’s instructions. Two-step RT-qPCR was 
performed using HPRT (Hypoxanthine-guanine phosphoribosyltransferase), CypA 
(Cyclophilin A) and RPLP0 (Large ribosomal protein) as housekeeping genes. cDNA 
synthesis was done using the iScript cDNA Synthesis kit (Bio-Rad) with 1 µg RNA. 
Quantitative PCR was conducted using ViiATM 7 Real-Time PCR System (Life 
Technologies), with final reaction volume of 5 µL (1 µL cDNA, 1.5 µL primers and 2.5 µL 
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iQ SYBR Green Supermix (Bio-Rad)). Thermocycling conditions were set as following: 
initial denaturation at 95 °C (10 min), denaturation at 95 °C (15 s), annealing at 60 °C (30 s) 
and extension at 72 °C (30 s). The sequences of the primers (5’ to 3’) used are listed below: 
AKR1B1 (F-CCA ACT TCA ACC ATC TCC AGG TG, R-GTC ACC ACG ATG CCT TTG 
GAC T), AKR1B10 (F-GAG GAC CTG TTC ATC GTC AGC A, R-CGT CCA GAT AGC 
TCA GCT TCA G), GCLM (F-TCT TGC CTC CTG CTG TGT GAT G, R-TTG GAA ACT 
TGC TTC AGA AAG CAG), HPRT (F-CAT TAT GCT GAG GAT TTG GAA AGG, R-CTT 
GAG CAC ACA GAG GGC TAC A), CypA (F- CCC ACC GTG TTC TTC GAC AT, R-
TGC TGT CTT TGG GAC CTT GTC T), RPLP0 (F-TGG TCA TCC AGC AGG TGT TCG 
A, R-ACA GAC ACT GGC AAC ATT GCG G). 
Western blot  
Western blot analysis was done as previously described [20,38]. Briefly, cells were incubated 
for 1 or 2 or 6 h with HNE 20 µM or fecal water (dilution 20x) at 37 °C, washed in ice-cold 
PBS, scrapped and pelleted by centrifugation. Cell pellets were then incubated in lysis buffer 
and homogenized by sonication. For the detection of nuclear Nrf2, whole cell lysates were 
fractionated using Nuclear Extraction kit (Active Motif) according to manufacturer’s 
protocols. Western blot of nuclear extracts (10 µg) was performed by SDS-PAGE and blots 
were transferred to PVDF membranes by Trans Blot Turbo Transfer System (Bio-Rad). 
Membranes were then saturated and incubated with primary antibodies (dilution 1000x in 
TBS, 3% BSA, 0.1% Tween) at 4 oC for a night under agitation. Fluorescent secondary 
antibodies (dilution 1000x in TBS, 3% BSA, 0.1% Tween) were incubated for 1 h and 
membranes were revealed using Odyssey® CLx Li-Cor Infrared Imaging System at 
wavelengths of 700 and 800 nm. 
Statistical analysis 
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The results (n≥3) were analyzed using software GraphPad Prism 4 for Windows. Different 
responses of treatments and genotype effect were analyzed by two-way ANOVA or student’s 
t-test. When ANOVA showed a statistically significant effect (p<0.05), comparison among 
data was done using Tukey’s HSD Post-hoc test.  
Results 
Apc knockdown HCECs exhibited lower apoptosis incidence compared to normal HCECs 
upon exposure to HNE and fecal water of Hb- and Bf-fed rats 
To characterize cell death by apoptosis in HCECs, we analyzed caspase-3/7 activation, 
membrane permeabilization and cleavage of PARP (poly (ADP-ribose) polymerase 1) and 
caspase-3 (Figure 1A-C), according to the guidelines of apoptosis identification [41]. HNE 
induced apoptosis in a higher rate and extent in CT cells compared to in CTA cells (Figure 
1A). This difference of apoptosis in CT and CTA cells was also observed upon exposure to 
fecal water of Hb- and Bf-fed rats, but not to fecal water of standard diet-fed rats. 
The difference of apoptosis between CT and CTA cells following exposure to HNE and fecal 
water of Hb- and Bf-fed rats was most considerable at 6 h, the time at which the apoptosis rate 
in CT cells reached its peak, with approximately 50% of CT cells exhibiting caspase-3/7 
activity. At this time, the amount of cells exhibiting caspase-3/7 activity and permeable 
membrane was significantly higher in CT cells compared to CTA cells (Figure 1B). Fecal 
water of standard diet-fed rats exerted relatively low caspase-3/7 activity and membrane 
permeabilization (< 20%) without any significant difference between CT and CTA cells.  
Apoptosis is also characterized by cleavage of PARP and caspase-3. We observed this 
cleavage at a higher extent in CT cells than in CTA cells following 6 h exposure to HNE and 
fecal water of Hb- and Bf-fed rats (Figure 1C and Supplementary Figure 1). Staurosporin was 
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used as a positive control for apoptosis. The expression BCL-2 (B-cell lymphoma 2), an anti-
apoptotic protein, was up-regulated in CT cells upon exposure to HNE and fecal water. 
However, BCL-2 was constantly present at a higher concentration in CTA cells than in CT 
cells both under basal conditions and upon exposure to HNE and fecal water (Figure 1C and 
Supplementary Figure 1).  
Apc knockdown HCECs demonstrated higher autophagy levels compared to normal HCECs 
under basal conditions and upon exposure to HNE and fecal water of Hb- and Bf-fed rats 
To characterize autophagy in HCECs, we performed immunofluorescence staining to 
investigate the formation of LC3 (Light chain 3) puncta in CT and CTA upon exposure to 
HNE (Figure 2A). LC3 is a protein that is involved in the formation of autophagosomes and 
the formation of LC3 puncta is correlated to the formation of autophagosomes. Here, we 
observed that CTA cells exhibited higher autophagy levels than CT cells under basal 
conditions. Prolonged HNE exposure induced autophagy in CT and CTA cells, but at a higher 
rate and extent in CTA cells (Figure 2B). To analyze the differential of autophagy in HCECs 
upon exposure to HNE and fecal water, we decided to choose the exposure time of 2 h since 
this was the longest incubation time at which the autophagy levels in CTA cells were superior 
to control while the autophagy levels in CT cells did not differ from the control. Indeed, 
following 2 h exposure to HNE and fecal water, we observed significantly higher number of 
LC3 puncta in CTA cells than in CT cells (p<0.05) (Figure 2A, 2C and Supplementary Figure 
2A). Rapamycin was used as autophagy inducer whereas wortmannin was used as autophagy 
inhibitor. 
We also verified the expression of several proteins involved in autophagy, such as Beclin-1, 
p62 and LC3. To halt protein-degrading autophagic flux by inhibiting lysosomal turnover, we 
used a mix of lysosomal inhibitors E64d and pepstatin A. The expression levels of Beclin-1 
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and p62 were constantly higher in CTA cells than in CT cells under basal conditions and upon 
exposure to fecal water (Figure 2D and Supplementary Figure 2B). In CT cells, different from 
the expression level of Beclin-1 that was relatively constant following the treatments, the 
expression level of p62 increased upon exposure to HNE and fecal water of Hb- and Bf-fed 
rats. Despite this increase, the expression level of p62 in CT cells remained lower than in 
CTA cells. The lipidation of LC3-I into LC3-II is also a characteristic of autophagy since 
LC3-II is a building block of autophagosomal membranes. Here, we observed higher ratio of 
LC3-II/LC3-I in CTA cells compared to CT cells under basal conditions and following 
exposure to HNE and fecal water when autophagy flux was blocked (Figure 2D and 
Supplementary Figure 2B), indicating higher autophagic activity in CTA cells compared to 
normal cells. 
Chemical modulation of autophagy regulated the sensitivity of HCECs towards HNE  
To study the effect of autophagy modulation on the resistance of HCECs towards HNE, we 
pretreated CT and CTA cells with rapamycin (autophagy inducer) or wortmannin (autophagy 
inhibitor) for 2 h before exposing them to HNE. At first, we used 3-methyladenine (3-MA), 
an inhibitor of phosphatidylinositol 3-kinases (PI3K), to inhibit autophagy in CT and CTA 
cells. However, at our surprise, this molecule appeared to induce autophagy instead of 
inhibiting it in our isogenic cell lines (Supplementary Figure 3A-B). The efficacy of 
rapamycin and wortmannin in inducing and inhibiting autophagy respectively was analyzed 
by the ratio of LC3-II/LC3-I (Figure 3A and Supplementary Figure 4A-B). Intervention of 
rapamycin in HNE-treated CT cells was evidenced to induce autophagy, shown by the 
increase of LC3-II/LC3-I ratio and this phenomenon was accompanied by the abolition of 
apoptosis, observed by the disappearance of cleaved PARP and cleaved caspase-3. On the 
contrary, incubating HNE-treated CTA cells with wortmannin nullified autophagy and 
induced apoptosis. Through the quantification of apoptotic nuclei, 3-MA, that appeared to 
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induce autophagy in CT and CTA cells, improved the resistance of CT cells towards HNE as 
observed in rapamycin-treated CT cells (Supplementary Figure 3C). 
By monitoring caspase-3/7 activation by time-lapse microscopy, we observed that chemical 
induction of autophagy by rapamycin rendered CT cells more resistant to HNE toxicity 
whereas chemical inhibition of autophagy by wortmannin sensitized CTA cells to HNE 
toxicity to a level where no difference of apoptosis was observed between CT and CTA cells 
(Figure 3B-C). The same phenomenon was observed by apoptotic nuclei quantification 
(Figure 3D).  
Chemical inhibition of apoptosis did not induce autophagy in HNE-treated Apc knockdown 
HCECs 
To investigate whether apoptosis inhibition can modulate autophagy levels in HCECs, we 
treated HCECs with HNE in the presence of pan caspase inhibitor Z-VAD-FMK 
(benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone) to inhibit apoptosis. We 
observed that Z-VAD-FMK improved the viability of HNE-treated CT cells (Figure 4A). We 
also confirmed the efficacy of Z-VAD-FMK in inhibiting apoptosis in HNE-treated CT cells, 
shown by the reduction of apoptotic nuclei and the reduction of cleaved PARP and caspase-3 
(Figure 4B-C and Supplementary Figure 5).  
By observing the formation of LC3 puncta, we observed that chemical inhibition of apoptosis 
by Z-VAD-FMK in HNE-treated CTA cells abolished the formation of autophagosomes 
(Figure 4D). However, the presence of Z-VAD-FMK alone reduced the basal level of 
autophagy in CTA cells. In HNE-treated CT cells, no noticeable modulation of LC3 puncta 
formation was observed following incubation with Z-VAD-FMK.  
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Nrf2 was involved in the difference of resistance between normal and Apc knockdown HCECs 
towards HNE and fecal water toxicity 
To analyze Nrf2 activation in HCECs upon exposure to HNE and fecal water, we investigated 
the nuclear localization of Nrf2. Since Nrf2 is a transcription factor, its nuclear localization 
reflects its activity. Figure 5A and Supplementary Figure 6A display the fluorescence 
intensity graphs representing the localization of Nrf2 (red channel) and the nuclei (blue 
channel) in CT and CTA cells under basal conditions and upon exposure to HNE and fecal 
water of Hb- and Bf-fed rats. Curcumin, a widely-known natural Nrf2 activator, was used as a 
positive control. Interestingly, Nrf2 was active in CTA cells under basal conditions, shown by 
its nuclear localization. In contrast, CT cells displayed less Nrf2 nuclear accumulation under 
basal conditions. Following 1 h exposure to HNE and fecal water of Hb- and Bf-fed rats, Nrf2 
was active in CT and CTA cells. Despite Nrf2 activation following exposure to HNE and 
fecal water of Hb- and Bf-fed rats in CT cells, nuclear Nrf2 level in CT cells remained lower 
than in CTA cells which demonstrated relatively constant level of nuclear Nrf2 (Figure 5B 
and Supplementary Figure 6B). By analyzing the expression level of HO-1 (heme oxygenase 
1), a canonical gene of Nrf2, we observed similar tendencies. Upon exposure to HNE and 
fecal water of Hb- and Bf-fed rats, HO-1 level was relatively constant in CTA cells but 
increased significantly in CT cells (p<0.05) (Figure 5B and Supplementary Figure 6B). Fecal 
water of standard diet-fed rats did not activate Nrf2 nor increase HO-1 level in CT cells. We 
also analyzed the expression of three Nrf2 target genes involved in HNE detoxification: aldo-
keto reductase family 1 member B1 (AKR1B1), aldo-keto reductase family 1 member B10 
(AKR1B10) and glutamate-cysteine ligase modifier subunit (GCLM). These genes were 
found to be more expressed in CTA cells than in CT cells under basal conditions (Figure 5C). 
Following exposure to HNE, the expression of these genes was up-regulated in CT cells. 
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Finally, to further investigate the mechanisms of Nrf2 activation by HNE and fecal water of 
Hb- and Bf-fed rats, we analyzed the expression of p62 (total and phosphorylated at Ser 351) 
and Keap1. In general, the level of p62 (total and phosphorylated) and Keap1 was higher in 
CTA cells than in CT cells under basal conditions (Figure 6A and Supplementary Figure 7A). 
Interestingly, basal autophagy in CTA cells under basal conditions (as previously shown in 
Figure 2A-D) was correlated with the degradation of p62 and Keap1, indicated by the 
increasing level of these proteins when autophagic flux was inhibited by E64d and pepstatin 
A. Upon exposure to HNE, the expression of p62 increased notably in CT cells, but the level 
of phosphorylated p62 remained relatively constant in CT and CTA cells. Keap1 was 
degraded by autophagy in CTA cells but not in CT cells following HNE exposure. However, 
the expression of Keap1 did not seem to be modulated by HNE in CT and CTA cells. The 
expression of Nrf2 increased following HNE exposure in CT cells but remained relatively 
constant and higher in CTA cells, independently on autophagic flux. By using fecal water of 
Hb- and Bf-fed rats, we observed similar findings regarding the expression level of total and 
phosphorylated p62 (Figure 6B and Supplementary Figure 7B). When the autophagic flux was 
blocked by E64d and pepstatin A, the increase of total p62 expression was observed only in 
CT cells and not in CTA cells upon exposure to fecal water of Hb- and Bf-fed rats. However, 
this increase of p62 in CT cells was not accompanied by the increase of p62 phosphorylation 
at Ser 351. Keap1 and Nrf2 were constantly present at higher amount in CTA cells than in CT 
cells upon exposure to fecal water. Nevertheless, we noticed an induction of Nrf2 expression 
in CT cells following exposure to fecal water of Hb- and Bf-fed rats. 
Discussion 
The aim of this study was to assess whether Apc down-regulation modulated the resistance of 
HCECs towards HNE and to understand the involved mechanisms. Here, we show that HNE 
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induced apoptosis preferentially in normal HCECs (termed CT) than in Apc knockdown 
HCECs (termed CTA) and this difference could at least be explained in part by higher cellular 
defense capacity in CTA cells through autophagy and Nrf2 activity. We also demonstrate that 
like HNE, fecal water of Hb- and Bf-fed rats exerted cell death rate in CT cells than in CTA 
cells. 
Higher resistance of Apc knockdown HCECs towards the toxicity of HNE and fecal water of 
Hb- and Bf-fed rats may explain the mechanism of colorectal carcinogenesis  
HNE is an important endproduct of n-6 fatty acid peroxidation by heme iron, both in terms of 
presence and toxicity [13]. Prior to this study, we evaluated the differential of resistance 
between mouse-origin normal and preneoplastic colon cells upon exposure to HNE. We 
demonstrated that preneoplastic cells were more resistant to HNE toxicity than normal cells 
[19] and we proposed that this positive selection of preneoplastic cells by HNE could be 
involved in the promotion of colorectal carcinogenesis. In this hypothesis, HNE applies a 
selective pressure in the colon that bottlenecks preneoplastic cells over normal cells, thus 
favoring cancer development. 
In this study, to have a better approach of human physiology, we used two isogenic lines of 
immortalized HCECs: CT and CTA cells. The concentration of HNE used in this study (20 
µM) was deduced from the TBARS level present in the feces of Bf-fed rats [(19.68±5.34) 
µM] [20] to mimic the global level of lipid peroxidation end products in feces. We exposed 
these cells to HNE 20 µM and found that CTA cells demonstrated a better resistance to HNE 
toxicity than CT cells by exhibiting less apoptotic properties such as caspase-3/7 activity, 
membrane permeabilization, DNA fragmentation and cleavage of PARP and caspase-3 
(Figure 1A-C, Figure 3D and Supplementary Figure 1). These results were in accordance with 
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our previous finding using mouse-origin colon cells [19], highlighting the role of Apc 
dysregulation in rendering colon cells more resistant to HNE toxicity.  
Fecal water of Hb- and Bf-fed rats, a complex matrix derived from luminal contents, is 
relevant for studying the effects of heme iron on luminal formation of aldehydes. We 
previously reported that Hb and Bf supplementation in rat diet increased drastically the 
TBARS and free HNE level in their fecal water (p<0.05) [20]. Like HNE, fecal water of Hb- 
and Bf-fed rats also induced higher apoptosis in mouse-origin normal cells compared to 
preneoplastic cells and this difference of toxicity was abolished when aldehydes were 
depleted from the fecal water [20]. In this study, by using human-origin cells, we verified that 
Apc invalidation improved the resistance of colon cells to HNE and fecal water of Hb- and 
Bf-fed rats, regardless of cells’ origin. Taken together, our findings suggested that Hb and Bf 
supplementation in diet results in lipid peroxidation end products that provoke a positive 
selection of colon cells at early stages of carcinogenesis over the normal ones. Such 
phenomenon may favor the development of colorectal carcinogenesis that should be validated 
in animal models. 
Autophagy potentially protects Apc knockdown HCECs from the toxicity of HNE and fecal 
water of Hb- and Bf-fed rats 
Numerous studies have shown the oncogenic roles of autophagy in carcinogenesis by favoring 
cancer cell survival upon stress, nutrient deprivation and even apoptosis triggers, therefore 
protecting cancer cells [42-44]. In the case of CRC, autophagy is known as a classical 
mechanism by which cancer cells resist nutrient deprivation and chemotherapy intervention 
[36,37]. Chemical inhibition of autophagy has been shown to sensitize colon cancer cells to 
chemotherapy agent 5-fluorouracil [45]. Autophagy impairment through inhibition of 
autophagic protein ATG7 (autophagy-related gene 7) in human CRC epithelial cells prevented 
Article 3: manuscript to be submitted 
 
21 
 
tumor initiation and suppressed tumor growth [35]. Despite these convincing findings on the 
important role of autophagy in cancer cells, studies focusing on the role of autophagy in early 
stages of colorectal carcinogenesis are still lacking.  
Here, we reported that CTA cells but not CT cells underwent autophagy under basal 
conditions, evidenced by the number of LC3 puncta and the lipidation of LC3-I (Figure 2A-
C). We also would like to perform electronic microscopy to observe the formation of 
autophagosomes in CT and CTA cells to enhance our results regarding autophagy. CTA cells 
also expressed higher level of basal autophagic proteins such as p62 and Beclin-1 compared 
to CT cells (Figure 2D and Supplementary Figure 2A-B). We suggested that this advantage 
would enable CTA cells to be more responsive to undergo further autophagy following 
exposure to HNE and fecal water of Hb- and Bf-fed rats. Interestingly, autophagy in CTA 
cells was likely to be linked to their resistance towards HNE and fecal water of Hb- and Bf-
fed rats. Several studies have revealed that apoptosis and autophagy inhibit each other 
mutually. While apoptosis kills cells, autophagy can allow a stress adaptation that avoids cell 
death (suppresses apoptosis) [46-48]. CT cells, which possessed lower level of basal 
autophagic proteins and exerted autophagy at a lower rate and extent compared to CTA cells, 
underwent higher apoptosis level upon exposure to HNE and fecal water of Hb- and Bf-fed 
rats (Figure 1A-C and Supplementary Figure 1). 
To prove that autophagy was involved in the resistance of CTA cells towards HNE toxicity, 
we optimized chemical autophagy modulation in CT and CTA cells. Indeed, inhibiting 
autophagy in CTA cells by wortmannin sensitized them to HNE whereas stimulating 
autophagy in CT cells rendered them more resistant to HNE (Figure 3A-D and Supplementary 
Figure 4A-B). However, this interplay between apoptosis and autophagy was not reciprocal. 
Inhibiting apoptosis in HNE-treated CT and CTA cells by Z-VAD-FMK did not necessarily 
induce autophagy (Figure 4D). Even, the treatment with Z-VAD-FMK reduced the formation 
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of LC3 puncta in HNE-treated CTA cells. Interestingly, Z-VAD-FMK also lowered basal 
autophagy level in CTA cells. We are unfortunately unable to explain this inhibitory effect of 
Z-VAD-FMK on basal autophagy in CTA cells. In the literature, Z-VAD-FMK has previously 
been shown to induce non-apoptotic cell death including autophagy [49-52].  
As previously mentioned, 3-MA, a PI3K inhibitor, induced autophagy in CT and CTA cells 
like rapamycin (Supplementary Figure 3A-B). This finding was surprising since 3-MA has 
been widely used to inhibit autophagy in numerous cell lines [53]. This phenomenon might be 
explained by the fact that 3-MA inhibits both PI3K Class I and PI3K Class III that have 
different effects on autophagy [54,55]. 3-MA inhibits transiently PI3K Class III that plays an 
important role in the nucleation of autophagosomes, thereby inhibiting autophagy. However, 
3-MA also inhibits persistently PI3K Class I that in turn will inhibit autophagy negative 
regulator mTOR (mammalian target of rapamycin), thus inducing autophagy. This dual role 
of 3-MA might suggest that caution should be exercised in the application of 3-MA in studies 
on autophagy. In this study, we finally used wortmannin, another PI3K inhibitor, to inhibit 
autophagy in CT and CTA cells.  
p62-dependent Nrf2 activity in Apc knockdown HCECs is involved in their resistance to HNE 
and fecal water of Hb- and Bf-fed rats 
The Nrf2-dependent antioxidant pathway is one of the major cellular defense mechanisms 
against oxidative stress. Nrf2 is often associated with cancer development since it is often up 
regulated during carcinogenesis and contributes to the resistance of cancer cells to 
chemotherapy [56-58]. Recently, our team showed that Nrf2 was involved in the resistance of 
mouse-origin preneoplastic colon cells to HNE and fecal water of Hb- and Bf-fed rats [20]. 
Here, by using HCECs, we reported similar findings. Nrf2 was active under basal conditions 
in CTA cells but not in CT cells (Figure 5A-B and Supplementary Figure 6A-B). This 
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phenomenon led to higher expression of at least three enzymes involved in HNE 
detoxification: AKR1B1, AKR1B10 and GCLM [26] (Figure 5C). These enzymes have been 
shown to be regulated by Nrf2 [59-61]. Indeed, we previously reported that mouse-origin 
preneoplastic colon cells expressed higher level of HNE detoxification enzymes because of its 
higher Nrf2 level compared to normal cells [20]. In addition to HNE detoxification enzymes, 
BCL-2, an anti-apoptotic protein regulated by Nrf2 [62], was also more expressed in CTA 
cells than in CT cells (Figure 1C). Higher expression of these cytoprotective proteins in CTA 
cells would give them advantages to better tackle oxidative stress and other insults, thus 
enabling them to resist and survive. Following exposure to HNE and fecal water of Hb- and 
Bf-fed rats, Nrf2 was activated in CT cells, shown by its nuclear translocation and the 
increase of HNE detoxification proteins (Figure 5A-C and Supplementary Figure 6A-B). 
Despite this activation, nuclear Nrf2 was constantly present at a lower level in CT cells 
compared to CTA cells. 
Several regulation mechanisms of Nrf2 activation have been studied and discussed. The most 
well-known canonical regulation of Nrf2 involves the disruption of Nrf2-Keap1 interaction. 
Keap1 is a member of an E3 ubiquitin ligase that constantly ubiquitinates Nrf2 for further 
degradation by proteasome. Oxidative stress or drug intervention can disrupt the link between 
Nrf2 and Keap1, leading to Nrf2 liberation and translocation into the nucleus to promote gene 
expression [24]. Lately, non-canonical mechanisms of Nrf2 regulation have been identified, 
including the involvement of autophagic protein p62 as a positive regulator of Nrf2. 
Phosphorylation of Ser 351 residue of p62 has been shown to increase the affinity between 
p62 and Keap1, which resulted in Nrf2 activation through sequestration of Keap1 onto the 
autophagosomes for lysosomal degradation [33]. Interestingly, p62 is also a target gene of 
Nrf2 [32]. Therefore, p62 can create a positive feedback loop for Nrf2 activation. 
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Under basal conditions, we observed higher expression of total and phosphorylated p62 (Ser 
351) in CTA cells compared to CT cells (Figure 6A and Supplementary Figure 7A). 
Interestingly, in CTA cells, we observed an autophagic flux of total and phosphorylated p62, 
indicating that p62 was constantly degraded under basal conditions. Combined with the 
autophagic flux observed on Keap1, we concluded that Nrf2 activity in CTA cells under basal 
conditions was mediated by p62. To assess whether this phenomenon is linked to Nrf2 
activation in CTA cells, we would perform western blotting of nuclear Nrf2 in function of 
autophagic flux. In CT cells, the level of phosphorylated p62 (Ser351) did not vary even upon 
exposure to HNE. However, the level of total p62 increased upon exposure to HNE. This 
phenomenon might be due to HNE-related Nrf2 activation in CT cells that promoted the 
expression of p62 as one of Nrf2 target genes.  
Like HNE, fecal water of Hb- and Bf-fed rats induced total p62 expression in CT cells, but the 
level was always lower than in CTA cells (Figure 6B and Supplementary Figure 7B). 
Exposure to HNE and fecal water did not induce p62 phosphorylation (Ser351) in both CT 
and CTA cells, indicating that the p62/Nrf2 pathway was not the main mechanism of HNE-
induced Nrf2 activation. This mechanism is more likely to be the canonical Nrf2/Keap1/ARE 
mechanism considering HNE ability to form protein adducts, including with cysteine residues 
of Keap1. Based on our findings, we proposed that the p62 galore in CTA cells enabled p62-
mediated basal activation of Nrf2 and also provided free p62 for the cells to undergo 
autophagy as a defense mechanism upon insults. However, in CT cells, p62 was present in 
relatively low level. Therefore, to undergo autophagy following exposure to HNE or fecal 
water, CT cells had to express p62 till a sufficient amount, with the help of HNE-mediated 
Nrf2 activation that promoted p62 expression. Therefore, the cellular defense mechanism in 
CT cells appeared to be late compared to CTA cells. This might explain the mechanisms by 
which CTA cells were more resistant than CT cells to the toxicity of HNE and fecal water. 
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Finally, realizing the potential importance of p62 in basal Nrf2 activation in CTA cells, we 
would carry out siRNA-mediated p62 invalidation in CTA cells to assess whether this would 
sensitize them to the toxicity of HNE and fecal water. 
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Figure Legends 
Figure 1. Apc knockdown HCECs (CTA) exhibited lower level of apoptosis compared to 
normal HCECs (CT) upon exposure to HNE or fecal water of Hb- and Bf-fed rats (Hb 
and Bf). Cells were treated with HNE 20 µM or fecal water. Control Hb and Control Bf 
(respective controls for Hb and Bf) were fecal water issued from standard diet-fed rats. (A) 
Percentage of cells exhibiting caspase-3/7 activity upon exposure to HNE or fecal water 
recorded over time. (B) Percentage of cells with positive caspase-3/7 activity and permeable 
membrane upon treatments with HNE or fecal water (t=6 h). (C) Western blotting analysis of 
apoptotic proteins cleaved PARP, cleaved caspase-3 and BCL-2 in HCECs following 
treatments with HNE or fecal water (t=6 h). Staurosporin was used as positive control for 
apoptosis. β-actin was used as loading control. The presented blots are representative of three 
independent experiments. The blot densitometry analysis is presented in Supplementary 
Figure 1. Data are expressed as mean ± SD (n=3). 
* Significant difference between CT and CTA (p<0.05), student’s t-test.  
# Significant difference between a treatment in a cell line and control (p<0.05), two-way 
ANOVA, followed by Tukey’s multiple comparison test. 
 
Figure 2. Apc knockdown HCECs (CTA) exhibited higher level of autophagy compared 
to normal HCECs (CT) under basal conditions and upon exposure to HNE or fecal 
water of Hb- and Bf-fed rats (Hb and Bf). Cells were treated with HNE 20 µM or fecal 
water. Control Hb and Control Bf (respective controls for Hb and Bf) were fecal water issued 
from standard diet-fed rats. (A) Images of immunofluorescence analysis of HNE-treated cells 
(t=2 h). Blue channel indicates nuclei and green channel indicates LC3. The mix of E64d and 
pepstatin A was supplemented in the media to inhibit autophagic flux. Image extension 
showing cells treated with fecal water is presented in Supplementary Figure 2A. (B) 
Percentage of cells with LC3 puncta observed by immunofluorescence analysis upon 
exposure to HNE (t=1-6 h). (C) Percentage of cells with LC3 puncta observed by 
immunofluorescence analysis upon exposure to HNE or fecal water (t=2 h). Rapamycin and 
wortmannin were used as positive and negative controls of autophagy respectively. (D) 
Western blotting analysis of autophagic proteins Beclin1, p62, LC3-I and LC3-II in HCECs 
following treatments with HNE or fecal water (t=2 h). β-actin was used as loading control. 
The presented blots are representative of three independent experiments. The blot 
densitometry analysis is presented in Supplementary Figure 2B. Data are expressed as mean ± 
SD (n=3). 
* Significant difference between CT and CTA (p<0.05), student’s t-test. 
# Significant difference between a treatment in a cell line and control (p<0.05), two-way 
ANOVA, followed by Tukey’s multiple comparison test. 
 
Figure 3. Chemical autophagy modulation in normal HCECs (CT) and Apc knockdown 
HCECs (CTA) regulated their resistance towards HNE. Cells were treated with HNE 20 
µM, with or without the presence of rapamycin (RAP) or wortmannin (WOR) as 
positive or negative controls of autophagy respectively. (A) Western blotting analysis of 
LC3-I, LC3-II, cleaved PARP and cleaved caspase-3 in HCECs following treatments with 
HNE, with or without RAP or WORT (t=2 h). The mix of E64d and pepstatin A was used to 
inhibit autophagic flux. β-actin was used as loading control. The presented blots are 
representative of three independent experiments. The blot densitometry analysis is presented 
in Supplementary Figure 4A-B. (B) Percentage of cells exhibiting caspase-3/7 activity upon 
exposure to HNE, with or without RAP or WOR recorded over time. (C) Percentage of cells 
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with positive caspase-3/7 activity upon treatments with HNE, with or without RAP or WOR 
(t=6 h). (D) Percentage of cells exhibiting apoptotic nuclei (condensed or fragmented) upon 
exposure to HNE, with or without RAP or WOR (t=6 h). Data are expressed as mean ± SD 
(n=3). 
* Significant difference between CT and CTA (p<0.05), student’s t-test.  
† Significant difference between a treatment in a cell line and treatment using HNE (p<0.05), 
two-way ANOVA, followed by Tukey’s multiple comparison test. 
 
Figure 4. Chemical apoptosis inhibition in normal HCECs (CT) and Apc knockdown 
HCECs (CTA) following HNE exposure did not induce autophagy. Cells were treated 
with HNE 20 µM or fecal water. Control  Hb and Control Bf (respective controls for Hb and 
Bf) were fecal water issued from standard diet-fed rats. (A) Percentage of viable cells (WST-1 
activity) upon exposure to HNE, with or without Z-VAD-FMK to inhibit apoptosis (t=6 h). 
Staurosporin was used as positive control for apoptosis. (B) Percentage of cells exhibiting 
apoptotic nuclei (condensed or fragmented) upon exposure to HNE, with or without Z-VAD-
FMK (t=6 h). (C) Western blotting analysis of apoptotic proteins cleaved PARP and cleaved 
caspase-3 in HCECs following treatments with HNE, with or without Z-VAD-FMK (t=6 h). 
β-actin was used as loading control. The presented blots are representative of three 
independent experiments. The blot densitometry is presented in Supplementary Figure 5. (D) 
Images of immunofluorescence analysis and quantification of cells with LC3 puncta upon 
exposure to HNE, with or without Z-VAD-FMK (t=2 h). Blue channels indicate nuclei and 
green channels indicate LC3. The mix of E64d and pepstatin A was supplemented in the 
media to inhibit autophagic flux. Rapamycin was used as positive control for autophagy. Data 
are expressed as mean ± SD (n=3). 
* Significant difference between CT and CTA (p<0.05), student’s t-test.  
# Significant difference between a treatment in a cell line and control (p<0.05), two-way 
ANOVA, followed by Tukey’s multiple comparison test.  
† Significant difference between a treatment in a cell line and treatment using HNE (p<0.05), 
two-way ANOVA, followed by Tukey’s multiple comparison test. 
 
Figure 5. Different Nrf2 activity in normal HCECs (CT) and Apc knockdown HCECs 
(CTA) contributed to their different resistance following exposure to HNE and fecal 
water of Hb- and Bf-fed rats (Hb and Bf respectively). Cells were treated with HNE 20 
µM. (A) Images of immunofluorescence analysis of HNE-treated cells (t=1 h). Blue channels 
indicate nuclei and red channels indicate Nrf2. The fluorescence intensity graphs represent the 
colocalization of blue signal (nuclei) and red signal (Nrf2) along regions of interest (ROI). 
Image extension showing cells treated with fecal water is presented in Supplementary Figure 
6A. (B) Western blotting analysis of Nrf2 (nuclear) and HO1 (total lysate) in HCECs 
following treatments with HNE and fecal water (t=1 h). Curcumin was used as positive 
control for Nrf2 activation. The blot densitometry analysis is presented in Supplementary 
Figure 6B. (C) Relative mRNA expression of HNE detoxification proteins AKR1B1 (Aldo-
keto reductase Family 1 Member B1), AKR1B10 (Aldo-keto reductase Family 1 Member 
B10) and GCLM (Glutamate-cysteine ligase, modifier subunit) in HCECs following exposure 
to HNE (t=5 h). Data are expressed as mean ± SD (n=6). 
* Significant difference between CT and CTA (p<0.05), student’s t-test.  
# Significant difference between a treatment in a cell line and control (p<0.05), student’s t-
test. 
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Figure 6. Different Nrf2 activity in normal HCECs (CT) and Apc knockdown HCECs 
(CTA) was associated to their different level of p62 expression and phosphorylation. 
Cells were treated with HNE 20 µM or fecal water. Control Hb and Control Bf (respective 
controls for Hb and Bf) were fecal water issued from standard diet-fed rats. Curcumin was 
used as positive control for Nrf2 activation. (A) Western blotting analysis of phosphorylated 
p62 (p62-P Ser 351), total p62 and Keap1 in HCECs following treatments with HNE, with or 
without the mix of E64d and pepstatin A to inhibit autophagic flux (t=2 h). (B) Western 
blotting analysis of phosphorylated p62 (p62-P Ser 351) and total p62 in HCECs following 
treatments with HNE or fecal water in the presence of E64d and pepstatin A to inhibit 
autophagic flux (t=2 h). In all blots, β-actin was used as loading control. All presented blots 
are representative of three independent experiments. The blot densitometry analysis is 
presented in Supplementary Figure 7A-B. 
 
Supplementary Figure 1. Densitometry analysis of Figure 1C showing western blotting 
analysis of apoptotic proteins cleaved PARP, cleaved caspase-3 and BCL-2 in HCECs 
following treatments with HNE or fecal water (t=6 h). All band densities were reported to β-
actin as loading control. Staurosporin was used as positive control for apoptosis. Data are 
expressed as mean ± SD (n=3). 
* Significant difference between CT and CTA (p<0.05), student’s t-test.  
# Significant difference between a treatment in a cell line and control (p<0.05), two-way 
ANOVA, followed by Tukey’s multiple comparison test. 
 
Supplementary Figure 2. (A) Extension of Figure 2A. Images of immunofluorescence 
analysis of normal HCECs (CT) and Apc knockdown HCECs (CTA) treated with fecal water 
of Hb- and Bf-fed rats (Hb and Bf respectively) (t=2 h). Blue channels indicate nuclei and 
green channels indicate LC3. The mix of E64d and pepstatin A was supplemented in the 
media to inhibit autophagic flux. (B) Densitometry analysis of Figure 2D showing western 
blotting analysis of autophagic proteins Beclin1, p62, LC3-I and LC3-II in HCECs following 
treatments with HNE or fecal water, with or without the mix of E64d and pepstatin A to 
inhibit autophagic flux (t=2 h). All band densities were reported to β-actin as loading control. 
Rapamycin was used as positive control for autophagy. Data are expressed as mean ± SD 
(n=3). 
* Significant difference between CT and CTA (p<0.05), student’s t-test.  
# Significant difference between a treatment in a cell line and control (p<0.05), two-way 
ANOVA, followed by Tukey’s multiple comparison test. 
• Significant difference between a treatment in a cell line with and without E64d/pepstatin A 
(p<0.05), two-way ANOVA, followed by Tukey’s multiple comparison test. 
 
Supplementary Figure 3. (A) Images of immunofluorescence analysis of cells treated with 
3-methyladenine (3-MA) (t=2 h). Rapamycin was used as positive control for autophagy. 
Blue channels indicate nuclei and green channels indicate LC3. The mix of E64d and 
pepstatin A was supplemented in the media to inhibit autophagic flux. (B) Percentage of cells 
with LC3 puncta observed by immunofluorescence analysis upon exposure to 3-MA or 
rapamycin (t=2 h). (C) Percentage of cells exhibiting apoptotic nuclei (condensed or 
fragmented) upon exposure to HNE, with or without 3-MA or rapamycin (t=6 h). Data are 
expressed as mean ± SD (n=3). 
* Significant difference between CT and CTA (p<0.05), student’s t-test.  
# Significant difference between a treatment in a cell line and control (p<0.05), two-way 
ANOVA, followed by Tukey’s multiple comparison test. 
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Supplementary Figure 4. Densitometry analysis of Figure 3A showing western blotting 
analysis of LC3-I, LC3-II, cleaved PARP and cleaved caspase-3 in HCECs following 
treatments with HNE, with or without (A) rapamycin or (B) wortmannin (t=2 h). All band 
densities were reported to β-actin as loading control. The mix of E64d and pepstatin A was 
used to inhibit autophagic flux. Data are expressed as mean ± SD (n=3). 
* Significant difference between CT and CTA (p<0.05), student’s t-test.  
# Significant difference between a treatment in a cell line and control (p<0.05), two-way 
ANOVA, followed by Tukey’s multiple comparison test. 
• Significant difference between a treatment in a cell line with and without E64d/pepstatin A 
(p<0.05), two-way ANOVA, followed by Tukey’s multiple comparison test. 
α Significant difference between a treatment in a cell line with and without rapamycin 
(p<0.05), two-way ANOVA, followed by Tukey’s multiple comparison test. 
β Significant difference between a treatment in a cell line with and without wortmannin 
(p<0.05), two-way ANOVA, followed by Tukey’s multiple comparison test. 
 
Supplementary Figure 5. Densitometry analysis of Figure 4C showing western blotting 
analysis of cleaved PARP and cleaved caspase-3 in HCECs following treatments with HNE, 
with or without Z-VAD-FMK to inhibit apoptosis (t=6 h). All band densities were reported to 
β-actin as loading control. Data are expressed as mean ± SD (n=3). 
* Significant difference between CT and CTA (p<0.05), student’s t-test.  
γ Significant difference between a treatment in a cell line with and without Z-VAD-FMK 
(p<0.05), two-way ANOVA, followed by Tukey’s multiple comparison test. 
 
Supplementary Figure 6. (A) Extension of Figure 5A. Images of immunofluorescence 
analysis of normal HCECs (CT) and Apc knockdown HCECs (CTA) treated with fecal water 
of Hb- and Bf-fed rats (Hb and Bf respectively) (t=1 h). Blue channels indicate nuclei and red 
channels indicate Nrf2. The fluorescence intensity graphs represent the colocalization of blue 
signal (nuclei) and red signal (Nrf2) along regions of interest (ROI). (B) Densitometry 
analysis of Figure 5B showing western blotting analysis of Nrf2 (nuclear) and HO1 (total 
lysate) in HCECs following treatments with HNE or fecal water (t=1 h). Curcumin was used 
as positive control for Nrf2 activation. Data are expressed as mean ± SD (n=3). 
* Significant difference between CT and CTA (p<0.05), student’s t-test.  
# Significant difference between a treatment in a cell line and control (p<0.05), two-way 
ANOVA, followed by Tukey’s multiple comparison test. 
 
Supplementary Figure 7. (A) Densitometry analysis of Figure 6A showing western blotting 
analysis of phosphorylated p62 (p62-P Ser 351), total p62 and Keap1 in HCECs following 
treatments with HNE, with or without the mix of E64d and pepstatin A to inhibit autophagic 
flux (t=2 h). (D) Densitometry analysis of Figure 6B showing western blotting analysis of 
phosphorylated p62 (p62-P Ser 351) and total p62 in HCECs following treatments with HNE 
or fecal water in the presence of E64d and pepstatin A to inhibit autophagic flux (t=2 h). All 
band densities were reported to β-actin as loading control. Data are expressed as mean ± SD 
(n=3). 
* Significant difference between CT and CTA (p<0.05), student’s t-test.  
# Significant difference between a treatment in a cell line and control (p<0.05), two-way 
ANOVA, followed by Tukey’s multiple comparison test. 
• Significant difference between a treatment in a cell line with and without E64d/pepstatin A 
(p<0.05), two-way ANOVA, followed by Tukey’s multiple comparison test. 
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The synthesis of Article 3 is presented in Figure 47. Nrf2 activity was found to be 
higher in CTA cells than in CT cells, leading to higher p62 expression in CTA cells and Nrf2 
auto-activation via p62-dependent Keap1 degradation. Upon exposure to HNE, CTA cells 
exhibited higher level of autophagy than CT cells, suspected to be associated with high basal 
level of autophagic protein p62 in CTA cells. Autophagy was suggested to exert protective 
effects against HNE toxicity and therefore, apoptosis was observed in higher level in CT cells 
compared to CTA cells. Some of these findings have also been observed by using fecal water 
of heme-fed rats. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 47. Schema for the role of Nrf2 and autophagy in                                                                
the resistance of CTA cells upon exposure to HNE 
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Chapter V 
DISCUSSION AND PERSPECTIVES 
 
 The principal results obtained during my thesis are that: 1) Nrf2 was involved in the 
resistance of mouse-origin APC Min/+ cells  upon exposure to HNE or fecal water of heme-
fed rats, 2) CTA cells were more resistant than CT cells towards HNE or fecal water of heme-
fed rats because of their higher Nrf2 activity and autophagy level and 3) aldehydes are in part 
responsible for the different toxicity of fecal water towards APC +/+ and APC Min/+ cells. In 
this chapter, all these points are discussed in detail. 
5.1. The use of HNE and fecal water of heme-fed rats represents a progressive 
complexification of lipid peroxidation model 
The hypothesis of lipid peroxidation in colorectal carcinogenesis (Figure 15, Chapter 
1.2.2.5.2) emphasizes the formation of cytotoxic aldehydes derived from heme-induced lipid 
peroxidation that exert higher toxicity towards normal colon cells than the preneoplastic ones, 
thereby generating a positive selection of preneoplastic colon cells favoring tumor 
development. Prior to my thesis, our team had focused on the role of HNE, a lipid 
peroxidation-derived aldehyde, in generating such a positive selection in vitro by exposing it 
to mouse-origin normal and preneoplastic cells. In this case, HNE was used as a pure 
substance synthesized in our laboratory. However, as a pure substance, HNE does not 
represent the complexity of intestinal contents that are directly in contact with colon cells. 
Therefore, the use of fecal water was suggested to better represent the complexity of intestinal 
contents. 
Fecal water is an aqueous extract of feces representing the bioavailable parts of fecal 
matters. In this study, two sources of heme were fed to azoxymethane-injected rats: 
hemoglobin (Hb) and raw beef meat (Bf). It is noteworthy that Hb and Bf represented a 
complexification in the rats’ diet: from Hb as a purified molecule of heme iron source to Bf as 
a real red meat. Fecal water of Hb- and Bf-fed rats represents a complex matrix of compounds 
generally excreted in the feces and substances derived from heme-induced lipid peroxidation 
in a biological system, including HNE but not only HNE. Therefore, fecal water of heme-fed 
rats is more representative to study the role of lipid peroxidation in colorectal carcinogenesis 
compared to HNE as a pure substance. Indeed, the use of HNE and fecal water of heme-fed 
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rats represents a progressive complexification of lipid peroxidation model: from HNE as a 
pure compound, to fecal water of rats fed with Hb as a pure compound and finally fecal water 
of rats fed with raw beef as a complex matrix. This progressive complexification is important 
to explain the importance of heme-induced lipid peroxidation in the promotion of colorectal 
carcinogenesis by red meat. In this study, HNE was found in general to be a representative 
model for heme-induced lipid peroxidation since the effects it provoked in our cellular models 
tended to be similar to those provoked by fecal water of heme-fed rats. 
5.2. APC disruption improves the resistance of mouse- and human-origin colon cells 
towards the toxicity of HNE and fecal water of heme-fed rats 
Prior to further discussion with regard to the role of APC disruption in cellular 
resistance, it appears primordial to highlight the two different experimental models used in 
this study: mouse-origin APC+/+ and APC Min/+ cells and human-origin CT and CTA cells. 
The APC disruption in both experimental models was obtained by different means. APC 
Min/+ cells exhibited APC mutation resulting in truncated APC protein (850 aa)  whereas CT 
and CTA cells underwent shRNA-mediated APC invalidation resulting in the degradation of 
APC mRNA that led to lowered expression of APC protein. It is noteworthy that the truncated 
APC protein in APC Min/+ cells contains intact armadillo repeat binding domain (Figures 5 
and 10) that suppresses tumoral incidence and is involved in apoptosis [89,342,343]. In 
sporadic human CRC, APC protein is often found to be truncated [469] rather than degraded 
as represented by CTA cells. Among the various sites in APC protein where the truncations 
may take place, the codon 1554 has been shown to be the “hotspot” for somatic mutation in 
human sporadic CRC [470]. Therefore, to approach the real characteristics of human CRC, 
gene cassettes may be inserted in CT cells to create APC mutation that results in the 
expression of truncated APC protein at codon 1554 as observed in human sporadic CRC. 
Another important point concerns the different means of immortalization in both 
experimental models. In APC +/+ and APC Min/+ cells, the immortalization was achieved by 
using thermolabile simian virus 40 large tumor antigen gene (AgT tsA58) that is active only at 
33 °C in the presence of interferon γ. Therefore, at treatment temperature of 37 °C without 
interferon γ, these cells are not immortalized and exhibit the phenotype of mouse normal 
colon epithelial cells. However, in CT and CTA cells, the immortalization was mediated by 
plasmid transfection of CDK4 (Cyclin-dependent kinase 4) and hTERT (Telomerase reverse 
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transcriptase) genes that are integrated in the genome. Therefore, these cells are constantly 
immortalized at the maintenance and treatment temperature of 37 °C.  
In Articles 1-3, APC disruption (APC mutation in preneoplastic APC Min/+ cells and 
shRNA-mediated APC invalidation in CTA cells) was shown to be involved in cellular 
resistance towards HNE or fecal water of heme-fed rats, both in mouse and human models. 
APC Min/+ and CTA cells underwent lower level of apoptosis following exposure to HNE or 
fecal water of heme-fed rats compared to wild type cells (APC +/+ and CT cells). This 
phenomenon might be related to Nrf2 activation in relation with APC disruption. APC 
disruption may activate Wnt signaling pathway that inhibits Nrf2 degradation by recruiting 
axin and GSK3β to the membrane (Figure 27) [273]. In vivo, Nrf2 knockout enhanced 
intestinal tumorigenesis in Min mice [471]. To assess the role of GSK3β in Nrf2 activation 
mediated by APC invalidation, I analyzed the basal expression level of GSK3β which 
appeared to be indifferent in CT and CTA cells (Figure 48). Following HNE exposure, the 
level of GSK3β diminished. We are currently unable to explain this phenomenon.  
 
 
 
 
 
 
Figure 48. Western blotting analysis and densitometry of GSK3β (n=3) in CT and 
CTA following treatment with HNE 20 µM (t=2 h). β-actin was used as loading control.                                                                             
# Significant difference between HNE and Control in a cell line (p<0.05).  
 
Another proposition is that Keap1, the inhibitor of Nrf2, scaffolds to the actin 
cytoskeleton [472] and since the cytoskeletal network is destructurized following APC 
disruption, Keap1 may be destabilized, leading to Nrf2 activation. To test these propositions, 
one can destructurize the actin network in APC +/+ or CT cells by cytochalasin B and observe 
the effects of this action in terms of Nrf2 activity and cell resistance towards HNE or fecal 
water. 
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Regarding cell resistance towards HNE or fecal water, co-culturing APC +/+ and APC 
Min/+ cells (or CT and CTA cells) can be considered to study and validate the Darwinian 
selection of preneoplastic cells over normal cells upon exposure to continuously-available 
HNE or fecal water in vitro. In this case, the two different cell lines have to be marked with 
two different fluorescent probes to distinguish them and the evolution of the surviving 
population following exposure to HNE or fecal water can be monitored by fluorescent 
microscopy.  
To analyze cell ability to acquire tumorigenic properties, experiments on clonogenicity 
can be done with soft agar colony formation assay to observe the tendency of CTA cells to 
form colonies. This assay would allow to confirm cellular anchorage, a property of cell that is 
associated with the tumorigenic potential of the cultured cells. Furthermore, these colonies 
can be xenografted into nude mice to investigate its ability to develop CRC in vivo. It is to be 
noted that soft agar colony formation assay would not be able to be done in APC +/+ and 
APC Min/+ cells since these cells do not proliferate at the treatment temperature of 37 °C 
because of the absence of immortalization. 
5.3. Different mechanisms undertaken by normal and preneoplastic cells may explain 
their different resistance towards HNE and fecal water of heme-fed rats 
In Articles 1-3, two mechanisms were reported to be able to explain the different 
resistance of normal and APC-disrupted colon cells towards HNE and fecal water of heme-fed 
rats: Nrf2-dependent antioxidant response (in APC +/+ and APC Min/+ cells, also in CT and 
CTA cells) and autophagy (in CT and CTA cells). These mechanisms, along with other 
mechanisms that are suggested to be involved in such a resistance, are discussed in this 
chapter. 
5.3.1. Higher Nrf2 activity in preneoplastic cells is associated with better ability to 
detoxify HNE  
Nrf2-dependent antioxidant response has been reported to be up regulated in CRC 
[234]. A clinical study has shown that Nrf2 and its regulated enzymes were highly expressed 
in CRC tissues compared to adjacent non-tumor tissues [473]. Article 1 clearly shows that 
Nrf2 was involved in the resistance of mouse-origin preneoplastic colon cells to HNE and 
fecal water of heme-fed rats compared to normal cells. Nrf2 activity was found to be higher in 
preneoplastic cells than in normal cells under basal conditions and this phenomenon led to 
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higher expression of HNE detoxification enzymes in preneoplastic cells, which appeared to be 
regulated by Nrf2. We thus suggested that higher Nrf2 activity and expression level of HNE 
detoxification enzymes under basal conditions gave preneoplastic cells advantages to tackle 
the insults provoked by HNE or fecal water of heme-fed rats in comparison with normal cells. 
Following exposure to HNE or fecal water of heme-fed rats, Nrf2 was indeed activated in 
normal cells. However, the final level of HNE detoxification enzymes was constantly higher 
in preneoplastic cells, therefore suggesting the reason for which the preneoplastic cells 
exerted higher resistance to HNE and fecal water of heme-fed rats compared to normal cells. 
As previously discussed, higher Nrf2 activity in preneoplastic cells might be due to 
APC mutation that activates Wnt signaling pathway (Figure 27) [273]. Preneoplastic cells 
expressed truncated APC protein at 850 aa with intact armadillo binding repeat domain but 
without β-catenin binding sites (Figure 5 and 10). This absence of β-catenin binding site 
would keep β-catenin free and thus constitutively activate Wnt signaling pathway in 
preneoplastic cells. The different Nrf2 activity between normal cells (expressing intact APC 
protein) and preneoplastic cells (expressing truncated APC protein at 850 aa) might indicate 
the inhibitory properties of β-catenin binding site in APC protein against Nrf2 activity or 
furthermore, the inducing properties of armadillo repeat binding domain regarding Nrf2 
activity. Another study using cells engineered to express APC protein lacking of armadillo 
repeat binding domain can be conceived to analyze the role of this domain in Nrf2 activity in 
mouse-origin colon epithelial cells. 
To investigate the important role of Nrf2 in the resistance of preneoplastic cells 
towards HNE or fecal water of heme-fed rats, siRNA-mediated invalidation of Nrf2 was done 
in normal and preneoplastic cells. In normal cells, because of their low Nrf2 activity, Nrf2 
invalidation did not modulate their sensitivity towards HNE or fecal water of heme-fed rats. 
However, Nrf2 invalidation sensitized preneoplastic cells to HNE and fecal water of heme-fed 
rats, showing that Nrf2 activity was primordial in the resistance of preneoplastic cells. 
Furthermore, it appears interesting to analyze the decrease of HNE detoxification enzymes in 
Nrf2-invalidated preneoplastic cells by RT-qPCR. To establish a causal relationship regarding 
the importance of Nrf2 in cell resistance, our team has transfected Nrf2 over-expression 
vectors in normal cells and this appeared to improve their resistance towards HNE 
(unpublished, article submitted).  
173 
 
In Article 3, Nrf2 activity was also shown to contribute to the resistance of CTA cells 
to HNE and fecal water of heme-fed rats. Nrf2 was found in higher level in CTA cells than in 
CT cells under basal conditions and this phenomenon was dependent on autophagic protein 
p62. Three HNE detoxification enzymes were expressed in higher level in CTA cells than in 
CT cells under basal conditions: AKR1B1 (aldo-keto reductase family 1, member 1), 
AKR1B10 (aldo-keto reductase family 1, member 10) and GCLM (glutamate-cysteine ligase, 
modifier subunit). GCLM is an enzyme involved in the synthesis of glutathione (GSH). Since 
the expression level of GCLM differed in CT and CTA cells under basal conditions, we 
analyzed the uptake of cystine, a source of intracellular GSH synthesis, in CT and CTA cells. 
Our preliminary results showed that basal uptake of cystine was higher in CTA cells than in 
CT cells. This finding can be verified by analyzing the GSH level in CT and CTA cells. Since 
GCLM expression and uptake of cystine were higher in CTA cells than in CT cells, the 
expected results would be higher GSH level in CTA cells than in CT cells. 
To verify whether Nrf2 activity is different between normal tissues and preneoplastic 
lesions (ACF or MDF) in vivo, one can separate normal and preneoplastic tissues in the colon 
of heme-fed rats by laser capture/cutting microdissection (LCM), a method of isolation of 
cells of interest from a tissue section under morphological control using laser beams [474]. 
Following the isolation of preneoplastic lesions from the normal tissues, the analyses of Nrf2 
activity or expression of HNE detoxification enzymes can be carried out and compared in 
normal and preneoplastic tissues. This experiment may also be done by using sections of cut 
human colon samples following colorectal surgery. However, it is to be noted that colorectal 
surgery is normally done in patients suffering from severe or advanced CRC and therefore, 
the lesions found in the colon section would be more likely to be cancerous instead of 
preneoplastic. 
In general, Nrf2 has been shown to possess a pivotal role in the resistance of 
preneoplastic colon cells towards HNE or fecal water of heme-fed rats. Such a resistance is 
believed to determine colorectal carcinogenesis. Concerning the role of Nrf2 in cancer 
prevention, a study within the team has revealed that treating normal APC +/+ cells with 
antioxidants like curcumin (bioactive compound of turmeric) or pterostilbene (bioactive 
compound of grapes and blueberries) enhanced their basal Nrf2 activity (unpublished, article 
submitted). This may give advantages to normal cells to better resist the toxicity of HNE or 
fecal water of heme-fed rats, thus minimizing the difference of mortality between normal and 
preneoplastic cells. Interestingly, curcumin and pterostilbene induced apoptosis in 
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preneoplastic cells but not in normal cells. Moreover, following pretreatments with curcumin 
or pterostilbene, normal cells underwent lower mortality than preneoplastic cells upon HNE 
exposure (unpublished, article submitted). This result evokes the interest of enhancing Nrf2 
activity in normal cells by antioxidants to improve their resistance towards HNE exposure, 
thereby impairing different mortality between normal and preneoplastic cells that favors CRC 
promotion. In order to investigate the importance of Nrf2 in the promotion of colorectal 
carcinogenesis and the role of antioxidant in this process in vivo, experiments using Nrf2-
knockout mice or rats can be conceived. Nrf2 activation by cinnamaldehyde has been reported 
to suppress azoxymethane/dextran sulfate sodium-induced CRC in wild type mice but not in 
Nrf2-knockout mice [475]. Another study has demonstrated that Nrf2-knockout mice 
possessed higher susceptibility to develop colitis-associated colorectal cancer than wild type 
mice [319]. To study the role of Nrf2 and antioxidants in red meat-associated promotion of 
colorectal carcinogenesis, normal and Nrf2-knockout mice or rats can be fed with sources of 
heme iron with/without antioxidants (curcumin or pterostilbene). The expected results would 
be significantly higher amount of preneoplastic lesions (ACF or MDF) found in heme-fed 
Nrf2-knockout mice or rats than in normal ones. Antioxidant supplementation would alleviate 
this effect in normal mice or rats. However, because of the absence of Nrf2, antioxidant 
supplementation would not exert protective effects against the promotion of colorectal 
carcinogenesis in Nrf2-knockout mice or rats fed with red meat. 
5.3.2. Higher level of autophagy in preneoplastic cells is associated with protection 
against apoptosis induced by HNE or fecal water of heme-fed rats 
Beside Nrf2, autophagy is also involved in the different resistance of CT and CTA 
cells towards HNE and fecal water of heme-fed rats, as discussed in Article 3. CTA cells 
underwent autophagy even under basal conditions and this was supported by higher basal 
expression of autophagic proteins Beclin1 and p62 in CTA cells compared to CT cells. CTA 
cells also demonstrated higher autophagy level than CT cells following exposure to HNE or 
fecal water of heme-fed rats, suggesting the potentially protective role of autophagy in 
inhibiting apoptosis provoked by HNE or fecal water of heme-fed rats. These findings 
concerning autophagy can also be verified in APC +/+ and APC Min/+ cells. Preliminary 
results within our group demonstrated that APC Min/+ cells expressed higher level of p62 
than APC +/+ cells, as evidenced by RT-qPCR and immunofluorescence analysis (data not 
shown). Therefore, autophagy might also be involved in the resistance of APC Min/+ cells 
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upon exposure to HNE and fecal water of heme-fed rats. In vivo, autophagy has been shown 
to be involved in intestinal tumorigenesis in Min mice [397,398]. 
Article 3 also denotes that chemical inhibition of autophagy using wortmannin 
sensitized CTA cells to HNE and fecal water of heme-fed rats whereas chemical stimulation 
of autophagy using rapamycin improved the resistance of CT cells towards HNE and fecal 
water of heme-fed rats. To further study the importance of autophagy in cell resistance, 
siRNA-mediated invalidation of genes involved in autophagy may be considered, for example 
invalidation of Beclin1, ATG5 (autophagy-related gene 5) or ATG7 (autophagy-related gene 
7) in CTA cells. This invalidation is expected to sensitize CTA cells to HNE or fecal water of 
heme-fed rats. In vivo studies have reported that inactivation of ATG7 or ATG5 down-
regulated autophagy and suppressed tumor growth in Min or azoxymethane/dextran sodium 
sulfate-injected mice respectively by enhancing apoptosis in tumor cells [398,476,477]. 
 In vivo experiments to verify the role of autophagy in colorectal carcinogenesis would 
also be interesting to carry out. Injection of autophagy-modulating substances  (rapamycin to 
induce autophagy or wortmannin to inhibit autophagy) can be done in Min mice fed with 
sources of heme iron (hemoglobin, hemin or red meat). Afterwards, the intestinal 
tumorigenesis can be observed. Firstly, preliminary experiments should be conducted by 
injecting the mice with autophagy-modulating substances (rapamycin or wortmannin) to 
verify whether these substances modulate autophagy in the intestinal cells. Two studies 
focused on the optimization of rapamycin dosing in obtaining antiangiogenic effects against 
cancer in mice reported the usage of rapamycin intraperitoneal doses of 1.5 mg/kg/day and 8 
mg/kg/day [478,479]. In vivo studies on carcinogenesis in mice demonstrated the usage of 
wortmannin intraperitoneal doses of 0.7 mg/kg/day and 2 mg/kg/day [480,481]. The expected 
results of these experiments would be that intervention of rapamycin or wortmannin would 
reduce the intestinal tumorigenesis in heme-fed Min mice since these substances abolished the 
difference of resistance between CT and CTA cells upon exposure to heme-fed rats in vitro. 
In addition, the intestinal mucosa can also be isolated for further analyses regarding immunity 
and inflammation, particularly the production of IL-12 and the infiltration of cytotoxic CD8+ 
T cells. These parameters have been reported to be involved in the role of autophagy in 
intestinal tumorigenesis in Min mice [398,399]. 
Numerous studies have shown the beneficial effects of rapamycin in chemotherapy 
treatments against several types of cancer, including CRC. Rapamycin and its analogs have 
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been demonstrated to enhance therapeutic efficacy of chemotherapy agents in CRC in humans 
[482,483]. The mechanism by which rapamycin inhibits tumor growth is through inhibition of 
mTOR (mammalian target of rapamycin), a downstream target of phosphoinositide 3-kinase 
(PI3K)/mTOR pathway that is often activated in cancer cells and results in uncontrolled 
proliferation and metastasis [484,485]. Up to 2012, the use of rapamycin and its analogs in 
cancer treatments had been approved for renal cancer whereas its status was still under 
clinical trials for the application in other types of cancer [486]. As for wortmannin, this 
substance has also been shown to inhibit several types of cancer including breast and 
pancreatic cancer but the studies on CRC are still lacking [487-490]. Nevertheless, 
chloroquine, another autophagy inhibitor, has been reported to potentiate chemotherapy 
treatments in CRC, thereby highlighting the interest of inhibiting autophagy in cancer 
treatments [491]. 
Article 3 demonstrates that the superior basal expression of p62 in CTA cells 
compared to CT cells was involved in basal Nrf2 activation in CTA cells. Indeed, 
phosphorylated p62 (Ser 351) and Keap1 in CTA cells were constantly degraded under basal 
conditions by autophagy, indicating the occurence of p62-dependent Nrf2 activation (Chapter 
1.4.2.4). This phenomenon was not observed in CT cells. To analyze whether CTA cells 
depend on p62 to activate Nrf2 under basal conditions, p62 can be invalidated in CTA cells by 
siRNA. Afterwards, we can observe whether this p62 invalidation reduces basal level of 
nuclear Nrf2 by immunofluorescence or western blotting. p62  invalidation can also be done 
to impair autophagy in CTA cells and observe whether autophagy impairment in CTA cells 
modulates their sensitivity to HNE or fecal water of heme-fed rats. The expected results 
would be that p62 invalidation reduced autophagy level in CTA cells upon exposure to HNE 
or fecal water of heme-fed rats. Furthermore, in vivo experiments using heme-fed p62-
knockout mice or rats can also be done to study the role of p62 in red meat-induced colorectal 
carcinogenesis, especially regarding autophagy and Nrf2 status. Indeed, dysregulation of p62 
has been reported to be associated with CRC proliferation [492,493]. Lastly, the role of 
antioxidants in modulating autophagy in CT and CTA cells would also be worth investigating. 
Several in vitro studies have reported that curcumin and pterostilbene induced autophagy in 
human cancer cell lines [494-497]. In terms of CRC, a study has shown that curcumin induced 
human CRC cell death via down-regulation of p62 expression [498]. 
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5.3.3. Other mechanisms that are probably involved in the resistance of preneoplastic 
cells to HNE or fecal water of heme-fed rats 
Beside the differential of Nrf2 and autophagy in normal and preneoplastic cells, other 
mechanisms are also suspected to be involved in the resistance of preneoplastic cells upon 
exposure to HNE or fecal water of heme-fed rats. Based on the preliminary results obtained 
within the team, the level of reactive oxygen species (ROS) and ER stress are suggested to be 
involved in such resistance. 
 The level of ROS has been shown to be generally more elevated in human colon 
tumoral tissues than in non-tumoral tissues [499-501]. Experiments within the team using 
H2DCF-DA (dihydrodichlorofluorescein diacetate) to evaluate cellular oxidative status 
revealed that basal ROS level was higher in APC Min/+ cells than in APC +/+ cells. Higher 
basal ROS level in APC Min/+ and CTA cells may explain their higher basal Nrf2 activity 
compared to APC +/+ and CT cells, through the oxidation of the cystein residues of Keap1 
and the liberation of Nrf2. In CT and CTA cells, we did not observe different basal ROS 
level. Nevertheless, higher basal Nrf2 activity in CTA cells compared to CT cells is suggested 
to be due to p62-dependent degradation of Keap1 that activates Nrf2.  
 ER stress is defined as disruption of ER function that causes an accumulation of 
misfolded and unfolded proteins in the ER lumen. In the cells, ER functions to properly fold 
and process secreted and transmembrane proteins. ER stress activates a signaling network 
called unfolded protein response (UPR) to alleviate this stress and restore ER homeostasis, 
promoting cell survival and adaptation. Failure of UPR promotes apoptosis [502]. ER stress is 
linked to Nrf2 via splicing of XBP1 and increased expression of Hrd1, an E3 ubiquitin ligase 
that ubiquitylates Nrf2 for further degradation by proteasome [274] (Figure 24C, Chapter 
1.4.2.3). Based on my preliminary results, the expression of XBP1s (spliced XBP1) and Hrd1 
tended to increase only in CT cells but not in CTA cells upon 2 h exposure to HNE (Figure 
49). This indicates that HNE provokes stronger ER stress in CT cells than in CTA cells and 
this ER stress contributes to Hrd1-dependent negative regulation of Nrf2 in CT cells. Higher 
HNE-induced ER stress in CT cells  might be caused by lower basal Nrf2 activity in CT cells 
that led to their lower expression of HNE detoxification enzymes compared to CTA cells. 
Indeed, HNE has been demonstrated to be able to induce ER stress based on its ability to form 
adducts with proteins [210,503]. For further studies regarding ER stress following HNE 
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exposure, ER stress in CT and CTA cells can be validated by analyzing all three pathways of 
ER stress: IRE1, PERK and ATF6 as discussed in Chapter 1.4.2.3.  
 
 
 
 
 
 
Figure 49. Western blotting analysis and densitometry of XBP1s and Hrd1 (n=3) in 
CT and CTA cells following treatment with HNE 20 µM (t=2 h). β-actin was used as loading 
control. * Significant difference between CT and CTA (p<0.05). # Significant difference in a 
cell line compared to control (p<0.05). 
 
5.4. Fecal aldehydes determine in part the difference of apoptosis between normal 
and preneoplastic cells upon exposure to HNE or fecal water of heme-fed rats 
In Articles 1 and 2, to analyze the importance of aldehydes derived from lipid 
peroxidation in fecal water, the depletion of fecal aldehydes was optimized by using carbonyl-
trapping resin (CTR). This depletion appeared to abolish the differential of apoptosis observed 
in normal and preneoplastic cells upon exposure to HNE or fecal water of heme-fed rats. 
Supporting this finding, exposure to fecal water control obtained from standard diet-fed rats 
also did not provoke difference of apoptosis in normal and preneoplastic cells. These results 
show the importance of lipid peroxidation-derived aldehydes in the promotion of colorectal 
carcinogenesis by generating positive selection of preneoplastic cells over normal cells. 
It is noteworthy that CTR does not only trap aldehydes in the fecal water, but all 
carbonyl compounds present in the fecal water. Apart from aldehydes, other carbonyl 
compounds that may present in the fecal water are ketones, carboxylic acids and esters. 
Regarding the chemical specificity of CTR towards carbonyl groups, CTR is very unlikely to 
bind with other potentially toxic molecules present in the fecal water, such as bile acid, 
bilirubin and lysophospholipids. Therefore, our study did not demonstrate that aldehydes were 
the sole responsible for different fecal water toxicity towards normal and preneoplastic cells. 
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Nevertheless, aldehydes are in part responsible for such a different fecal water toxicity since 
the reduction of TBARS and free HNE in CTR-treated fecal water was positively correlated 
with the abolition of different fecal water toxicity towards normal and preneoplastic cells. 
To verify the effect of lipid peroxidation-derived aldehydes in colorectal 
carcinogenesis in vivo, especially HNE, a study using azoxymethane-injected rats fed with a 
precise amount of HNE is conducted in our team. The preliminary results showed that fecal 
water of HNE-fed rats was more cytotoxic to APC +/+ cells compared to APC Min/+ cells, as 
analyzed by time-lapse microscopy using fluorochrome for the detection of caspase-3/7 
activity. Upon the completion of this study, the formation of preneoplastic lesions (ACF or 
MDF) in the colon can be observed and isolated from normal adjacent tissues by laser 
capture/cutting microdissection (LCM). Afterwards, the level of autophagy, Nrf2 or the 
expression of HNE detoxification enzymes can be analyzed and compared between the 
preneoplastic lesions and the normal tissues.  
Since HNE is an aldehyde existing among a plethora of molecules present in fecal 
water of heme-fed rats, a question remains to answer: is HNE the sole agent determining the 
different fecal water toxicity between normal and preneoplastic cells? Or is it used only as a 
model for lipid peroxidation? Previously, in Articles 1 and 2, we showed that aldehydes were 
in part responsible for the different toxicity of fecal water of heme-fed rats in normal and 
preneoplastic cells. Therefore, it appears interesting to carry out studies to identify different 
potential aldehydes present in fecal water of heme-fed rats, especially those that are present in 
relatively high amount and strongly modulated by heme intake. This can be done by 
aldehydomics, a method for identifying aldehydes present in samples (fecal water) without “a 
priori” and analyzing their concentration. This method, that is developed in our team, can be 
done by using a probe that traps carbonyl compounds in the fecal water, followed by the 
analysis of the trapped carbonyl compounds by liquid chromatography coupled with high 
resolution mass spectrometry (LC/HRMS). Following aldehydomics, the relevant potential 
aldehydes can then be screened, for example in terms of their toxicity by treating epithelial 
colon cells with these purified aldehydes and analyzing their viability by WST-1 activity. This 
would allow the identification of  pertinent aldehydes as fecal biomarkers of the promotion of 
colorectal carcinogenesis associated with red meat. In addition, aldehydomics would also 
allow to identify the carbonyl compounds in fecal water that are trapped by CTR because like 
CTR, the probe used in aldehydomics does not only trap aldehydes but all carbonyl 
compounds present in fecal water. 
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Chapter VI 
CONCLUSIONS 
 
 My thesis allows to highlight the importance of heme-induced lipid peroxidation in the 
promotion of colorectal carcinogenesis by using biological matrix. Heme iron in hemoglobin 
or red meat, through its role as a potent catalyst for  lipid peroxidation in the lumen of the 
colon, gives rise to the formation of cytotoxic aldehydes in the fecal water of heme-fed rats. 
One of these aldehydes is 4-hydroxy-2-nonenal (HNE), that was used in this study as a model 
for lipid peroxidation. HNE or fecal water of heme-fed rats exerted preferentially higher 
toxicity towards mouse-origin normal colon cells compared to colon cells with APC mutation 
(preneoplastic) in vitro. This finding was also extrapolated in human model by using human 
colonic epithelial cells (HCECs). APC knockdown HCECs (representing preneoplastic 
phenotype) were more resistant than wild type HCECs towards HNE or fecal water of heme-
fed rats. This difference of resistance between normal and preneoplastic colon cells may 
explain the promotion of colorectal carcinogenesis through the positive selection of 
preneoplastic cells by fecal water of heme-fed rats. Fecal aldehydes were in part responsible 
for the different toxicity of fecal water of heme-fed rats towards normal and preneoplastic 
cells. 
 Furthermore, my thesis also points out autophagy (in human model) and Nrf2-
dependent antioxidant responses (in mouse and human models) as mechanisms that are 
potentially involved in the resistance of preneoplastic cells to the toxicity of HNE and fecal 
water of heme-fed rats. Autophagy and Nrf2 were more up-regulated in preneoplastic colon 
cells compared to normal colon cells, both under basal conditions and upon exposure to fecal 
water of heme-fed rats. These mechanisms were suggested to be protective to preneoplastic 
cells and invalidation of these mechanisms sensitized preneoplastic cells to fecal water of 
heme-fed rats. In human model, high basal autophagy level in APC knockdown HCECs was 
associated with Nrf2 activation mediated by autophagic protein p62.  
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